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CHAPTER I 
 
 
INTRODUCTION 
Much research has been reported on probiotics and their use in swine.  
Some of areas that have been researched are influence on growth and 
performance, sub therapeutic antibiotic replacement, improved immune function, 
and pathogen reduction. One of the most commonly used probiotics is 
lactobacilli.   
 It has been demonstrated in nursery pigs that a mixture of lactobacilli has 
the capability to enhance the immune system.  Feeding this mixture increased 
the cytokine interleukin 8 (IL-8) following a challenge of the pigs with 
lipopolysaccharide (LPS) (Walsh et al. 2008).  A combination of certain species 
of lactobacilli, when combined with selenium, improved immunoglobulin G (IgG) 
levels in weanling pigs (Yu et al. 2004).  A five-strain probiotic product, with 
species of Lactobacillus, decreased the prevalence of Salmonella Typhimurium.  
In addition, the probiotic reduced diarrhea and increased feed intake in the 
challenged swine (Casey et al. 2007).  A commercially available product that 
contained streptococci and lactobacilli improved average daily gain and feed 
intake in pigs that were subjected to stress (Estienne et al. 2005).  Various 
cultures of lactobacilli have the ability to excrete substances that are beneficial to 
the pig.  Researchers have reported lysine and amylase production by different 
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cultures of lactobacilli isolated from swine.  These secreted constituents 
improved the overall growth and performance of swine that consumed the 
cultures (Gilliland 1990, Lee et al. 2001).  Also, lyophilized L. reuteri has shown 
to improve feed conversion in Landrace piglets (Chang et al. 2001). 
The objective of this study was to evaluate eight different cultures of 
lactobacilli to determine which one(s) offer(s) the greatest potential as a probiotic 
for nursery pigs.  There were two studies involved where each study contained a 
control group and four treatment (culture) groups.  Growth and performance of 
individually housed nursery pigs were evaluated, as well as certain blood 
chemistry analytes and various components of the immune system.  Additionally, 
the possible immune enhancing effects of the probiotic cultures were tested. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
PROBIOTICS/DIRECT-FED MICROBIALS: 
 Probiotics (direct-fed microbials) are defined as “A live microbial feed 
supplement which beneficially affects the host animal by improving its intestinal 
microbial balance” (Fuller 1992).  Some of the more widely used bacterial 
probiotics include species of the following genera: Lactobacillus, Bifidobacterium, 
Propionibacterium, Enterococcus, Streptococcus, Pediococcus, Lactococcus, 
Bacillus, and Leuconostoc (Fuller 1992).  Lactobacilli and bifidobacteria are the 
most common species of direct-fed microbials (DFM) (Saarella et al. 2000).  
There are several criteria a bacterium must fulfill before it can be considered for 
use as a probiotic.  The microorganism should be included on the Generally 
Recognized As Safe (GRAS) list.  The bacterium must be able to survive, grow, 
and function in the gastrointestinal tract of the host, should be host specific, and 
acid and bile tolerant (Fuller 1992).  There have been numerous studies 
performed with lactic acid bacteria (LAB) as beneficial probiotics.  Lactic acid 
bacteria have demonstrated the ability to achieve the following:  improvement of 
the nutritional value of food, anti-carcinogenic activity, control of intestinal 
pathogens, management of serum cholesterol levels, and enhancement of 
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lactose utilization (Gilliland 1990). 
LACTIC ACID BACTERIA (LAB): 
 Lactic acid bacteria (LAB) are catalase negative, Gram positive rods or 
cocci that produce lactic acid as a major end product of fermentation (Sneath et 
al. 1986).  The bacteria are found in decomposing plant material.  The many 
genera that encompass the LAB are Lactobacillus, Lactococcus, Leuconostoc, 
Pediococcus, and Streptococcus (Sneath et al. 1986).  Lactic acid bacteria are 
often mentioned as being important to improve health.  These bacteria are used 
in cultured foods, such as dairy, vegetables, and meat, to create desired texture, 
flavor, nutritional value, and shelf-life of various foods and beverages.  
Bacterocins are antimicrobial proteins or peptides produced by some LAB.  
These compounds have known antimicrobial properties and thus may be 
important in improving shelf-live.  Lactic acid bacteria, when used as probiotics or 
DFM, have been shown to improve the health of humans and animals (Downes 
and Ito 2001). 
 Research reports have indicated probiotics and DFM improve the 
nutritional value of food.  It has been shown that natural lactic acid fermentation, 
when used on grains, can increase the nutritional availability of various nutrients.  
An increase in nutritional value of corn by lactic acid bacteria results from 
increased the availability of essential amino acids (Gilliland 1990).  Another 
nutritional value is that some LAB excrete lysine.  It has been demonstrated that 
pigs fed a diet low in protein, compared to the control, tended to have higher 
weight gains when fed a Lactobacillus strain that excreted lysine (Gilliland 1990). 
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 Lactic acid bacteria and bifidobacteria can improve the growth of piglets 
and newborn calves.  Abe et al. (2005) reported Holstein calves administered B. 
pseudolongum or L. acidophilus demonstrated a significant (P<0.05) increase in 
body weight compared to the control group.  It was also observed that the feed to 
gain ratio and feed intake was better in both DFM groups than the control.  In the 
same study, another study was done using 40 piglets.  The piglets were 
administered B. thermophilus and B. animals or the control milk replacer.  The 
mortality rate of the piglets fed Bifidobacteria was significantly (P<0.05) lower 
than the control.  In addition, it was revealed that the pigs fed direct-fed 
microbials had higher weight gains than the control. 
Swine have often been used as animal models to study lowering of 
cholesterol by lactobacilli.  One report that used Göttingen minipigs revealed a 
lowering effect on serum cholesterol levels using a cocktail of two strains of L. 
johnsonii and one strain of L. reuteri all isolated from pigs.  This was associated 
with an increase in numbers of Lactobacillus in the feces (Du Toit et al. 1998).  In 
a study done by De Rodas et al. (1996), Yorkshire barrows were used to test the 
effects of lowering cholesterol using a combination of a strain of L. acidophilus 
and calcium.  It was revealed that the DFM and the calcium tend to boost the 
reduction of serum cholesterol.  The swine in the latter studies were fed a high 
cholesterol diet.  This is helpful in understanding the way the human system 
works, since swine are closely related to humans when it comes to the treatment 
of hypercholesterolemia. 
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Lactic acid bacteria have been shown to decrease numbers of microbial 
intestinal pathogens.  A major foodborne pathogen is Escherichia coli O157:H7.  
It was first identified as a pathogen in the early 1980’s and has been a continual 
problem in the food industry (Brashears et al. 1998).  Smith et al. (2005) reported 
that E. coli O157:H7 was inhibited in ground beef by a cocktail of LAB by 3 log 
cycles after 3 days at refrigeration temperatures.  Another study done by Gilliland 
and Speck (1977) revealed a decrease of E. coli using L. acidophilus strains 
when grown in associative broth cultures.  This study showed as much as an 
87% inhibition of E. coli by a strain of L. acidophilus.  Lactobacilli also have the 
capability to inhibit other pathogens, such as Salmonella Typhimurium, 
Staphylococcus aureus, and Clostridium perfringens, in associative broth 
cultures (Gilliland and Speck 1977).  Lactobacilli have also been shown to 
decrease E. coli O157:H7 in fecal shedding of cattle (Younts-Dahl et al. 2005).   
LACTOBACILLUS REUTERI AND REUTERIN PRODUCTION: 
 Lactobacillus reuteri is a heterofermentative, non-spore forming bacterium 
that is found in the gastrointestinal tract of animals and humans.  Named after a 
German bacteriologist, G. Reuter, L. reuteri is a Gram positive lactic acid 
bacterium that is a slightly bent rod that can occur in singles, pairs, or small 
clusters.  The mesophilic bacterium grows at 45°C, is catala se negative, and 
produces ammonia from arginine (Sneath et al. 1986). 
Lactobacillus reuteri as a Probiotic/Direct-fed Microbial: 
Lactobacillus reuteri has been used in many different animal species as a 
direct-fed microbial and humans as a probiotic.  Yogurt supplemented with L. 
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rhamnosus and L. reuteri was fed to twelve Nigerian HIV positive women at a 
concentration of 2.5 x 109 cfu/mL.  The supplemented yogurt eliminated nausea, 
diarrhea, and flatulence in all 12 treatment patients compared to 2 of the 12 
control patients.  The treatment group also exhibited an overall increase in 
cluster of differentiation 4 (CD4) counts; therefore, increasing the immune system 
(Anukam et al. 2008). 
Mukai et al. (2002) tested the competitive binding of L. reuteri and 
Helicobacter pylori to H. pylori glycolipid receptor molecules, sulfatide and 
gangliotetraosylceramide (asialo-GM1).  The objective of the study was to see if 
L. reuteri competed for the same glycolipids as H. pylori.  The L. reuteri TM105 of 
chicken origin and the laboratory isolate strain JCM1081 both bound to the 
asialo-GM1 and sulfatide glycolipids, thus preventing H. pylori from binding.  It 
was suggested that the lactobacilli produced a cell surface protein that inhibited 
H. pylori binding. 
Lactobacillus reuteri was used in a survival and persistence swine study 
that was reported by De Angelis et al. (2007).  The treatment pigs were fed a 
cocktail of L. plantarum 4.1 and L. reuteri 3S7 at 1010 viable cells per day where 
as the control group was not.  The L. reuteri survived in the gastrointestinal tract 
of the pigs and was able to persist in the feces at 106 – 108 cfu/g for six days 
after administration. 
Fermented milk containing the probiotic L. reuteri was fed to swine 
(Ratcliffe et al. 1986).  An additional treatment was yogurt that contained L. 
acidophilus and Streptococcus thermophilus.  The results revealed that the 
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fermented milk and yogurt treatments did not differ significantly with both causing 
increases in total lactobacilli and decreases in Enterobacteriaceae. 
Reuterin: 
Lactobacillus reuteri produces a low molecular weight compound known 
as reuterin (Sung et al. 2003).  Reuterin or β-hydroxypropionaldehyde (3-HPA) is 
produced under anaerobic conditions from the fermentation of glycerol.  Reuterin 
is an antimicrobial compound that is water soluble, resistant to lipolytic and 
proteolytic activity, and active at a very wide pH spectrum (Arqués et al. 2004).  It 
also has a wide antimicrobial range against Gram positive and Gram negative 
bacteria, along with protozoa, yeast, and molds (Kabuki et al. 1997, Cleusix et al. 
2007). 
Researchers reported in 2008 the sensitivity of intestinal bacteria to 
reuterin produced from L. reuteri ATCC 55730.  Most of the bacteria tested, 
including E. coli, were inhibited by concentrations of 7.5-15.0 mM.  Bacteroides 
species, Bifidobacterium species, Eubacterium species, and Clostridium difficile 
displayed a sensitivity of less than 7.5 mM of reuterin.  However, certain species 
of lactobacilli and Clostridium clostridioforme displayed a resistance of 15.0 to 
50.0 mM of reuterin (Cleusix et al. 2008). 
Reuterin also has been tested in dairy products.  Various concentrations 
of reuterin were tested to study the antagonistic effect toward Listeria 
monocytogenes and E. coli O157:H7 in milk and cottage cheese.  Results 
revealed that the reuterin had a more inhibitory effect on the E. coli O157:H7 
than the L. monocytogenes.  Reuterin did, however, show a bactericidal effect on 
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both pathogens in the milk and cottage cheese.  It was also discovered that the 
supplementation of 3% salt improved the effects of reuterin (El-Ziney and 
Debevere 1998). 
Another dairy study tested reuterin (R) in inoculated caujada, a dairy 
product manufactured in Spain, for control of the foodborne pathogens L. 
monocytogenes and S. aureus.  It was observed that when the reuterin was 
added to the caujada there was a slight or minimal inhibition of the pathogens.  
However, when the reuterin was added with nisin (N) and lactoperoxidase (LPC) 
system, inhibition was seen.  After day 12 the R + N + LPS combination 
produced the best results with L. monocytogenes being non-detectable and the 
S. aureus counts displaying a five log cycle decrease compared to the control 
(Arqués et al. 2008). 
GASTROINTESTINAL TRACT MICROFLORA IN SWINE: 
The gastrointestinal tract of swine is heavily populated with 
microorganisms.  There are approximately 107 - 109 cfu/g in the stomach, 109 
cfu/g in the distal small intestine, and 1010 - 1011 cfu/g in the large intestine.  
Some of the common genera that dominate these areas are Lactobacillus, 
Streptococcus, Peptococcus, Eubacterium, Bacteroides, Bifidobacterium, and 
Clostridium with over 90% of the bacteria being Gram positive (De Angelis et al. 
2006, Barnes 1986).  The genera of most importance are Lactobacillus and 
Streptococcus because of their capability to help the gut function properly and 
improve health (Mare et al. 2006).  It is believed that the first inhabitants of the 
 10
swine intestinal tract are streptococci and Enterobacteriaceae; however, 
lactobacilli counts do increase immensely after a week of birth (Natio et al. 1995). 
It is suggested that Lactobacillus ssp. exist predominantly in the small 
intestine at cell numbers between 107 – 109 cfu/mL (Mare et al. 2006).  A report 
by Naito et al. (1995) described that the most common species of lactobacilli in 
the piglet are L. acidophilus and L. reuteri.  It was observed that the first 
Lactobacillus that appeared in the piglets’ intestines was L. reuteri, which was 
isolated on the first day of birth.  Lactobacillus acidophilus first colonized the gut 
after a week of birth.  It was also observed that the isolated lactobacilli were from 
the dams, as well as, the environment.  Lactobacilli, along with species of 
Bacillus, Bifidobacterium, Enterococcus, and Saccharomyces, are common 
probiotics associated with swine (Mountzouris 2006).  There are many uses for 
lactobacilli in swine as probiotics, such as, control of intestinal pathogens, 
eliminating antibiotic usage, and an increase in growth and performance. 
DIRECT-FED MICROBIALS IN SWINE: 
Xenotransplantation: 
There have been numerous applications of lactobacilli direct-fed 
microbials in swine.  One new use of lactobacilli as a beneficial dietary adjunct is 
for swine being grown for xenotransplantation.  Germfree piglets orally inoculated 
once with Lactobacillus paracasei ssp. paracasei GS-1, a pig isolate, at two days 
of age did not have a significant effect on piglet growth.  A few reasons for this 
insignificance could be that the L. paracasei GS-1 was utilizing nutrients for its 
own biological activities or it was causing an inflammatory response in the 
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intestine that affected nutrient utilization.  It was also stated that this microbe 
could have the potential to cause an infection in these xenotransplant swine by 
infecting the blood and non-alimentary tissue (Loynachan et al. 2005).  This is a 
problem if the organs from the porcine are going to be used for human organ 
transplantation. 
Feed Additive: 
Another area for the use of lactobacilli in swine is as an additive in pelleted 
feeds.  De Angelis et al. (2006) subjected thirty-five pig isolates to a number of 
tests to determine if the isolates could survive in the stomach and intestinal tract 
of the pig.  Additionally, they did tests to determine if the cultures might have 
antimicrobial activities against pathogens, viability after freeze drying, and be 
resistant to heat during feed pelleting.  The results revealed that two subspecies 
of lactobacilli, L. plantarum and L. reuteri, had the capability to survive in high 
numbers in all of the latter conditions, thus making them possible swine feed 
additive DFM. 
Pollmann et al. (1980) tested two commercially available swine feed 
additives to determine the effects on growth and performance of starter and 
finisher pigs.  Probios, containing L. acidophilus, and Feed-Mate 68, that 
contains S. faecium type Cernelle 68, were the DFM products used.  Pigs fed 
Probios were superior in performance when compared to the pigs fed S. faecium.  
It was also observed that the DFM, Probios, performed better on starter pigs than 
on finishers. 
Control of Viruses: 
 12
Kritas and Morrison (2007) evaluated the influence of feeding 
Lactobacillus casei ssp. rhamnosus for the treatment of porcine reproductive and 
respiratory syndrome (PRRS).  The direct-fed microbial was ingested orally 
through the water system at 6 x 109 cfu per day.  Although the DFM did not have 
an effect on immune response in a way to affect PRRS virus, it did contribute a 
benefit in regards to average daily gain after pigs were challenged with the virus. 
Antibiotic Alternative: 
A freeze dried culture composed primarily of Lactobacillus acidophilus was 
used to test its effects on growth performance of swine when compared to the 
antibiotic virginiamycin.  The results revealed that this commercial DFM did not 
improve feed intake, feed efficiency, or average daily gain (Harper et al. 1983).  
The reason for this occurrence could be that the bacteria were not isolated from 
the host it was used in or its benefits in the swine were elsewhere.  Another 
reason for no significant difference could have been from the low concentration 
of the DFM, 4 x 106 viable cells per gram.  Maybe the concentration of the direct 
fed microbial should have been higher in order to have an effect on the animal 
(Fuller 1992). 
 A total of 21,755 nursery pigs were used to test the efficacy of the product 
BioPlus 2B against subtherapeutic antibiotic usage.  BioPlus 2B is a probiotic 
that contains B. licheniformis and B. subtilis.  There was no difference in feed to 
gain ratio, mortality rate, daily gain, daily feed intake, or feed cost per pig when 
compared to the control animals.  Therefore, this DFM could be used in place of 
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the subtherapeutic antibiotics with no negative consequences (Kritas and 
Morrison 2005). 
Increased Immunity: 
Improving the health status of the swine industry by enhancement of the 
immune system is another area where direct-fed microbials have exhibited 
positive effects.  A five-strain DFM product containing 2 strains of L. murinus, and 
one strain each of L. pentosus, L. salivarius, and Pediococcus pentosaceus was 
administered to Large White x Landrace crossbred weaned pigs.  It was 
observed that the peripheral cluster of differentiation 4 and 8 plus T cells 
(CD4+CD8+T cells) were significantly (P<0.05) higher in the pigs fed DFM than 
the controls, 7.1% vs. 5.2%.  After a lipopolysaccharide (LPS) challenge, the 
DFM group displayed a significant (P< 0.05) increase in the cytokine, interleukin 
8 (IL-8), when compared to the control.  Therefore, the DFM pigs exhibited an 
increased immune system when compared to the control pigs (Walsh et al. 
2008). 
When direct-fed microbials were combined with selenium a positive effect 
on swine immunodulation was observed.  A total of ninety-six weaned pigs were 
randomly allotted to four treatment groups.  The treatments were as follows: 
control, 0.3% DFM (L. acidophilus, L. pentose, and B. subtilis), 0.3% DFM + 0.3 
ppm of organic selenium, and 55 ppm of carbadox.  One week before the end of 
the trial, LPS was injected in the neck of each pig.  The production of 
immunoglobulin G (IgG) was significantly (P<0.05) higher in the DFM + selenium 
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pigs than control pigs.  However, the other treatments also exhibited a trend 
toward higher IgG concentrations than did the controls (Yu et al. 2004). 
Another study tested the effects of two different DFM feed additives that 
are approved in the European Union.  The probiotics of interest were Cylactin® 
(Enterococcus faecium NCIMB 10415) and Toyocerin® (Bacillus cereus var. 
toyoi NCIMB 40112).  The study included two separate trials.  In the both trials, 
Landrace x Duroc sows were randomly allocated into two groups, control or 
direct-fed microbial.  Sows were fed the DFM 25 days after fertilization and the 
entire lactation period.  Piglets of the DFM group had full access to the feed 
supplements 15 days after parturition, during weaning, and post weaning.  
Bacillus cereus increased immunoglobulin A (IgA) levels in the intestines in the 
sows.  This DFM also showed an increase in the fecal IgA concentrations in the 
piglets from the DFM group right after weaning (Scharek et al. 2007). 
Pathogen Elimination and Prevention: 
Lactobacilli have been used in swine to reduce numbers of pathogens 
and/or potential pathogens present in the intestines and/or feces.  Maré et al. 
(2006) revealed a decrease in colonization in pigs inoculated with Enterococcus 
faecalis.  The direct-fed microbials used were L. plantarum and L. salivarius.  The 
L. salivarium was of porcine origin.  However, the L. plantarum isolate was 
isolated from sorghum beer and thus tolerated low pH.  The study stated that the 
E. faecalis was inhibited only by 25% in the ileum by the L. salivarius.  It was 
stated that the reason for the L. plantarum colonization of the ileum and colon 
was because the microbe was capable of withstanding the low pH of the small 
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intestine and thus could colonize the lower gut.  Lactobacillus plantarum showed 
no effect on inhibition of E. faecalis. 
Research reported by Gardiner et al. (2004) revealed a decrease in mean 
numbers of fecal Enterobacteriaceae by L. salivarius, L. pentosus, Pediococcus 
pentasaceus and a DFM cocktail (L. salivarius, L. pentosus, P. pentasaceus and 
two strains of L. murinus).  The mean reduction in counts for the treatments were 
98%, 97%, 87%, and 97%, respectively, 21 days after culture inoculation.  
However, the control had a mean reduction of 83%.  This revealed no significant 
differences among the control. 
An in vitro report studied the effects on adhesion of Escherichia coli K88, 
which causes post-weaning diarrhea, when porcine lactobacilli DFM were 
present (Blomberg et al. 1993).  Using ileal mucus from a 35-day-old pig 
revealed proteins produced by each of the three lactobacilli caused an 
approximate 50% reduction in adhesion of E. coli K88 cells.  The study should be 
done in vivo to further confirm their results. 
Salmonella is one of the major culprits of gastroenteritis in humans; 
therefore, the elimination of the pathogen in swine is a must (Mead et al. 1999).  
A five-strain DFM product (two strains of L. murinus, L. pentosus, L. salivarius, 
and Pediococcus pentosaceus) was tested for ability to inhibit Salmonella in 
swine.  There were three different treatments, a control, fermentate, and cell 
suspension.  The pigs were fed for a total of 30 days.  Six days after stopping the 
DFM, the crossbred pigs were challenged with Salmonella Typhimurium.  There 
was a significant (P=0.01) reduction of Salmonella in the feces of both the 
 16
fermentate and suspension.  Also, there was a reduction in diarrhea and a 
greater weight gain for the two direct-fed microbial treatments (Casey et al. 
2007). 
Growth and Performance: 
Improving growth and performance of an animal has always been favored.  
There have been numerous studies performed that use lactobacilli as a direct-fed 
microbial in the swine industry to increase growth and performance.  Estienne et 
al. (2005) used a commercially available swine DFM that contained lactobacilli 
and streptococci.  This study revealed that there was no significant difference in 
pre-weaning performance.  However, when the piglets were mixed (non-
littermate litters), there was a significant (P=0.05) increase in average daily gain 
and feed consumption of the mixed pigs.  In this case, the DFM helped piglets 
that were subject to stress. 
It has been demonstrated that Lactobacillus acidophilus can improve the 
starch utilization of feed in swine.  After various tests were done, a L. acidophilus 
isolated from swine, which had a high amylolytic activity, was used for a feeding 
trial.  Seventy-five Yorkshire pigs were allotted into three different treatments.  
The treatment groups were the following:  control, low (3 x 108 cells/feeding), and 
high (3 x 109 cells/feeding).  The DFM treatments demonstrated a significantly 
(P<0.05) higher average daily gain than the control.  However, only the low level 
of direct-fed microbial had a significantly (P<0.05) better feed to gain than the 
other treatments (Lee et al. 2001). 
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Chang et al. (2001) used a swine isolate of L. reuteri to test the feed 
conversion rate and live weight gain in twenty-five Landrace piglets.  The DFM 
was lyophilized and fed at two different concentrations, 106 (P6) and 108 (P8) 
cfu/g.  There were five treatment groups:  control, antibiotic fed, P6, P8, and P8 
plus antibiotics.  There was a significant (P<0.01) increase in total counts of 
lactobacilli in all of the DFM treatments.  The direct-fed microbial groups feed 
conversion rate was significantly (P<0.01) better than the other two treatments.  
The P6 and P8 treatments consumed 34% less and the P8 plus antibiotics 
consumed 11% less feed than the control groups. 
A total of 144 weaner pigs were used to test the effects of dry feed (DF) 
vs. liquid feed (LF).  While performing the experiment, the microbial activity of the 
liquid feed was tested.  It was revealed that the liquid feed was heavily populated 
with lactobacilli after five days and resembled a fermented feed.  Results 
revealed that the LF pigs had a significantly (P<0.001) better daily gain than the 
DF pigs suggesting that the lactobacilli were at least partially responsible 
(Russell et al. 1996). 
Direct-fed microbials have shown a potential to improve the performance 
of sows.  A total of thirty-three first parity German Landrace sows were assigned 
to one of two groups (control or DFM).  Enterococcus faecium DSM 7134 was 
fed to the DFM sows as a premix at 5 x 108 cfu/kg from day 90 of pregnancy until 
day 28 of lactation.  There was a significant (P<0.03) difference in daily feed 
intake during lactation with the DFM sows consuming 0.45 kg/day more.  The 
number of piglets born alive was significantly (P<0.05) higher in the DFM-fed 
 18
sows (9.2 vs. 7.7 piglets/litter).  There was a trend to decrease mortality in the 
direct-fed microbial group than the control, 9% and 11%, respectively (Böhmer 
2006). 
There are many different potential benefits of Lactobacillus species as a 
DFM in swine.  It is generally accepted that to have a positive impact on the 
animals it should be host specific and capable of surviving the stomach and 
gastrointestinal tract.  However, it also should be understood that not every 
isolate of lactobacilli has positive effects on its host, in this case, a pig. 
FOODBORNE PATHOGENS IN SWINE: 
Salmonella: 
 Salmonella was first isolated from meat that had caused food poisoning in 
1888 by Gaertner (Jay 2000).  The bacterium is a Gram negative rod that is a 
facultative anaerobe (Krieg 1984).  Salmonella are primarily found in the 
intestines of farm animals, humans, birds, reptiles, and rarely insects (Jay 2000).  
Some of the general symptoms of salmonellosis are fever, abdominal cramping, 
vomiting, chills, diarrhea, nausea, powerlessness and has the potential to be fatal 
(Ray 2001).  It was reported in 1999 that 1,381 deaths were due to acute 
gastroenteritis where Salmonella accounted for 31% of those deaths (Mead et al. 
1999).  The Centers for Disease Control and Prevention (CDC) reported 
approximately 40,000 cases of salmonellosis occur a year in the United States 
with roughly 400 people dying from the bacterium a year.  Salmonella is also 
more prevalent in the summer than the winter.  The most common serotypes in 
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the United States are Typhimurium and Enteritidis (Centers for Disease 
Prevention and Control 2008b). 
 The incidence of Salmonella in U. S. swine farms is distributed throughout 
the United States.  A recent study tested the prevalence of Salmonella species in 
farms for various animal species.  There were 18 farms in five states (California, 
Alabama, North Carolina, Tennessee, and Washington) tested over a 2 year 
period.  The types of swine farms included were production and farrowing.  
Various types of samples were taken including feces, rectal swabs, feed, 
bedding, soil, and litter.  The percent of Salmonella positives are as follows:  
33.3% fecal material, 16.7% fresh feed, 6.0% rectal swabs, 22.9% soil, and 
29.2% trough feed (Rodriguez et al. 2006). 
 Several Salmonella species have been discovered in slaughterhouses.  In 
1989 there was a study that reported the frequency of Salmonella and other 
pathogens on swine carcasses and the slaughterhouse atmosphere.  There were 
several different items tested for the pathogen including pig feces, diaphragms, 
slaughterhouse floor, and cold room floor.  Salmonella was discovered in 45 of 
the 448 total samples obtained which turned out to be 10% of the pigs being 
carriers.  The total number of positives were as follows:  3 of 200 diaphragms, 2 
of 16 cold room floor swabs, 4 of 16 slaughterhouse floor swabs, and 36 of 200 
feces.  The most common strain found was S. brandenburg (Mafu et al. 1989). 
 Another study tested the prevalence of Salmonella in the slaughterhouse, 
the farm the swine came from, and the trucks used for transportation.  It was 
demonstrated that S. bovismorbificans was isolated from the truck and the 
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carcasses.  Isolates of S. bredeney were recovered from the truck and cecal 
contents.  The truck, cecal contents, and lymph nodes were positive for S. Derby.  
Therefore, these species of Salmonella were introduced to the swine after the 
farm during transportation.  Isolates of S. Typhimurium were found in the swine 
and environmental samples, but never at the slaughterhouse.  However, this 
species was the most prevalent found at the farm (Magistrali et al. 2008). 
 Yet a different study reported that Salmonella Typhimurium was the most 
prevalent species detected in the slaughterhouse (Botteldoorn et al. 2003).  The 
samples collected included environmental, mesenteric lymph nodes, feces from 
the colon, and carcass.  They found 37% of the carcasses, 19% of the feces, and 
21% of the mesenteric lymph nodes were positive for Salmonella.  It was 
estimated that cross-contamination accounted for 29% of the carcass positives.  
The most prevalent Salmonella serotypes isolated from the environment and the 
feces were Typhimurium, Derby, and Livingstone.  The most prevailing bacterium 
that was isolated from the carcasses was S. Typhimurium.   
 A major concern of salmonellosis is the multidrug-resistant S. 
Typhimurium DT104.  This strain of Salmonella is usually resistant to at least 5 
drugs, which are tetracycline, ampicillin, streptomycin, chloramphenicol, and 
sulfonamides.  The first known isolate of DT104 was in the United Kingdom in the 
early 1980’s.  By the 1990’s, the isolate was worldwide.  Salmonella 
Typhimurium DT104 has been isolated from beef, sheep, pigs, and poultry 
(Helms et al. 2005).  Lee et al. (2007) acquired intestinal contents from 152 
Korean pigs.  Salmonella species were recovered from ten of the samples with 
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one isolate having the characteristics of DT104.  Another study performed by 
Farzan et al. (2008), tested 100 Ontario farms.  Seventeen percent of the farms 
tested positive for S. Typhimurium DT104.  There was a total of 80 positive 
isolates that was recovered from the swine feces and environmental samples. 
 However, it was been reported that Salmonella is more prevalent in 
antimicrobial-free (ABF) swine production systems than the conventional 
systems.  From 20 farms sampled in North Carolina (10 conventional and 10 
ABF) there were a total of 889 pigs and 743 carcasses tested for the presence of 
Salmonella.  There was a significant difference between positive Salmonella 
isolates between the conventional and ABF production systems, 4.2% and 
15.2%, respectively (Gebreyes et al. 2006). 
Campylobacter: 
 Campylobacter enteritis is considered to be the most prevalent foodborne 
pathogen in the United States, even more prevalent than E. coli and Salmonella 
(Jay 2000).  The pathogen is a Gram negative, microaerophilic spirella bacterium 
(Krieg 1984).  It is estimated by the CDC that approximately 124 people die per 
year from infections from Campylobacter.  Like Salmonella, Campylobacter 
occurs more frequently in the summer than the winter (Centers for Disease 
Control and Prevention 2008a).  The majority of the species responsible for the 
enteritis is C. jejuni.  Some of the symptoms of Campylobacter enteritis are fever, 
abdominal cramps, headache, and diarrhea.  In severe cases, the symptoms 
may include bloody stools where the diarrhea is similar to ulcerative colitis.  The 
bacterium is found in warm-blooded animals rather than the environment with a 
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large proportion of the meat animals shedding it in their feces (Jay 2000).  The 
common species in swine is C. coli (Jacobs-Reitsma 2000). 
 Campylobacter is very prevalent in antibiotic-free swine production 
systems.  Harvey et al. (1999) examined four continuous-flow farms that were 
free of subtherapeutic antibiotics for five years.  The nine month study collected 
the viscera from the pigs during slaughter and cecal contents obtained from the 
viscera were used for testing.  It was discovered that Campylobacter species 
were isolated from 70% to 100% of the swine tested.  Of the samples tested, C. 
coli was dominant followed by C. jejuni and C. lari.  The average log10 
concentrations of C. coli and C. jejuni isolates were 4.65 cfu/g.  Another study 
was done to test the prevalence of C. coli in five antimicrobial-free (ABF) herds.  
It was done to see if there was any difference in outdoor (extensive) and indoor 
(intensive) environmental systems.  The extensive swine were reared outside 
and had full access to soil.  However, the intensive swine were raised in 
confinement with slatted floors, no soil.  There were two types of samples 
obtained, farm and slaughter.  Farm samples were feces from live swine and the 
slaughter samples were carcass swabs.  Of the 546 samples collected, 526 were 
positive for C. coli, with 160 from slaughter and 366 from the farm.  There was no 
significant difference observed between the extensive and intensive rearing 
(Gebreyes et al. 2005).  One could argue that the reasons for such high numbers 
of Campylobacter are because of the continuous-flow system and from the 
elimination of the subtherapeutic antibiotics. 
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 However, Campylobacter is also ubiquitous in swine slaughter facilities 
where the pigs are housed in different swine systems.  Malakauskas et al. (2006) 
studied the prevalence of Campylobacter in the slaughterhouses.  It was 
discovered that 120 samples were positive for Campylobacter.  It was also found 
that C. coli was the most prevalent isolate and C. jejuni was second.  Another 
study by Pearce et al. (2003) tested the occurrence of Campylobacter in swine 
facilities.  A total of 360 carcasses were sampled over a 30-day period.  Just as 
in the previous study, C. coli was dominant followed by C. jejuni.  However, this 
study revealed that there was no measurable presence of Campylobacter on the 
carcasses after chilling them overnight. 
 Species of Campylobacter have been reported on uncooked retail pork.  
Of approximately 1000 uncooked retail meats from various animal species, 259 
samples were positive for Campylobacter.  Of these positive samples, 21 were 
pork products.  There were 18 C. jejuni positives and 3 C. coli positives isolated 
(Wong et al. 2007). 
 A Campylobacter species of possible concern that has been identified in 
swine is C. hyointestinalis.  A report by Gorkiewicz et al. (2002) described a case 
study where an elderly woman acquired a bacterial gastroenteritis infection.  
After many characteristics tests were performed, the infecting bacterium was 
identified as C. hyointestinalis.  Following further investigation, it was discovered 
that the isolate was acquired from a pig that the woman owned. 
Escherichia coli O157:H7: 
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Escherichia coli O157:H7 is a facultative anaerobic, Gram negative rod 
bacterium that was first identified as a foodborne pathogen in 1982 (Krieg 1984, 
Buchko et al. 2000).  Escherichia coli O157:H7 causes symptoms such as fever, 
vomiting, bloody diarrhea, hemolytic uremic syndrome, and in some cases, 
death.  It is estimated that more than 73,000 human infections occur each year in 
the U.S (Alam and Zurek 2006).  Beef and dairy cattle are known carriers of this 
pathogenic bacterium (Standford et al. 2005).  However, over the past decade, E. 
coli O157:H7 has been reported in healthy pigs in the United States, Japan, 
Sweden, and Canada (Cornick and VuKhac 2008).  It was reported that in Chile, 
the prevalence of E. coli O157:H7 was higher in swine than cattle with 
occurrence being 10.8% and 2.9%, respectively (Cornick and Helgerson 2004). 
Cornick and VuKhac (2008) reported that young adult swine, 100 to 150 lbs., 
can transmit E. coli O157:H7 indirectly.  In the study, a donor pig was inoculated 
with 5 x 108 cfu of E. coli O157:H7 by ingestion of inoculated feed.  There was a 
100% recovery of the pathogen from the pigs that had nose-to-nose contact with 
the donor and an 83% recovery from the pigs that were housed in the same room 
as the donor pig.  The reason behind the indirect transmission is likely from 
contaminated aerosols (Cornick and VuKhac 2008). 
One reason that E. coli O157:H7 isn’t observed as much in swine is the 
conditions.  One study reported by Cornick and Helgerson (2004), stated that the 
infectious dose for 3 month old pigs was 6 x 103 cfu of E. coli O157:H7.  The 
pathogen was transmitted by an infected pig at a dose less than 104 cfu/g.  Three 
of the seven pigs exposed to the donor pigs that were shedding approximately 
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102 cfu/g of the pathogen were positive.  There was a 100% transmission of the 
pathogen to naïve pigs were the donor pigs were shedding more than 104 cfu/g.  
The study also stated that there is no difference in the type of housing used, 
floors vs. decks.  Therefore, swine do not have a resistance to E. coli O157:H7 
and under the right conditions could be a reservoir for the pathogen.  A few 
reasons as to why swine have a very low occurrence of the pathogen could be 
that the farms have good management practices and the majority of the herds 
don’t have any contact with the bacterium (Cornick and Helgerson 2004). 
The National Animal Health Monitoring System (NAHMS) collected 2,526 
fecal samples from 57 swine farms in 13 of the 17 major swine-producing states.  
The samples were obtained from August 2000 to April 2001.  The fecal samples 
that were obtained were from 20 weeks or older finishers and cull sows that were 
within 10 days of slaughter.  The feces were tested for several different 
pathogens, including E. coli O157:H7.  The results revealed that only 4.2% of the 
samples tested positive for the O157 serotype (Feder et al. 2007). 
Feral swine in Central California have the ability to contract and transmit E. 
coli O157:H7.  It is assumed that the feral swine contracted the bacteria from 
cattle that were residents to the neighboring area.  The swine then possibly 
contaminated the surrounding spinach fields by fecal contamination.  The 
spinach from these fields was linked to an outbreak of E. coli O157:H7 that 
occurred in 27 U.S. states and Canada.  The outbreak led to 3 deaths and 205 
cases of illness.  It was also reported that there was E .coli O157:H7 
transmission between the feral pigs (Jay et al. 2007). 
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The first intensive testing for E. coli O157:H7 in swine was in 2003.  The 
pathogen was recovered from the colon of slaughtered swine.  Samples taken 
from the distal colon from 305 pigs were collected over an 8 month period.  
Approximately two to three inches of the feces-filled colon was obtained for 
testing.  After enrichment, characteristic tests, pulsed-field gel electrophoresis 
(PFGE), ribotyping, and polymerase chain reaction (PCR) were performed, 6 of 
the 305 samples were positive for E. coli O157:H7.  It was stated that swine do 
have the potential to harbor this foodborne pathogen (Feder et al. 2003). 
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ABSTRACT 
 
 The objective of this study was to determine the effects of different 
cultures of lactobacilli on growth and performance of nursery swine as well as 
blood chemistry and immune response.  Sixty Duroc x (Landrace x Yorkshire) 
crossbred pigs were divided into two studies with 2 experiments/study that were 
fed a typical nursery diet without antibiotics.  Study one treatments were as 
follows:  1. control milk, 2. milk + L. reuteri DS-33 (DS-33), 3. milk + L. reuteri 
WB-74 (WB-74), 4. milk + L. reuteri WB-75 (WB-75), and 5. milk + L. acidophilus 
L-23 (L-23).  Study two treatments were as follows:  1. control milk, 2. milk + L. 
reuteri DS-36 (DS-36), 3. milk + L. reuteri WB-37 (WB-37), 4. milk + L. reuteri 
WB-72 (WB-72), and 5. milk + L. reuteri WB-76 (WB-76).  The pigs were 
individually house in metabolic crates and allowed an approximate one week 
adjustment period.  The pigs were fed 10 mL of milk twice a day for 21 days.  
The culture treatment groups received the 10 mL of milk + 109 cfu/mL of the 
desired cultures twice daily.  Weights and feed (dry weight basis) were measured 
weekly.  The feed was collected, weighed, and dried.  Growth and performance 
data were obtained weekly for 3 weeks.  Blood was drawn weekly.   The serum 
was collected and analyzed for various blood analytes and immunoglobulins.  
After a 3 week feeding trial, all of the pigs were subjected to a challenge with an 
Escherichia coli O111:B4 lipopolysaccharide (LPS).  Blood was drawn and rectal 
temperatures were measured at hours 0, 1.5, 3.0, 6.0, 12, and 24.  Additionally, 
pig weights were measured at hours 0, 6, 12, and 24.  The same analyses were 
performed as mentioned before.  The results for each study were variable.  
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Cultures DS-33, L-23, and DS-36 tended to cause better feed to gain ratios than 
observed for the control groups.  Pigs fed culture L-23 exhibited a significantly 
higher total serum protein level than pigs in the control group.  A significant 
difference was observed for serum aspartate aminotransferase (AST) where the 
culture DS-33 caused a lower level than the control pigs.  The cultures WB-74, L-
23, and WB-72 tended to increase serum IgA, IgG, and IgM, respectively.  
Culture DS-36 caused a significantly lower globulin level when compared to the 
control and DS-37 groups.  Albumin:globulin ratio for pigs fed DS-36 or WB-76 
was significantly higher than the control pigs at hour 3.0.  Also, pigs fed DS-37 
showed a significant reduction of levels of total bilirubin, triglyceride, and very 
low-density lipoprotein (VLDL) at hour 12 during the LPS challenge. 
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INTRODUCTION 
 
Probiotics (direct-fed microbials) are defined as “A live microbial feed 
supplement which beneficially affects the host animal by improving its intestinal 
microbial balance” (Fuller 1992).  Some of the more widely used bacterial 
probiotics and direct-fed microbials (DFM) include species of the following 
genera: Lactobacillus, Bifidobacterium, Propionibacterium, Enterococcus, 
Streptococcus, Pediococcus, Lactococcus, Bacillus, and Leuconostoc (Fuller 
1992).  Lactobacilli and bifidobacteria are the most common species of direct-fed 
microbials (Saarella et al. 2000).  Some of these lactic acid bacteria reportedly 
have the ability to achieve the following:  improvement of the nutritional value of 
food, anti-carcinogenic activity, control of intestinal pathogens, management of 
serum cholesterol levels, and enhancement of lactose utilization (Gilliland 1990). 
Much research has been conducted on the use of lactobacilli to improve 
growth and performance of swine.  A previous study by Lee et al. (2001) reported 
the production of amylase by a culture of L. acidophilus improved feed efficiency 
in nursery pigs.  Lyophilized L. reuteri improved feed conversion in Landrace 
piglets (Chang et al. 2001).  A commercially available swine DFM, containing 
lactobacilli and streptococci, did not improve growth and performance in pre-
weaning piglets.  However, when the pigs were mixed (non-littermate litters) the 
DFM caused an increase in feed consumption and average daily gain (Estienne 
et al. 2005). 
Another area of direct-fed microbial research in swine is improving the 
immune system.  Feeding a mixture of lactobacilli to nursery pigs increased the 
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cytokine interleukin 8 (IL-8) following a lipopolysaccharide (LPS) challenge 
(Walsh et al. 2008).  During another LPS challenge immunoglobulin IgG was 
increased in weanling pigs that were administered a combination of lactobacilli, 
Bacillus, and selenium (Yu et al. 2004). 
The focus of the present study was to determine the effects of cultures of L. 
reuteri as potential use as direct fed microbials.  A total of sixty nursery pigs were 
used in two different studies.  Each study consisted of four different cultures for a 
total of eight cultures.  Feed conversions were calculated for each pig.  Blood 
serum was used to test for IgA, IgG, and IgG, as well as serum blood chemistry.  
In addition the pigs were injected with a lipopolysaccharide (LPS) at the end of 
each trial to study the effects of the cultures of lactobacilli during an immune 
response.  
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MATERIALS AND METHODS 
SWINE CULTURES: 
Source of Cultures: 
 Cultures were obtained from Oklahoma State University’s food 
microbiology culture collection.  Five isolates of lactobacilli from a Sus scrofa 
(wild boar, WB) and nine from Sus scrofa domestica (domestic swine, DS) were 
investigated.  The wild boar cultures were isolated from the small intestine of a 
wild boar in Canadian, Texas and were identified as the following based on 
phenotypic characteristics:  Lactobacillus reuteri WB-72, WB-74, WB-75, WB-76, 
and WB-78.  Eight of the domestic swine cultures were isolated from the feces of 
domestic, free ranging sows in Checotah, Oklahoma and were identified as the 
following based on phenotypic characteristics:  L. reuteri DS-29, DS-31, DS-33, 
DS-35, DS-36, DS-37, DS-38, and DS-39.  The last domestic swine culture, L. 
acidophilus L-23, was isolated from the feces of a pig that was housed in the 
swine barn at Oklahoma State University.  The latter culture was used because it 
has been shown to improve growth and performance in pigs fed a high starch-
based diet. 
Maintenance of Cultures: 
 Weekly subcultures of each swine isolate were performed by using 1% 
inocula into 10 mL of sterile Lactobacilli de Man, Rogosa, and Sharpe (MRS) 
broth (Difco Laboratories, Franklin Lakes, NJ).  The cultures were incubated at 
37°C for 18 hours.  Each culture was stored at refrigera tion temperatures (2-5°C) 
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between subcultures.  The isolates were subcultured daily three consecutive 
times before use in any assay or feeding trial. 
IDENTIFICATION OF CULTURES: 
 Cultures were subjected to the following characteristic tests:  Gram stain, 
catalase test, growth at 15°C and 45°C, arginine hyd rolysis test, and 
carbohydrate fermentation patterns using Analytab Products Inc. (API) 50 CH 
system (bioMérieux, France).   
 The following characterization tests were performed to identify the 
cultures.  Gram stains were performed on each to identify Gram positive rods.  
Those that were Gram positive were streaked on MRS agar, incubated at 37°C 
for 24 hours.  Plates were flooded with a 3% hydrogen peroxide solution.  The 
presence of effervescence confirmed a positive for catalase.  Gram positive, 
catalase negative rods were regarded to be a Lactobacillus species. 
Growth at 15°C and 45°C was performed by placing a 1%  inoculum in 10 
mL of sterile MRS broth.  Before inoculating the 15°C tubes, they were placed in 
a 15°C water bath and allowed to equilibrate to tha t temperature.  The 15°C and 
45°C tubes were incubated for 5-7 days in a water bath  and 48 hours in an 
incubator, respectively.  The arginine hydrolysis test was done by inoculating 
(1%) 10 mL of arginine broth followed by incubation at 37°C for 24 hours (McCoy 
and Gilliland 2007).  The arginine broth was prepared from individual 
components following the manufacturer’s (Difco Laboratories, Franklin Lakes, 
NJ) directions.  One drop of Nessler’s reagent (Sigma-Aldrich, St. Louis, MO) 
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was mixed with one drop of each culture.  The production of ammonia from 
arginine was indicated by an orange/gold precipitate.  The fermentation patterns 
of the cultures were performed by using the API 50 CH system following the 
manufacturer’s directions except that the strips were incubated in a Gas Pak 
anaerobic jar rather than placing mineral oil into each cuplet.  The species of the 
cultures of lactobacilli were determined by comparing results from growth at 15°C 
and 45°C, ammonia production from arginine, and the carbohydrate fermentation 
patterns to those of the lactobacilli in the 9th Edition of Bergey’s Manual of 
Determinative Bacteriology (Sneath et al. 1986). 
BILE TOLERANCE ASSAY: 
 Bile tolerance assay was performed on each isolate as described by 
Walker and Gilliland (Walker and Gilliland 1993).  However, the following 
exceptions were made to the method.  The cultures were inoculated with 1% 
inoculum in 10 mL of MRS broth + 0.3% oxgall (Difco Laboratories, Franklin 
Lakes, NJ).  Each tube was incubated in a 37°C water ba th for seven hours.  
Absorbance readings at 620 nm were measured using a Milton Roy Spectronic 
21D UV/VIS Spectrophotometer (Rochester, NY).  Comparisons of cultures were 
based on the increases in absorbance from 0 to 4 hour.  The assay was 
performed twice. 
FEEDING STUDIES: 
Preparation and Plating of Cultures: 
 The control milk was a 10% reconstituted skim milk solution that was 
resuspended with deionized water.  Four hundred milliliters of reconstituted milk 
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was brought to a boil, allowed to cool, and aliquoted to four 250 mL sterile bottles 
(100 mL each).  The bottles were stored in the refrigerator (2-5°C) for no longer 
than 3 to 4 days.  Control milk was prepared every 3 to 4 days. 
 Frozen concentrated cultures of the swine isolates were prepared as 
described by Gilliland and Rich (Gilliland and Rich 1990) with the following 
exception.  The cultures were grown statically in 500 mL of sterile MRS broth for 
18 hours at 37°C.  The concentrated cultures were stored  in liquid nitrogen until 
needed.  The frozen cultures were prepared two to three weeks before the start 
of each experiment.  The number of viable cells per vial was verified by the pour 
plate method using appropriate decimal dilutions on MRS agar with an overlay.  
Sterile diluents were 0.1% peptone (Difco Laboratories, Detroit, MI) and 0.001% 
Antifoam A (Sigma-Aldrich, St. Louis, MO) in deionized water.  The plates were 
incubated at 37°C for 48 hours.  The appropriate numb er of vials were thawed in 
cold tap water (100 mL of water/vial) and added to 400 mL of milk prepared as 
the control milk for a concentration of 1 x 108 cfu/mL.  The control milk was 
prepared as described earlier.  The 400 mL of milk containing the lactobacilli 
were distributed into four sterile 250 mL bottles (100 mL each) and stored at 2-
5°C for no longer than four days.  Treatment milk was prepared fresh every 3 to 4 
days until the end of each experiment. 
 The control and treatment groups were plated by the pour plate method 
with an overlay on MRS agar on day 0 and day 3 following preparation to confirm 
the appropriate concentration of cells was being administered.   
Feeding Studies: 
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 Each experiment consisted of fifteen Duroc x (Landrace x Yorkshire) pigs 
of the same sex (gilts or barrows) that were randomly allocated into one of five 
treatments at 3 replicates per treatment per experiment for a total of 6 replicates 
per treatment.  The range of the pigs’ ages when the experiments began were 
between 33 – 47 days of age.  The pigs were randomly blocked by body weight 
and ancestry and housed in a controlled environment in individual metabolic 
crates manufactured by Alternative Design (Springdale, AR).  There were two 
sets of treatments with two experiments per treatment study.  Each set of 
treatments contained 30 pigs with an equal number of barrows and gilts.  Study 
one treatments were as follows:  1. control milk, 2. milk + L. reuteri DS-33, 3. milk 
+ L. reuteri WB-74, 4. milk + L. reuteri WB-75, and 5. milk + L. acidophilus L-23 
(Appendix B Table B2).  Study two treatments were as follows:  1. control milk, 2. 
milk + L. reuteri DS-36, 3. milk + L. reuteri WB-37, 4. milk + L. reuteri WB-72, and 
5. milk + L. reuteri WB-76 (Appendix C Table C2).  Each pig received 10 mL 
twice a day of their respective treatment for three weeks.  A one week 
adjustment period was used prior to the treatment period to permit the pigs to 
adjust to the crates, diet, and administration of the control milk.  The pigs were 
fed ad libitum of a ground corn-soybean meal diet without antibiotics (Table 1).  
(The diet nutrients exceeded requirements based on the swine National 
Research Council (NRC).)  After the adjustment period, the experiment was 
started by recording the appropriate baseline measurements (day 0).  The 
pounds of feed consumed were recorded for each pig.  Any wasted and/or 
uneaten feed from each pig was collected, dried, and weighed weekly.   
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Consumed and wasted/uneaten feed was used to calculate average daily feed 
intake and feed efficiency.  Body weights were measured weekly and used to 
calculate average daily gain and feed to gain ratios.  After each replication, the 
metabolic crates were washed with detergent and rinsed with water, thus 
disinfected. 
PLATING, ENRICHMENTS, AND BAX® SYSTEM: 
Plating: 
 Fecal samples, obtained by rectal palpation, were collected weekly from 
each pig.  The person(s) taking the samples wore Nitrile gloves.  However, if 
feces could not be obtained by this method, an apparent freshly voided fecal 
dropping was obtained from the pig’s metabolic crate.  New gloves were worn for 
each pig to prevent cross contamination.  Feces were kept on ice no longer than 
2 hours until plating could be accomplished.  One gram of feces was weighed 
into a sterile Whirl-Pack filter bag (Nasco, Fort Atkinson, WI) and a 99 mL sterile 
diluent was added and pummeled for 60 seconds using an IUL Masticator (IUL 
Instruments, Barcelona, Spain).  Additional dilutions were prepared as described 
earlier and plated with an overlay using the pour plate technique on Lactobacillus 
selection agar (LBSA) and Violet Red Bile agar (VRBA) (Difco Laboratories, 
Franklin Lakes, NJ).  The LBSA was prepared following the manufacturer’s (BBL 
Microbiology Systems, Cockeysville, MD) formulation.  The LBSA plates were 
incubated at 37°C for 48 hours in a carbon dioxide inc ubator (VWR International, 
West Chester, PA).  The VRBA plates were incubated at 37°C for 24 hours. 
Enrichments: 
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 Fecal enrichment cultures for detection of Salmonella and Campylobacter 
were performed weekly for each pig.  Salmonella enrichment was performed by 
aseptically transferring 1 mL of the 1:100 dilution prepared during plating (one 
from the filter bag) to 10 mL of sterile tetrathionate (TT), hajna broth (Difco 
Laboratories, Franklin Lakes, NJ) (Downes and Ito 2001).  The broth was 
incubated for 18-24 hours at 37° C and placed at 2-5°C  until the enrichment 
could be tested on the Bax® System (DuPont Qualicon, Wilmington, DE), which 
was no longer than four hours.   
Enrichment of Campylobacter was done by aseptically transferring one 
gram of fresh feces to a sterile Whirl-Pack filter bag, adding 100 mL of sterile 
Bolton broth (Oxoid, Lenexa, KS) and stomaching as described earlier.  The 
Bolton broth was supplemented with the following antibiotics in accordance to the 
Bacteriological Analytical Manual:  20 mg/L of sodium cefoperazone (Sigma-
Aldrich, St. Louis, MO), 20 mg/L of trimethoprim lactate (Sigma-Aldrich, St. Louis, 
MO), 20 mg/L of vancomycin (Sigma-Aldrich, St. Louis, MO), and 2 mg/L of 
amphotericin B (Sigma-Aldrich, St. Louis, MO) (Hunt et al. 2001).  After 
stomaching, the fecal solution was aseptically transferred to sterile 600 mL tissue 
culture flasks with 0.2 µm vented caps (BD, Franklin Lakes, NJ).  The enrichment 
cultures were incubated according to the method described by Reilly and 
Gilliland (Reilly and Gilliland 2003).  The cultures were incubated for 1-2 hours at 
37°C followed by 20-24 hours at 42°C (Downes and Ito 2001).  After enrichment, 
the fecal samples were stored at 2-5°C until tested on the Bax® System, which 
was fewer than four hours. 
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Carried out on only experiment two of study two was enrichment of E. coli 
O157:H7.  One gram of feces was aseptically transferred to 10 mL of 
supplemented Gram negative (GN), hajna broth (Difco Laboratories, Franklin 
Lakes, NJ).  The added supplements were the following:  50 ng/mL cefixime 
(Sigma-Aldrich, St. Louis, MO), 8 µg/mL vancomycin (Sigma-Aldrich, St. Louis, 
MO), and 10 µg/mL cefsulodin (Sigma-Aldrich, St. Louis, MO) (Cuesta Alonso et 
al. 2007).  Samples were incubated for 18-24 hours at 37°C.  The enriched 
samples were placed at refrigeration (2-5°C) temperatu re for no longer than four 
hours until further use on the Bax® System. 
Bax® System: 
 All of the enrichment samples were tested on the Bax® System in 
accordance to the manufacturer’s instructions.  Salmonella enrichments were 
done using the Salmonella Bax® System PCR Assay kit (Dupont Qualicon, 
Wilmington, DE).  Escherichia coli O157:H7 MP Bax® System PCR Assay kit 
(Dupont Qualicon, Wilmington, DE) was used for the E. coli O157:H7 
enrichments.  Real-time polymerase chain reaction (PCR) was performed on the 
Campylobacter enrichments using the Campylobacter jejuni/coli/lari Bax® 
System PCR Assay kit (Dupont Qualicon, Wilmington, DE).  The Salmonella and 
E. coli O157:H7 kits only revealed if the sample was positive or negative for the 
pathogen.  However, the Campylobacter kit confirmed a positive, the species 
present, and the estimated concentration (cfu/mL). 
 Confirmation of Salmonella positives were verified by streaking the 
presumptive positive enrichment cultures for isolation on XLT4 agar (Difco 
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Laboratories, Franklin Lakes, NJ).  A confirmed Salmonella colony appeared 
black on the XLT4 agar.  The enrichments that were positive for E. coli O157:H7 
were subcultured three consecutive times in 10 mL of the supplemented GN 
broth at 37°C for 18 hours.  In accordance to Cuesta Alonso et al. (Cuesta 
Alonsa et al. 2007) samples were immunoconcentrated on the mini Vidas system 
using the Vidas I.C.E. coli O157 kit (bioMérieux, France).  The 
immunoconcentrated samples were spread plated on sorbitol MacConkey agar 
(SMAC) (Difco Laboratories, Franklin Lakes, NJ) and Chrom O157 agar (Chrom) 
(Chromagar Microbiology, Paris, France).  The SMAC agar was supplemented 
with 50 µg/mL cefixime (Sigma-Aldrich, St. Louis, MO) and 2.5 µg/mL potassium 
tellurite (MP Biomedicals, Solon, OH). The antibiotics that were added to the 
Chrom agar were cefixime (0.025 µg/mL) (Sigma-Aldrich, St. Louis, MO), 
cefsulodin (5 µg/mL) (Sigma-Aldrich, St. Louis, MO), and potassium tellurite (2.5 
µg/mL) (MP Biomedicals, Solon, OH).  Assumptive E. coli O157:H7 colony 
positives on SMAC appear colorless and appear mauve on Chrom.  The colonies 
from the SMAC and Chrom were identified as E. coli O157:H7 positives by 
testing for the O157 and H7 antigens with Remel’s agglutination test kits 
(Lenexa, KS). 
BLOOD COLLECTION AND BLOOD CHEMISTRY ANALYSIS: 
 Blood samples from the pigs were collected on day 0 and weeks 1, 2, and 
3.  The day 0 sampling periods were used as the baseline for all weekly blood 
chemistry tests.  Blood was drawn from the anterior vena cava using 10 mL 
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sterile serum vacutainers (BD, Franklin Lakes, NJ).  The blood samples were 
placed on ice after collection and then refrigerated (2-5°C) overnight. 
 The samples were centrifuged for 10 minutes at 3,000 x g to separate the 
plasma from the serum.  The serum was collected using a plastic transfer pipet 
and dispensed into seven appropriately labeled cryogenic vials per sample.  The 
vials were stored at -20°C until further analyses. 
Blood serum samples were analyzed for complete metabolic profile and 
lipid panel by the Stillwater Medical Hospital laboratory using a Vitros 5,1 FS 
Chemistry System (Ortho-Clinical Diagnostics, Raritan, NJ) (Table 2). 
ESCHERICHIA COLI LIPOPOLYSACCHARIDE (LPS) CHALLENGE: 
 At the end of each 21 day experiment, each pig was subjected to a 
lipopolysaccharide (LPS) challenge to test the immune response.  The LPS 
source was Escherichia coli O111:B4 (Sigma-Aldrich, Co., St. Louis, MO) that 
was suspended in 9 g/L of sterile saline for a final concentration of 25 µL/kg of 
body weight.  The pigs were fasted for approximately 8 hours before the 
administration of LPS and were between 55 – 69 days of age.  Before the LPS 
challenge, rectal temperature, body weight, and blood samples were taken from 
each pig (hour 0).  Pigs were injected at 5 minute intervals into the intraperitoneal 
cavity in the lower abdomen with the weight-dependent LPS suspension.  
Besides the hour 0 readings that were recorded, rectal temperatures and blood 
was taken at hours 1.5, 3.0, 6.0, 12, and 24 at 5 minute intervals.  In addition to 
the hour 0 body weight, weights were obtained at hours 6.0, 12, and 24.  The 
pigs were fed 0.91 kg (2.0 lb) of feed after the 12 hour reading.  The 
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wasted/uneaten feed was dried and weighed to calculate feed intake.  Blood was 
drawn, handled, and transferred as described earlier.  The vials were stored at -
20°C until blood chemistry analyses were done as previo usly explained. 
IMMUNOGLOBULIN ANALYSIS: 
 All blood serum samples were analyzed for immunoglobulins A (IgA), G 
(IgG), and M (IgM).  To test the concentrations of the immunoglobulins, an 
enzyme linked immunosorbent assay (ELISA) quantization kit was used (Bethyl 
Laboratories, Inc., Montgomery, TX).  Serum samples were analyzed following 
the manufacturer’s instructions. 
STATISTICAL ANALYSIS: 
 All weekly and LPS challenge blood chemistry and serum immunoglobulin 
data were analyzed using a repeated measures analysis of variance (ANOVA) by 
means of the SAS software (SAS Institute, 2003).  The first-order autoregressive 
covariance structure was implemented.  Slice effect was used to test for any 
differences between treatments at different time points.  Rectal temperatures 
from the LPS challenge were also analyzed in the exact manner.  When there 
was a significant difference at day 0, a covariate was adopted.  Differences were 
considered significant at the p<0.05 level.  Pairwise differences were used when 
there was a significant difference. 
 The Fischer’s exact test, using the SAS Software (SAS Institute, 2003), 
was used to evaluate the data from the fecal samples before and after 
enrichment for Campylobacter.  Samples were considered positive for 
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Campylobacter if they were positive for any of the three species using the Bax® 
System and Campylobacter jejuni/coli/lari PCR Assay kit. 
 Using the SAS Software (SAS Institute 2003), a Proc Mixed ANOVA was 
utilized to analyze the performance data, which included average daily feed 
intake (weekly and LPS challenge), average daily gain (weekly and LPS 
challenge), feed:gain (weekly and LPS challenge), and LPS challenge weights.  
A slice effect was used to test for any differences in treatments among study.  A 
significant difference was observed when p<0.05.  When a significant difference 
was observed, pairwise differences were used to examine differences among 
treatments.  Data for numbers of fecal lactobacilli, fecal coliforms, and fecal 
Campylobacter counts using the Bax® System were analyzed in the same 
manner.  The microbial counts were transposed into log10 cfu/g or mL before 
statistics were done 
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Feed Stuffs Amount (lb)
Corn grain 642.48
Soybean meal 292.60
L-Lysine HCl 1.90
L-Threonine 0.50
DL-Methionine 0.20
Soybean oil 30.00
Dicalcium phosphate 14.22
Limestone, ground 8.84
Sodium chloride 5.00
OSU Trace Mineral Mixa 1.50
OSU Vitamin Mixa 2.50
Ethoxyquin 0.25
TOTAL 1000.00
Table 1. Composition of swine diet
aVitamin and mineral mix (Oklahoma State 
University, Stillwater, OK)
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Analytes Tested Units
Glucose mg/dL
BUNb mg/dL
Creatinine mg/dL
BUN:Creatinie ratio
Sodium  mEq/L
Potassium mEq/L
Chloride mEq/L
Carbon dioxide mEq/L
Anion gap
Calcium mg/dL
Total protein g/dL
Albumin g/dL
Globulin g/dL
Albumin:Globulin ratio
ASTc U/L
ALTd U/L
ALKPhose U/L
Bili, total mg/dL
Cholesterol mg/dL
Triglycerides mg/dL
HDLf mg/dL
VLDLg mg/dL
Table 2. Blood chemistry analysisa
aPerformed using a Vitros 5,1 FS Chemistry System 
(Stillwater Medical Center, Stillwater, OK) 
gVLDL -  very low-density lipoprotein
fHDL -  high-density lipoprotein
eALKPhos - alkaline phosphatase
dALT -  alanine aminotransferase
cAST -  aspartate aminotransferase
bBUN -  blood urea nitrogen
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RESULTS 
 
SWINE CULTURES: 
Culture Identification: 
 The identities of the cultures from domestic swine (DS) and wild boar 
(WB) were based on characteristics reported in the 9th edition of Bergey’s Manual 
of Determinative Bacteriology (Sneath et al., 1986).  A total of 29 phenotypic 
characteristics were tested.  The following cultures were identified as L. reuteri:  
DS-29, DS-31, DS-33, DS-35, DS-36, DS-37, DS-38, DS-39, WB-72, WB-74, 
WB-75, WB-76, and WB-78.  The identity of L. acidophilus L-23 (Lee et al. 2001) 
was confirmed as well.  (The phenotypic identification characteristics for all 
cultures are listed in Appendix A in Tables A1, A2, and A3.) 
Bile Tolerance Assay: 
 The cultures of lactobacilli performed very similar in the bile tolerance 
assay with a range for the increases in A520nm for hour 4 of 0.309 – 0.598 (Table 
3).  All of the cultures of L. reuteri performed better than L. acidophilus L-23.  The 
culture that appeared to have the highest bile tolerance was L. reuteri DS-36.  
The bile tolerance (based on A520nm data) of culture for study 1 feeding trial 
ranged from 0.309 to 0.557 and included cultures L. acidophilus L-23 (L-23), L. 
reuteri WB-74 (WB-74), WB-75 (WB-75), and DS-33 (DS-33).  The ranges for 
study 2 were 0.430 to 0.598 and included cultures L. reuteri DS-36 (DS-36), DS-
37 (DS-37), WB-72 (WB-72), and WB-76 (WB-76).  (For the averages of the 
complete bile tolerance assay view Table A4 in Appendix A.) 
FEEDING STUDIES: 
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Enumeration of Lactobacilli: 
 For both studies all of the treatments (milk with added lactobacilli), besides 
the control, met the target count of 8.00 log10 cfu/mL.  The counts for study 1 DS-
33 and L-23 counts remained fairly constant from day 0 to day 3 or 4 for each 
batch of milk prepared.  Study 2 cultures DS-36 and DS-37 also were stable.  
However, in study 1 cultures WB-74 and WB-75 declined in viability by 
approximately 0.5 log cycle from day 0 to day 3 or 4.  A decrease of 1.00 log 
cycle was observed for study 2 cultures WB-72 and WB-76.  (See Table B1 in 
Appendix B and Table C1 in Appendix C for the treatment counts.) 
Growth & Performance: 
Beginning (day 0) and ending weights (week 3) in study 1 were measured 
to test growth.  There was no overall treatment (P=0.9827) effect or treatment x 
experiment interaction (P=0.9675) for day 0.  A significant experiment (P=0.0350) 
effect was seen where the pigs (barrows) in experiment 2 were heavier.  
However, there were no differences among treatments (P=0.7946) or a treatment 
x experiment interaction (P=0.8801).  Study 2 beginning weights did not 
demonstrate a difference in treatment (P=0.9987), experiment (P=0.6364), or 
treatment x experiment interaction (P=0.9985).  Week 3 did reveal a trend for the 
experiment (P=0.0703), but no treatment (P=0.8654) effect or treatment x 
experiment interaction (P=0.8849).  The pigs in experiment 1 (gilts) in study 2 
tended to be heavier than those in experiment 2 (barrows).  (The weights are 
listed in Table B3 in Appendix B and in Table C3 in Appendix C.) 
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When analyzing the data from study 1, it was observed that during week 2 
a control pig (# 13) was an outlier, thus we removed his data from the week 2 
results of the growth and performance analyses.  There was no overall treatment 
(P=0.5641) effect or treatment x experiment interaction (P=0.6176) for average 
daily gain (ADG).  Numerically, the ADG for the group receiving the culture DS-
33 was higher than the control group although the difference was not significant.  
There was a significant experiment (P=0.0099) effect where the pigs in 
experiment 2 (barrows) gained more weight than those in experiment 1 (gilts).    
The overall average daily feed intake (ADFI) did not reveal any significant 
differences for the treatment (P=0.6803) or treatment x experiment interaction 
(P=0.9127).  Pigs fed culture DS-33 numerically consumed more feed than the 
control.  There was a significant experiment (P=0.0473) effect where the barrows 
consumed more feed.  Analysis of data for feed efficiency did not reveal any 
differences among the treatments (P=0.1078) or treatment x experiment 
interaction (P=0.1022), but a experiment (P=0.0001) effect was observed.  
Numerically, culture DS-33 caused the most efficient feed to gain (F:G).  Pigs in 
experiment 1 (barrows) had a better overall F:G than those in experiment 2 
(gilts).  There was a trend (P=0.0667) in the experiment 1, but not in experiment 
2 (P=0.1667), where some of the treatments had a more efficient F:G than the 
control.  The cultures of lactobacilli that caused a better F:G were L-23, DS-33, 
and WB-75 although the differences were not significantly different (P>0.05) 
(Table 3).  (The raw data for growth and performance are in Tables B4, B5, B6, 
and B7 in Appendix B.) 
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Data for ADG in study 2 did not reveal a treatment (P=0.3507) effect or 
treatment x experiment interaction (P=0.3432).  However, numerically culture 
DS-36 caused a greater ADG than the control group.  A experiment (P<0.0001) 
effect was observed where experiment 1(gilts) gained more weight than 
experiment 2 (barrows).  There was an overall experiment (P<0.0001) effect for 
ADFI, but no differences were found in the treatment (P=0.3218) effect or the 
treatment x experiment interaction (P=0.8559).  The pigs in experiment 1 (gilts) 
gained more weight throughout the entire study.  The treatment DS-36 
numerically had a higher ADFI than the control.  There was not an overall 
treatment (P=0.5542) effect, but there was a experiment (P=0.0055) and 
treatment x experiment interaction (P=0.0352) for feed efficiency.  The barrows 
F:G was better than gilts.  A treatment (P=0.0318) effect was observed in the 
barrows.  In this case, DS-37 treatment F:G was poorer than the control and 
other cultures of lactobacilli.  A experiment (P=0.0145) effect, a treatment x 
experiment interaction (P=0.0145), and a treatment (P=0.0642) trend at week 1 
was noticed.  The control group performed poorer than DS-36, WB-72, and WB-
76 groups.  The gilts were more efficient in converting feed to gain.  A treatment 
(P=0.0011) effect was observed in the barrows.  The culture DS-37 had an 
inferior F:G compared to the control and other DFM treatments (Table 4).  (The 
raw growth and performance data is in Appendix C in Tables C4, C5, C6, and 
C7.) 
Microbial Analysis of Feces: 
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 No significant effects of any treatments on numbers of coliform or total 
facultative lactobacilli were found for either study.  There was an exception.  
Study 2 had a week 2 treatment (P=0.0454) effect where culture WB-76 was 
significantly lower than the control group.  There also was no effect of any 
treatment on number of Campylobacter in the fecal material for either study.  In 
most cases the numbers, if present, were below the detection level for direct 
plating.  (The counts for the study 1 see Tables B8, B9, and B10 in Appendix B 
and Tables C8, C9, and C10.) 
 For both studies, enrichment cultures for the detection of Campylobacter 
revealed that all treatments had positive carriers for C. coli, but not for C. jejuni or 
lari.  No trend was observed throughout the studies for the incidence of positives 
confirmed with Bax® System.  Also, none of the pigs in study 1 were confirmed 
Salmonella positive.  There were only two pigs confirmed positive for Salmonella 
in study 2.  The enrichment tests for Escherichia coli O157:H7 did not reveal any 
to be positive.  Thus, there were not sufficient numbers or positive samples to 
enable any observed effect of feeding the lactobacilli.  (For the results of the 
Bax® positives, see Appendix B in Tables B11, B12, and B13 and Appendix C in 
Tables C11, C12, C13, and C14.) 
Serum Blood Chemistry: 
 Compared to the control group for either study none of the cultures 
caused significant (p>0.05) changes in the following blood serum levels: glucose, 
blood urea nitrogen (BUN), creatinine, BUN:creatinine ratio, sodium, potassium, 
chloride, carbon dioxide, calcium, albumin, globulin, albumin:globulin ratio, 
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alanine aminotransferase (ALT), alkaline phosphatase (ALKPhos), total bili, 
cholesterol, triglycerides, high-density lipoprotein (HDL), and very low-density 
lipoprotein (VLDL).  (Raw data for blood chemistry analytes are in Tables B14-
B35 in Appendix B and Tables C15-C36 in Appendix C.) 
In study 1, there was a significant treatment (P=0.0067) and week 
(P<0.0001) effect on total serum protein, but no treatment x week interaction 
(P=0.4121).  Culture DS-33 caused the lowest amount of serum protein, but it 
was not different than the control group.  However, culture L-23 resulted in the 
highest overall mean serum protein compared to the control (P<0.05).  An 
increase for total protein was observed over time for all treatments and the 
control.  There were differences in treatments (P=0.0101) at week 3.  The groups 
that were fed the cultures WB-74 and L-23 exhibited higher (P<0.05) serum 
protein than did the group fed DS-33.  The control and WB-75 groups were the 
same and not different from the cultures DS-33, L-23, or WB-74 (P<0.05).  Even 
though there were effects on total serum protein, there were no significant 
differences in levels of albumin or globulin.  In study 2, there was no treatment 
(P=0.9096) effect for total protein or treatment x week interaction (P=0.6131), but 
a week (P<0.0001) effect was observed.  Numerically the groups fed the cultures 
DS-36, WB-72, and WB-76 had overall higher total serum protein than the control 
group (Table 5). 
For study 1, there was an overall significant treatment (P=0.0181) and 
week (P<0.0001) effect for serum aspartate aminotransferase (AST).  Treatment 
x week interaction (P=0.1715) was not significant.  The group fed the culture DS-
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33 exhibited significantly lower AST than did the control and other groups, except 
WB-74.  The highest numerical AST level was observed in L-23, but it was not 
different from the control.  A significant treatment (P=0.0008) effect was revealed 
at week 1.  The results were the same for week 1 as seen in the overall 
treatment effect.  Therefore, DS-33 group had the lowest level with no 
differences between it and the group fed WB-74.  The treatment with the highest 
level was the group fed L-23, but there was no difference between it and the 
control.  There were no differences in AST levels among treatments (P=0.9356) 
or treatment x week interaction (P=0.7318) for study 2.  A significant week 
(P=0.0411) effect was observed.  The group fed the culture DS-36 had a much 
higher level of AST on day 0 than the control group and other treatment groups, 
but it dropped drastically by the end of week 1 (Table 6). 
Serum Immunoglobulins: 
No significant treatment effects were observed on immunoglobulin A (IgA) 
for either study.  There was a trend toward higher IgA levels in the groups fed 
culture L-23, WB-74, or WB-75 than for the control group (P=0.1116) in study 1.  
A numerical difference was observed at week 1.  The groups fed WB-74 or WB-
75 showed an increased change in IgA while the control group decreased.  All of 
the treatment and control groups exhibited increases in IgA by week 3 compared 
to week 2.  In study 2 all the treatment and control groups had increased IgA at 
week 1 with pigs fed culture WB-76 causing the highest increase (Figure 1). 
 No treatment differences for study 1 or 2 were observed for levels of 
serum immunoglobulin G (IgG).  In study 1 pigs fed L-23 had an overall higher 
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IgG level than the control group.  The increases for the group fed culture L-23 
were consistently higher than any of the groups.  The control group exhibited little 
change during the entire feeding study.  In study 2 none of the cultures caused 
greater increases in IgG than the control group.  The serum levels DS-37, DS-36, 
and WB-71 decreased some during week 1; however, that for WB-76 did not.  
After week 1, all of the treatment and control groups increased until the end of 
the feeding trial.  At the end of the study culture DS-37 exhibited a slightly higher 
change than the control group (Figure 2). 
 No effect was observed for serum immunoglobulin M (IgM) for either 
study.  At week 1, in study 1 culture, WB-74 was the only treatment that exhibited 
an increased change.  Just as observed for the IgA levels, the IgM levels for the 
control group remained fairly constant.  Cultures WB-74, WB-75, and L-23 
caused increased changes at week 3.  In study 2 the cultures DS-37, WB-72, 
and WB-76 had an increased change at week 1 with culture WB-72 having the 
largest increase.  This trend continued to week 2 with the pigs fed culture WB-72 
still exhibiting the largest increase.  Throughout the entire study the control 
demonstrated little change in IgM levels (Figure 3).   
LIPOPOLYSACCHARIDE (LPS) CHALLENGE: 
Rectal Temperatures: 
 An overall hourly (P<0.0001) effect was observed for rectal temperatures 
for both studies, but there was no treatment effect or treatment x hour interaction.  
The temperatures increased from hour 0 to hour 3.0.  The temperatures started 
to fall after hour 3.0 and continued to decrease until hour 12 (Figure 4). 
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Serum Blood Chemistry: 
 There were very few significant differences for the blood analytes 
observed during the LPS challenge.  There were no overall differences for 
treatment or treatment x hour interaction for the following: glucose, BUN, 
creatinine, BUN:creatinine ratio, sodium, potassium, chloride, carbon dioxide, 
anion gap, calcium, total protein, albumin, albumin:globulin ratio, AST, ALT, 
cholesterol, and HDL.   (All of the LPS challenge blood analytes are listed in 
Tables B42-B63 in Appendix B and Tables C43-C64 in Appendix C.) 
 While there were no treatment differences in study 1 for serum globulin 
levels during the LPS challenge, numerically, culture WB-74 caused a higher 
serum globulin average than observed for the control group.  For study 2 an 
overall treatment (P=0.0462) and hour (P<0.0001) effect was noticed for serum 
globulin levels, but there was no treatment x hour interaction (P=0.9994).  The 
control group exhibited a higher level than the pigs fed DS-36 (Table 7). 
 There were no overall significant treatment differences observed for 
studies 1 and 2 for albumin:globulin ratio.  In study 1, the overall ratios for pigs 
fed cultures of lactobacilli were numerically higher than the control group.  This 
also was true for each hourly measurement.  At 3.0 hour post challenge, pigs fed 
cultures DS-36 and WB-76 had higher ratios than the control pigs in study 2 
(P<0.05) (Table 8).  These cultures continued to exhibit higher ratios (although 
not significant) than the control group throughout the challenge (Table 8). 
Levels of bilirubin (bili) in serum LPS challenge were not significantly 
influenced by treatments in either study, but there was an hour (P<0.0001) effect.  
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In study 1, the culture DS-33 caused a numerically lower bili average than the 
control group at each time beyond hour 3.0.  Levels of bili in study 2 tended to be 
lower in pigs fed culture DS-37 than the control group.  Culture DS-37 caused a 
significantly (P<0.05) lower total bili level than the control group at hour 12 (Table 
9). 
 Serum triglycerides in study 1 were not significantly influenced by any 
treatment.  Values for the control group tended to be higher than all of the groups 
fed cultures of lactobacilli.  Study 2 revealed a trend toward treatment (P=0.1105) 
and an hourly (P<0.0001) effect with no treatment x hour interaction (P=0.9349).  
The control group had an overall higher triglyceride level than all of the direct-fed 
microbial cultures.  At 12 hour post challenge, the control group was significantly 
(P=0.0093) higher than pigs fed cultures DS-36, DS-37, and WB-72 with the DS-
37 group exhibiting the lowest level (Table 10). 
 A treatment effect for study 1 was not observed for serum VLDL.  There 
was no treatment x hour interaction (P=0.9490), but a treatment (P=0.1105) trend 
and hourly (P<0.0001) effect for study 2.  The control group had a higher VLDL 
average than all of the cultures of lactobacilli with this trend continuing for every 
hourly reading.  A significant treatment (P=0.0128) effect was observed at hour 
12 where the control group was higher than pigs fed DS-37 (Table 11). 
Serum Immunoglobulins: 
Serum IgA for study 1 or 2 was not significantly affected by treatment.  An 
hourly (P=0.0002) effect was observed for study 1.  The pigs fed L-23, at hours 
1.5 and 3.0, were the only ones that exhibited an increased change in IgA.  In 
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study 2 there was an hourly (P<0.0001) effect on levels of IgA and a treatment x 
hour interaction (P=0.0128).  At hours 1.5, 3.0, and 6.0 the culture DS-36 had a 
larger increased change than the control group (Figure 5). 
 No treatment effect for levels of serum IgG in either study was observed, 
but both exhibited an hourly (P<0.0001) effect (Figure 6).  All pigs showed a 
decrease in IgG levels at hour 1.5.  Pigs fed L-23 tended to have a higher level of 
IgG than the control pigs at hour 6.0 in study 1.  Culture WB-76 from study 2 was 
the only culture that caused an apparent increase at hour 1.5 while all the others 
exhibited a decrease in IgG (Figure 6). 
 No significant treatment differences in either study were observed for 
serum IgM.  Both studies did have an hour (P<0.0001) effect.  Culture L-23 
numerically had a higher IgM average than the control group.  In study 1, the 
levels of IgM dropped at hour 1.5 for all treatment and control groups.  However, 
at hour 3.0 pigs fed L-23 caused a larger increased change than the control pigs.  
In study 2, pigs fed culture WB-76 was the only group that exhibited an increased 
change at hour 1.5 (Figure 7). 
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Isolate Rep 1b Rep 2b Mean
L. reuteri DS-29 0.575 0.512 0.544
L. reuteri DS-31 0.550 0.516 0.533
L. reuteri DS-33 0.598 0.516 0.557
L. reuteri DS-35 0.536 0.500 0.518
L. reuteri DS-36 0.653 0.542 0.598
L. reuteri DS-37 0.463 0.397 0.430
L. reuteri DS-38 0.542 0.478 0.510
L. reuteri DS-39 0.576 0.481 0.529
L. reuteri WB-72 0.702 0.436 0.569
L. reuteri WB-74 0.577 0.397 0.487
L. reuteri WB-75 0.650 0.388 0.519
L. reuteri WB-76 0.685 0.427 0.556
L. reuteri WB-78 0.643 0.366 0.505
L. acidophilus L-23 0.354 0.263 0.309
Table 3. Comparisons of bile tolerance of different 
cultures of lactobacillia
aIn deMan, Rogasa, Sharpe (MRS) broth + 0.3% oxgall 
bValues are increases in A620nm after hour 4 at 37°C
 
 66
Studya Treatmenta Experiementa ADGb (kg) ADFIc (kg) F:Gd
1 0.53 0.93 1.68
2 0.52 0.88 1.69
Mean 0.53 0.91 1.69
1 0.68 1.09 1.52
2 0.53 0.93 1.77
Mean 0.60 1.01 1.65
1 0.57 1.02 1.75
2 0.51 0.93 1.84
Mean 0.54 0.98 1.80
1 0.61 1.01 1.59
2 0.46 0.88 1.90
Mean 0.54 0.94 1.74
1 0.60 0.98 1.57
2 0.53 0.93 1.78
Mean 0.56 0.96 1.68
1 0.36 0.57 1.59y
2 0.50 0.88 1.69
Mean 0.43 0.71 1.64
1 0.40 0.63 1.57y
2 0.55 0.93 1.71
Mean 0.47 0.78 1.64
1 0.29 0.52 1.77z
2 0.53 0.88 1.66
Mean 0.41 0.70 1.72
1 0.35 0.55 1.56y
2 0.49 0.86 1.76
Mean 0.42 0.71 1.66
1 0.38 0.59 1.56y
2 0.50 0.88 1.75
Mean 0.44 0.73 1.65
WB-72
2
WB-76
Control
DS-33
WB-74
WB-75
1
L-23
Table 4. Growth and performance of nursery pigs fed different cultures of 
lactobacilli
y,zValues for F:G in study 2 followed by different subscript letters differ significantly 
(P<0.05).
dF:G - feed to gain ratio
cADFI - average daily feed intake
bADG - average daily gain
aDescription of treatments for study 1: control, L. reuteri DS-33, L. reuteri WB-74, 
L. reuteri WB-75, and L. acidophilus L-23.  Experiment 1 - barrows and 
experiment 2 - gilts, n=15 pigs/rep.  Description of treatmentsfor study 2: control, 
L. reuteri DS-36, L. reuteri DS-37, L. reuteri WB-72, and L. reuteri WB-76.  
Experiment 1 - gilts and experiment 2 - barrows, n=15 pigs/experiment
Control
DS-36
DS-37
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Studya Treatmenta Day 0 Week 1 Week 2 Week 3 Mean
Control 4.8 4.4 4.6 5.2y,z 4.8x,y
DS-33 4.4 4.5 4.8 4.9y 4.6x
WB-74 4.6 4.5 4.9 5.6z 4.9y,z
WB-75 4.7 4.5 4.7 5.2y,z 4.8x,y
L-23 4.7 4.9 5.0 5.6z 5.1z
Control 4.6 4.6 5.0 5.1 4.8
DS-36 4.9 4.5 5.0 5.1 4.8
DS-37 4.5 4.6 5.1 5.0 4.8
WB-72 4.8 4.7 5.0 5.2 4.9
WB-76 4.8 4.4 5.3 5.2 4.9
1
2
aDescription of treatments see Table 4
Table 5. Influence of different cultures of lactobacilli on weekly serum total 
protein (g/dL)
x,y,zValues in different columns in study 1 followed by different subscript 
letters differ significantly (P<0.05).
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Studyb Treatmentb Day 0 Week 1 Week 2 Week 3 Mean
Control 68 71y,z 49 51 60y,z
DS-33 54 50x 52 45 50x
WB-74 62 58x,y 47 55 55x,y
WB-75 64 80z 52 52 62y,z
L-23 73 77z 52 62 66z
Control 81 73 70 52 69
DS-36 138 60 56 49 76
DS-37 68 68 74 52 65
WB-72 90 63 64 48 66
WB-76 69 67 66 62 66
Table 6. Influence of different cultures of lactobacilli on weekly serum ASTa 
(U/L)
1
2
bDescription of treatments see Table 4
x,y,zValues in different columns in study 1 followed by different subscript 
letters differ significantly (P<0.05).
aAST - aspartate aminotransferase
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Studyb Treatmentb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24 Mean
Control 2.0 1.8 1.7 1.9 2.0 2.0 1.9
DS-33 1.7 1.6 1.5 1.7 1.8 1.9 1.7
WB-74 2.1 2.0 1.8 2.0 2.0 2.1 2.0
WB-75 1.8 1.6 1.7 1.8 1.8 1.9 1.8
L-23 2.1 1.9 1.8 1.9 2.0 1.9 1.9
Control 2.1 1.9 2.3 2.1 2.0 2.1 2.1z
DS-36 1.9 1.7 2.0 1.7 1.7 1.8 1.8y
DS-37 2.1 2.0 2.3 1.9 1.9 2.0 2.0z
WB-72 2.0 1.9 2.2 1.7 1.8 1.9 1.9y,z
WB-76 2.0 1.9 2.1 1.8 1.9 1.9 1.9y,z
y,zValues for globulin mean in study 2 followed by different subscript letters differ significantly 
(P<0.05).
bDescription of treatments see Table 4
2
1
Table 7. Influence of different cultures of lactobacilli on LPSa challenge serum globulin (g/dL)
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
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Studyb Treatmentb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24 Mean
Control 1.6 1.4 1.4 1.5 1.4 1.4 1.5
DS-33 1.9 1.8 1.6 1.8 1.7 1.6 1.7
WB-74 1.8 1.6 1.4 1.6 1.5 1.4 1.6
WB-75 1.9 1.8 1.6 1.7 1.7 1.6 1.7
L-23 1.8 1.6 1.6 1.8 1.7 1.5 1.7
Control 1.4 1.4 1.6y 1.5 1.4 1.3 1.4
DS-36 1.8 1.7 2.0z 1.8 1.7 1.7 1.8
DS-37 1.4 1.4 1.6y 1.5 1.4 1.3 1.4
WB-72 1.6 1.6 1.8y,z 1.7 1.6 1.5 1.6
WB-76 1.6 1.6 1.9z 1.7 1.6 1.5 1.6
Table 8. Influence of different cultures of lactobacilli on LPSa challenge serum albumin:globulin 
ratio
1
2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments see Table 4
y,zValues for hour 3.0 albumin:globulin ratio in study 2 followed by different subscript letters differ 
significantly (P<0.05).
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Studyb Treatmentb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24 Mean
Control 0.15 0.18 0.25 0.33 0.78 0.10 0.30
DS-33 0.18 0.18 0.13 0.29 0.57 0.13 0.25
WB-74 0.17 0.18 0.18 0.38 0.80 0.25 0.33
WB-75 0.18 0.17 0.20 0.42 0.63 0.12 0.29
L-23 0.23 0.20 0.22 0.30 0.70 0.10 0.29
Control 0.12 0.10 0.22 0.25 0.62z 0.12 0.24
DS-36 0.22 0.13 0.28 0.28 0.45y,z 0.10 0.24
DS-37 0.13 0.15 0.20 0.13 0.28y 0.12 0.17
WB-72 0.10 0.18 0.25 0.12 0.53z 0.12 0.22
WB-76 0.20 0.17 0.20 0.20 0.53z 0.18 0.25
Table 9. Influence of different cultures of lactobacilli on LPSa challenge serum bili, total (mg/dL)
1
2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments see Table 4
y,zValues for hour 12 total bilirubin in study 2 followed by different subscript letters differ 
significantly (P<0.05).
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Studyb Treatmentb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24 Mean
Control 31 25 23 21 59 33 32
DS-33 29 31 21 22 56 41 33
WB-74 34 36 30 30 63 51 41
WB-75 37 30 24 28 82 38 40
L-23 46 29 25 25 70 40 39
Control 44 37 45 36 70z 45 46
DS-36 35 32 38 28 52x,y 36 37
DS-37 38 34 37 22 38x 34 34
WB-72 35 32 38 24 54x,y 33 36
WB-76 41 31 39 24 58y,z 34 38
Table 10. Influence of different cultures of lactobacilli on LPSa challenge serum triglycerides 
(mg/dL)
1
2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatment see Table 4
x,y,zValues for hour 12 triglycerides in study 2 followed by different subscript letters differ 
significantly (P<0.05).
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Studyc Treatmentc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24 Mean
Control 6.0 5.0 4.3 4.2 11.8 6.5 6.3
DS-33 5.8 6.3 4.0 4.3 11.2 8.2 6.6
WB-74 6.8 7.0 6.0 6.0 12.7 10.0 8.1
WB-75 7.5 5.8 4.8 5.8 16.3 7.8 9.0
L-23 9.2 5.8 4.5 4.8 11.5 9.0 8.1
Control 8.7 7.7 9.0 7.2 13.8z 8.8 9.2
DS-36 8.2 6.5 7.7 5.7 10.5y,z 7.5 7.5
DS-37 8.5 6.8 7.5 4.5 7.7y 7.0 9.8
WB-72 6.8 6.3 7.5 4.7 10.7y,z 6.7 7.1
WB-76 8.3 6.2 7.7 5.0 11.5z 6.8 7.6
Table 11. Influence of different cultures of lactobacilli on LPSa challenge serum VLDLb (mg/dL)
1
2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
cDescription of treatment see Table 4
x,y,zValues for hour 12 VLDL in study 2 followed by different subscript letters differ significantly 
(P<0.05).
bVLDL - very low-density lipoprotein
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Figure 1.  Changes in weekly serum IgA levels from day 0 in response to different 
cultures of lactobacilli.  Six pigs per treatment and two experiments per study.  A)  
Treatment descriptions:  ♦ control, ◊ L. reuteri DS-33, ■ L. reuteri WB-74, □ L. 
reuteri WB-75, ● L. acidophilus L-23.  B) Treatment descriptions: ♦ control, ◊ L. 
reuteri DS-36, ■ L. reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri WB-76. 
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Figure 2.  Changes in weekly serum IgG levels from day 0 in response to 
different cultures of lactobacilli.  Six pigs per treatment and two experiments per 
study.  A)  Treatment descriptions:  ♦ control, ◊ L. reuteri DS-33, ■ L. reuteri WB-
74, □ L. reuteri WB-75, ● L. acidophilus L-23.  B) Treatment descriptions: ♦ 
control, ◊ L. reuteri DS-36, ■ L. reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri 
WB-76. 
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Figure 3.  Changes in weekly serum IgM levels from day 0 in response to 
different cultures of lactobacilli.  Six pigs per treatment and two experiments per 
study.  A)  Treatment descriptions:  ♦ control, ◊ L. reuteri DS-33, ■ L. reuteri WB-
74, □ L. reuteri WB-75, ● L. acidophilus L-23.  B) Treatment descriptions: ♦ 
control, ◊ L. reuteri DS-36, ■ L. reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri 
WB-76. 
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Figure 4.  Rectal temperatures of different cultures of lactobacilli in response to 
Escherichia coli O111:B11 lipopolysaccharide.  Six pigs per treatment and two 
experiments per study.  A)  Treatment descriptions:  ♦ control, ◊ L. reuteri DS-33, 
■ L. reuteri WB-74, □ L. reuteri WB-75, ● L. acidophilus L-23.  B) Treatment 
descriptions: ♦ control, ◊ L. reuteri DS-36, ■ L. reuteri DS-37, □ L. reuteri WB-72, 
● L. reuteri WB-76. 
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Figure 5.  Changes in serum IgA levels from hour 0 of different cultures of 
lactobacilli in response to Escherichia coli O111:B11 lipopolysaccharide.  Six 
pigs per treatment and two experiments per study.  A)  Treatment descriptions:  ♦ 
control, ◊ L. reuteri DS-33, ■ L. reuteri WB-74, □ L. reuteri WB-75, ● L. 
acidophilus L-23.  B) Treatment descriptions: ♦ control, ◊ L. reuteri DS-36, ■ L. 
reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri WB-76. 
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Figure 6.  Changes in serum IgG levels from hour 0 of different cultures of 
lactobacilli in response to Escherichia coli O111:B11 lipopolysaccharide.  Six 
pigs per treatment and two experiments per study.  A)  Treatment descriptions:  ♦ 
control, ◊ L. reuteri DS-33, ■ L. reuteri WB-74, □ L. reuteri WB-75, ● L. 
acidophilus L-23.  B) Treatment descriptions: ♦ control, ◊ L. reuteri DS-36, ■ L. 
reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri WB-76. 
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Figure 7.  Changes in serum IgM levels from hour 0 of different cultures of 
lactobacilli in response to Escherichia coli O111:B11 lipopolysaccharide.  Six 
pigs per treatment and two experiments per study.  A)  Treatment descriptions:  ♦ 
control, ◊ L. reuteri DS-33, ■ L. reuteri WB-74, □ L. reuteri WB-75, ● L. 
acidophilus L-23.  B) Treatment descriptions: ♦ control, ◊ L. reuteri DS-36, ■ L. 
reuteri DS-37, □ L. reuteri WB-72, ● L. reuteri WB-76. 
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DISCUSSION 
 
DIRECT-FED MICROBIALS FOR SWINE: 
 Direct-fed microbials (DFM) offer several potential benefits for swine 
including:  improved growth and performance, pathogen reduction, increased 
immunity, and less post-weaning stress.  Some of the most commonly used DFM 
for swine are species of Lactobacillus, Bifidobacteria, Enterococcus, and 
Saccharomyces (Mountzouris 2006).   
Lactobacillus acidophilus L-23 (L-23) was used for study 1 because it was 
shown to improve growth and performance in nursery pigs in previous studies.  
The culture was isolated from a pig from Oklahoma State University’s swine 
herd.  It produces amylase and is bile tolerant.  The culture had improved 
average daily gain (ADG) and feed:gain (F:G) of weaning pigs on a high starch 
diet (Lee et al. 2001). 
 The cultures of L. reuteri used in this study were isolated from feces of 
open range pigs and from the small intestines of a wild boar.  Lactobacillus 
reuteri is one of the first species of lactobacilli to colonize the intestines of pigs 
(Naito et al. 1995).  The cultures from the domestic swine and wild boar were 
more bile tolerant than L-23.  Lactobacillus reuteri DS-36 (DS-36) was the most 
bile tolerant followed by L. reuteri WB-72 (WB-72), DS-33 (DS-33), and WB-76 
(WB-76).  Because they appeared more bile tolerant than the other cultures, they 
were chosen for the studies.  A previous study revealed, of cultures tested, the 
more bile tolerant lactobacilli, fed to newborn calves resulted higher levels of 
intestinal lactobacilli (Gilliland et al. 1984).  Also, a mid-range bile tolerant culture 
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was chosen, L. reuteri WB-75 (WB-75) along with two other cultures that were 
similar in bile tolerance to L-23, L. reuteri WB-74 (WB-74) and DS-37 (DS-37). 
FEEDING STUDIES: 
Growth & Performance: 
 While L-23 was shown in a previous study to significantly improve growth 
and performance in swine (Lee et al. 2001), it did not cause similar results in the 
present study.  This may have resulted from the variations in dietary 
components.  More likely the difference was due to how the culture had been 
grown.  In the study reported by Lee et al. (2001) the culture was grown in broth 
containing starch as the sole carbohydrate to insure active amylase in the cells.  
For the present study the growth medium contained glucose as the only 
carbohydrate.  Thus, a sufficient level of amylase may have been lacking. 
 Pigs fed cultures L-23 and DS-33 did better than the control especially in 
experiment 1 of study 1(P=0.067).  These cultures caused a more efficient F:G 
than any of the cultures of lactobacilli and the control for study 1.  Even though 
differences were marginal, cultures DS-33 or L-23 might be considered for future 
larger scale feeding trials.  In study 2, pigs fed the culture DS-36 exhibited a 
trend toward higher ADG and ADFI than did those in the control group.  While the 
differences were not significant nor was there an indication of improved F:G, DS-
36 might merit further consideration based on this information.  When data on 
performance is considered for both studies there is no clean cut information to 
support the use of any of the cultures to improve performance of the pigs.  
Perhaps future research focused on growth and performance of nursery pigs 
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should further evaluate DS-33, L-23, or DS-36.  This should involve more pigs 
and imposition of less handling of the pigs for feeding and/or drawing blood.  In 
the future studies the pigs should be handled in a setting similar to that used in 
the commercial industry. 
Microbial Counts: 
 No conclusive results can be drawn from either study in reducing coliforms 
or Campylobacter in swine.  The most prevalent species of Campylobacter in 
swine is C. coli (Jacobs-Reitsma 2000).  These results coincide with both studies 
in the present study in that the only species of Campylobacter identified was C. 
coli.  Salmonella was detected in only two pigs and they were in study 2.  It is 
thought that prevalence of Salmonella is herd related (Done 2001).  Escherichia 
coli O157:H7 was tested in study 2 experiment 2 with no confirmed positives 
reported.  The bacterium, E. coli, is one of the major cause of illness in nursery 
pigs with E. coli K88 being the most virulent (Done 2001).  There have been no 
reported cases of E. coli O157:H7 in commercial pigs in the United States.  It is 
believed that swine do not harbor this pathogen because of the management 
practices and little contact with the pathogen (Cornick and Helgerson 2004), but 
they are capable of harboring it (Cornick and VuKhac 2008). 
Serum Blood Chemistry: 
  The normal range for total serum protein in pigs is 4.40-8.28 g/dL 
(Lindemann et al. 1993, Mersmann and Pond 2001, Odink et al. 1990, 
Tumbleson and Kalish 1972).  Plasma is approximately 5-7% protein.  Total 
protein in blood serum includes albumin and globulin (Kaneko 1989b).  In study 1 
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pigs fed L-23 and WB-74 exhibited a significantly higher total protein level than 
the control group.  For study 2 there was no overall treatment effect.  Several 
factors could have increased total protein, such as albumin or globulin levels 
(Mersmann and Pond 2001).  Thus L. acidophilus L-23 or L. reuteri WB-74 
appears to be the best choice for increasing total serum protein. 
 Catalyzing L-aspartate and 2-oxoglutarate to oxaloacetate and glutamate 
is one of the functions of AST.  An elevated level of this enzyme in the serum is a 
good indicator of soft tissue damage, but the location of the damage not known 
because the enzyme is not organ-specific (Kramer 1989).  Elevation of the blood 
enzyme has been associated with white muscle disease in pigs (Cardinet 1989).  
For AST, there was an overall treatment effect where the level for the group fed 
DS-33 was significantly lower than that of the control.  There was also a 
significant week 1 effect where DS-33 was lower than the control.  To effectively 
reduce levels of AST in pigs, L. reuteri DS-33 is a clear choice among the 
cultures tested. 
Serum Immunoglobulins: 
 The normal range for levels of serum IgA in pigs are 0.369 to 0.609 
mg/mL (Swamy et al. 2008, White et al. 2002).  In study 1 weekly IgA values 
increased more, although not significantly, in the group fed culture WB-74 than in 
the control animals.  During the first week the values for cultures WB-75 and L-23 
also increased more than the control.  In study 2 none of the culture groups 
caused consequently greater increases compared to the control group.  Based 
on these observations, WB-74 appears to be the culture of choice. 
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Reported ranges for serum IgG are 4.980 to 7.904 (Swamy et al. 2008, 
White et al. 2002).  Pigs in study 1 were outside of this range.  Culture L-23 
exhibited the largest increase in change for study 1 of all groups.  None of the 
cultures in study 2 had higher increases when compared to the control group.  It 
is recommended that culture L-23 be used to increase IgG in nursery pigs. 
 The IgM levels for both studies were within the reported normal serum 
values (Swamy et al. 2008, White et al. 2002).  The only culture in study 1 that 
had a higher increase than the control group was culture WB-74.  The same 
trend was noticed in study 2 with culture WB-72 exhibiting higher changes than 
the control group.  This culture had a large increase of serum IgM.  Thus, to 
increase serum IgM levels in the nursery pig culture L. reuteri WB-72 could be 
administered. 
LIPOPOLYSACCHARIDE (LPS) CHALLENGE: 
 The Escherichia coli O111:B4 lipopolysaccharide (LPS) was used to study 
the immune response of the pigs ingesting lactobacilli.  This LPS has been 
shown to cause an immune response in nursery pigs (Mandali et al. 2000, 
Mandali et al. 2002, Smith 2006).  Lipopolysaccharide, a cell wall component, 
affects the animal immunologically as live bacteria would (Mandali et al. 2002). 
Rectal Temperatures: 
   The temperatures of the pigs for both studies peaked at hour 3.0 with no 
significant differences observed.  This is an indication that an immune response 
occurred (Van Gucht et al. 2004).  Similar results were reported by Smith (2006).  
In study 2, pigs fed DS-37, although not significant, had a lower temperature than 
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the control group.  This could be an indication of reduced response by the pigs to 
the LPS. 
Serum Blood Chemistry: 
 Blood is involved in many functions of the body.  Blood has the capability 
to regulate body temperature by distributing heat.  It helps remove metabolic 
wastes by transporting them to the liver, kidneys, lungs, or intestines.  A defense 
system of white blood cells and antibodies is another function.  It is involved in 
respiration and nutrient transportation.  Blood regulates metabolism through 
hormone transportation.  Acid-base balance of the body is also maintained in the 
blood (Rand and Murray 2000). 
 Total protein consists mainly of globulin and albumin.  Serum total protein 
levels may be decreased as result of catabolism, which is a result of a fever, 
inflammation, or chronic disease.  Total protein may also be altered by serum 
IgG since it is composed of 15-25% of IgG.  Globulin and albumin levels are 
similar in the pig, but this is not true for all mammalian species.  Albumin levels 
run parallel with total protein levels (Mersmann and Pond 2001).  Globulin is 
found in three fractions, α, β, and γ, with various bodily responsibilities (Kaneko 
1989b).  With that no differences were found for globulin levels in study 1.  
Culture DS-36 in study 2 had a significantly lower globulin level than the control 
and DS-37 groups.  A possible explanation for the lower globulin level may be 
that culture DS-33 exhibited the lowest IgG level.  Serum IgG is one of the most 
abundant globulins found in the γ fraction (Swenson 1984).   
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Albumin:Globulin ratio will increase in dehydration because of an increase 
in albumin levels or as a result of a decrease in globulins.  Albumin may also 
increase due to it binding to serum constituents to be filtered by the kidneys.  
However, a decrease in albumin:globulin ratio could be a sign of liver problems 
(Kaneko 1989b).  In study 1 no differences were observed.  In study 2 the ratios 
were higher than the control group at hour 3.0 for cultures DS-36 and WB-76.  
These cultures numerically had the highest albumin levels for that hour as well.  
Cultures L. reuteri DS-36 or WB-76 may be helpful in reducing blood constituents 
during an immune response or cause dehydration. 
Total bilirubin (bili) is a measurement of the end product of red blood cell 
turnover.  It is produced by specialized macrophages in the liver.  It is conjugated 
in the liver and secreted into the bile.  It is converted several different times and 
is finally secreted out the feces which give it its brown color.  One of the end 
products is absorbed into the kidneys thus giving urine its yellow color (Yen 
2001).  In study 1, control group bili levels were numerically higher than pigs fed 
cultures DS-33, WB-75, and L-23.  In study 2 pigs fed DS-37 had a significantly 
lower level than the control.  It is thought that the lipopolysaccharide caused an 
inflammatory response in the pigs.  This response triggered the release of 
cytokines.  The cytokine, tumor necrosis factor (TNF), promoted anemia in the 
body by shortening red blood cells’ life span and decreasing production 
(Stockham 2000).  Since total bili is related to erythrocyte turnover, it is possible 
that the control group may have a higher TNF than pigs fed DS-37.  Thus, the 
control group red blood cells life spans were reduced, having a higher turnover, 
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and subsequent higher total bili.  When liver injury was induced, a reduction in 
total bilirubin has been reported in rats rectally supplemented with L. plantarum 
(Adawi et al. 1997).  The culture DS-37 has the possibility to reduce turnover of 
red blood cells in nursery pigs during an immune response. 
Serum triglyceride levels are increased during fasting (Mersmann and 
Pond 2001).  This held true for both studies.  The triglyceride levels drastically 
increased from hour 0 to hour 12 following the challenge with LPS.  The pigs 
were fed after the hour 12 measurement and by hour 24 triglyceride levels 
dropped.  Study 1 did not have any noticeable differences in serum triglyceride 
levels.  However, during study 2, the control had a significantly higher level than 
did the group fed DS-37.  It has been demonstrated that as hours of feed 
deprivation are increased so are triglyceride levels (Webel et al. 1997).  Keeping 
triglyceride levels low during a LPS challenge or feed deprivation in swine is 
possible by feeding the culture L. reuteri DS-37. 
The proteins VLDL, HDL, and LDL are considered to be α-globulins.  
Stress from temperature can cause VLDL and LDL to increase in the serum 
(Kaneko 1989a).  Very low-density lipoprotein (VLDL) is composed of 60% serum 
triglycerides (Mersmann and Pond 2001).  Study 1 did not have any observed 
differences for VLDL.  Study 2 pigs fed DS-37 had a significantly lower serum 
VLDL than the control pigs.  The reason could be the higher percentage of 
triglycerides found in VLDL.  Since the triglycerides increased, a trickle effect 
occurred where the VLDL also increased.  Another explanation is that LPS was 
bound by VLDL, HDL, and low-density lipoprotein (LDL) and secreted out of the 
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system through the liver cells, hepatocytes (Tuin 2006).  Therefore, culture DS-
37 will decrease VLDL during an intestinal Gram-negative challenge. 
Serum Immunoglobulins: 
 Immunoglobulins are a portion of γ-globulins and considered plasma 
proteins (Swenson 1984).    These proteins are secreted by plasma cells, B cells, 
unlike other globulins, which are synthesized in the liver (Rand and Murray 
2000).  They are able to function as membrane-bound and soluble proteins 
(Modiano 2000).  There are five classifications of immunoglobulins (Ig), IgA, IgD, 
IgE, IgG, and IgM.  Immunoglobulin G (IgG) is the most abundant of the 
immunoglobulins.  It is found in the blood and tissue (Swenson 1984).  It can bind 
to inflammatory cells that have special surface receptors (Modiano 2000).  
Immunoglobulin G opsonizes bacteria which makes it easier for phagocytosis.  It 
is also the main antibody for the secondary response that neutralizes viruses and 
bacterial toxins (Rand and Murray 2000).  The glycoprotein IgA is found in 
external excretions, such as colostrum, saliva, and tears.  It is involved in 
infections of microorganisms in the gastrointestinal tract and mouth (Swenson 
1984).  This immunoglobulin provides an important barrier at mucosal epithelial 
cells, which are involved in pathogenic bacteria (Porter 1973).  The initial 
antibody produced, IgM, attacks foreign red blood cells (Modiano 2000, Swenson 
1984). 
 Serum IgA levels for pigs fed culture L-23 was the only group in study 1 
that exhibited an increase, but it was only slight.  Study two culture DS-36 
caused a trend toward higher increased changes than the control pigs at hour 
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1.5, 3.0, and 6.0.  Therefore, a choice to increase IgA levels during a LPS 
response might be culture DS-36. 
 Serum IgG levels for pigs fed DS-33 in study 1 increased more than in the 
control group at hours 3.0 and 6.0.  In study 2, at hours 1.5 and 12, culture DS-
36 had higher increases than the control pigs.  A choice to increase IgG levels 
during a Gram-negative challenge are the cultures L. reuteri DS-33 and DS-36. 
 At hour 3.0 in study 1, culture L-23 exhibited the largest increased change 
serum IgM.  Culture WB-76 in study 2 had a higher increased change than the 
control for hours 1.5 and 12.  Thus, cultures L-23 and WB-76 have the potential 
to increase serum IgM during an LPS challenge. 
 It should also be mentioned that in study 2 there was an age difference in 
pigs in the two experiments.  Pigs in experiment 2 were 11 days younger than 
those in experiment1.  Some of the variability observed for this study could be 
related for this age difference. 
 Since the LPS was injected into the gut, studying the effects of intestinal 
immunoglobulins is future work to be completed.  It will be interesting to observe 
the differences of blood serum and intestinal immunoglobulins for the different 
cultures of lactobacilli.  Fecal immunoglobulins will be completed for this trial 
before submitting a manuscript for publication.  It has already been stated that 
IgA is secreted into the intestines.  Therefore, it will be interesting to observe the 
fecal IgA levels for the studies. 
As well as testing serum immunoglobulins, cytokines are another indicator 
of an immune response.  Webel et al. (1997) reported after 2 hours of an 
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intraperitoneal injection of 5 µL/kg of body weight of LPS E. coli K-235,  plasma 
tumor necrosis factor- α (TNF-α) was elevated 10-fold.  Interleukin-6 (IL-6) was 
elevated 200-fold by hour 4 of the challenge.  These cytokines are made by 
stimulated macrophages (Van Heugten et al. 1994).  The cytokines TNF-α and 
IL-6 will be tested on blood serum before manuscript submission.   
Suggested future research would be to evaluate the influence of different 
cultures of lactobacilli on complete blood cell counts.  The blood cells should 
respond to a bacterial infection.  Erythrocytes and platelets will change during 
most bacterial infections.  Mast cells contribute a role in unique inflammatory 
responses.  Basophils and eosinophils have an essential role in tissue 
inflammation (Stockham 2000).  Thus, it would be interesting to study these 
effects on pigs fed the cultures of lactobacilli during a similar LPS challenge. 
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APPENDIX A 
SWINE CUTLURES 
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Carbohydrate Bergey'sb DS-29c DS-31c DS-33c DS-35c DS-36c DS-37c DS-38c DS-39c
D-Arabinose + - - - - - - - -
Ribose + + + + + + + + +
D-Xylose - - - + + + + + +
Galactose + + + + + + + + +
D-Glucose + + + + + + + + +
D-Fructose + - - - - - - - -
D-Mannose - - - - - - - - -
Rhamnose - - - - - - - - -
Mannitol - - - - - - - + -
Sorbitol оd - - - - - - - -
Amygdaline оd - - - - - - - -
Esculine - - - - - - - - -
Salicine - - - - - - + - -
Cellobiose - - - - - - + - -
Maltose + + + + + + + + -
Lactose + + + + + + + + -
Melibiose + + + + + + + + +
Saccharose + - - + + + - + +
Trehalose - - - - - - + - -
Melezitose - - - - - - - - -
D-Raffinose + + + + + + + + +
Gluconate + - - - - - - - -
Growth at 15°C - - - - - - - - -
Growth at 45°C + + + + + + + + +
NH4+ from Arg. + + + + + + + + +
d
о = reaction not determined
Table A1. Identification of isolates from domestic pigs of Lactobacillus reuteri by phenotypic characterizationa
bThe carbohydrate reactions are from the 9th Edition of Bergery's Manual of Determinative Bacteriology
aBased on the API 50 CH system (bioMérieux, France)
cAll were Gram positive, catalase negative rods
 
 99
Carbohydrate Bergey'sb WB-72c WB-74c WB-75c WB-76c WB-78c
D-Arabinose + - - - - -
Ribose + + + + + +
D-Xylose - + + + + +
Galactose + + + + + +
D-Glucose + + + + + +
D-Fructose + + - + + +
D-Mannose - - - - - -
Rhamnose - - - - - -
Mannitol - - - - - -
Sorbitol оd - - - - -
Amygdaline оd + - - - -
Esculine - + + + + +
Salicine - + + - + -
Cellobiose - - - - - -
Maltose + + + + + +
Lactose + + + + + +
Melibiose + + + + + +
Saccharose + + + + + +
Trehalose - - - - - -
Melezitose - - - - - -
D-Raffinose + + + + + +
Gluconate + + + - - +
Growth at 15°C - - - - - -
Growth at 45°C + + + + + +
NH4+ from Arg. + + + + + +
Table A2. Identification of isolates from wild boar intestines of Lactobacillus reuteri  by 
phenotypic characterization
d
о = reaction not determined
cAll were catalase negative, Gram positive rods
aBased on the API 50 CH system (bioMérieux, France)
bThe carbohydrate reactions are from the 9th Edition of Bergery's Manual of Determinative 
Bacteriology
 
 100
Carbohydrate Bergey'sb
D-Arabinose -
Ribose -
D-Xylose -
Galactose +
D-Glucose +
D-Fructose +
D-Mannose +
Rhamnose -
Mannitol -
Sorbitol -
Amygdaline +
Esculine +
Salicine +
Cellobiose +
Maltose +
Lactose +
Melibiose +/-
Saccharose +
Trehalose +/-
Melezitose -
D-Raffinose +/-
Amidon +
Gluconate -
Growth at 15°C -
Growth at 45°C +
NH4+ from Arg. -
aBased on the API 50 CH system (bioMérieux, France)
bThe carbohydrate reactions are from the 9th Edition of 
Bergery's Manual of Determinative Bacteriology
cL. acidophilus  L-23 is a catalase negative, Gram positive 
rod
+
+
+
+
-
+
-
-
+
+
-
-
+
+
+
-
+
+
+
+
+
+
+
Table A3. Identification of Lactobacillus acidophilus  L-23 
by phenotypic characterizationa
L. acidophilus  L-23c
-
+
+
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Isolate Rep Hour 1b Hour 2b Hour 3b Hour 4b Hour 5b Hour 6b Hour 7b
1 0.040 0.105 0.299 0.575 0.785 1.166 1.341
2 0.034 0.085 0.239 0.512 0.682 0.959 1.154
Mean 0.037 0.095 0.269 0.544 0.734 1.063 1.248
1 0.043 0.111 0.278 0.550 0.694 1.044 1.154
2 0.039 0.076 0.227 0.516 0.718 1.024 1.234
Mean 0.041 0.094 0.253 0.533 0.706 1.034 1.194
1 0.046 0.136 0.343 0.598 0.983 1.153 1.203
2 0.032 0.092 0.257 0.516 0.818 0.824 1.210
Mean 0.039 0.114 0.300 0.557 0.901 0.989 1.207
1 0.040 0.103 0.274 0.536 0.693 1.006 1.231
2 0.036 0.088 0.246 0.500 0.648 0.928 1.168
Mean 0.038 0.096 0.260 0.518 0.671 0.967 1.200
1 0.057 0.135 0.342 0.653 0.765 0.937 1.180
2 0.036 0.100 0.287 0.542 0.689 0.776 1.180
Mean 0.047 0.118 0.315 0.598 0.727 0.857 1.180
1 0.039 0.980 0.231 0.463 0.722 0.854 0.971
2 0.048 0.098 0.228 0.426 0.623 0.720 1.019
Mean 0.044 0.539 0.230 0.445 0.673 0.787 0.995
1 0.035 0.139 0.315 0.542 0.861 0.945 1.030
2 0.039 0.106 0.276 0.478 0.660 0.662 1.048
Mean 0.037 0.123 0.296 0.510 0.761 0.804 1.039
1 0.052 0.146 0.326 0.576 0.672 0.937 0.824
2 0.047 0.106 0.266 0.481 0.753 0.956 0.921
Mean 0.050 0.126 0.296 0.529 0.713 0.947 0.873
1 0.036 0.114 0.304 0.702 0.971 1.416 1.446
2 0.025 0.078 0.215 0.436 0.659 0.767 0.821
Mean 0.031 0.096 0.260 0.569 0.815 1.092 1.134
1 0.041 0.100 0.250 0.577 0.811 1.431 1.301
2 0.022 0.061 0.190 0.397 0.601 0.703 0.771
Mean 0.032 0.081 0.220 0.487 0.706 1.067 1.036
1 0.036 0.100 0.267 0.650 0.846 1.384 1.414
2 0.022 0.060 0.180 0.388 0.601 0.699 0.769
Mean 0.029 0.080 0.224 0.519 0.724 1.042 1.092
1 0.034 0.100 0.288 0.685 0.863 1.217 1.507
2 0.022 0.068 0.200 0.427 0.619 0.701 0.767
Mean 0.028 0.084 0.244 0.556 0.741 0.959 1.137
1 0.037 0.101 0.269 0.643 1.046 1.401 1.221
2 0.019 0.054 0.171 0.366 0.570 0.682 0.742
Mean 0.028 0.078 0.220 0.505 0.808 1.042 0.982
1 0.036 0.076 0.153 0.354 0.548 0.678 0.732
2 0.036 0.060 0.126 0.263 0.476 0.658 0.738
Mean 0.036 0.068 0.140 0.309 0.512 0.668 0.735
L. reuteri DS-31
L. reuteri DS-39
L. reuteri DS-38
L. reuteri DS-37
L. reuteri DS-36
L. reuteri DS-35
L. reuteri DS-33
Table A4. Bile tolerance of cultures of lactobacillia
L. reuteri DS-29
aIn deMan, Rogasa, Sharpe (MRS) broth + 0.3% oxgall 
bValues are increases in A620nm at 37°C.
L. acidophilus L-23
L. reuteri WB-78
L. reuteri WB-76
L. reuteri WB-75
L. reuteri WB-74
L. reuteri WB-72
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Isolate Rep 1b Rep 2b Mean
L. reuteri DS-29 0.575 0.512 0.544
L. reuteri DS-31 0.550 0.516 0.533
L. reuteri DS-33 0.598 0.516 0.557
L. reuteri DS-35 0.536 0.500 0.518
L. reuteri DS-36 0.653 0.542 0.598
L. reuteri DS-37 0.463 0.397 0.430
L. reuteri DS-38 0.542 0.478 0.510
L. reuteri DS-39 0.576 0.481 0.529
L. reuteri WB-72 0.702 0.436 0.569
L. reuteri WB-74 0.577 0.397 0.487
L. reuteri WB-75 0.650 0.388 0.519
L. reuteri WB-76 0.685 0.427 0.556
L. reuteri WB-78 0.643 0.366 0.505
L. acidophilus L-23 0.354 0.263 0.309
Table A5. Comparisons of bile tolerance of cultures of 
lactobacillia
bValues are increases in A620nm after hour 4 at 37°C.
aIn deMan, Rogasa, Sharpe (MRS) broth + 0.3% oxgall 
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APPENDIX B 
STUDY 1 RAW DATA 
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Treatmentb Exp. Day 0 Day 3 or 4
1 1.72 3.08
2 2.38 2.86
1 7.91 8.00
2 8.06 8.06
1 8.00 7.53
2 7.98 6.76
1 7.23 6.60
2 7.30 6.62
1 7.76 7.71
2 7.96 7.90
aPlated on deMan, Rogasa, Sharpe agar (MRSA)
bIdeal count for treatments was 8.00 log10 cfu/mL
L. acidophilus L-23
L. reuteri WB-75
L. reuteri WB-74
Table B1. Study 1 treatment counts of lactobacillia 
(Log10 cfu/mL)
Control
L. reuteri DS-33
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Study Treatmenta
Exp. 1 
Pigb
Crate 
Number
Exp. 2 
Pigc
Crate 
Number
10-4 3 33-12 1
5-1 8 30-9 3
2-5 13 41-7 14
9-3 2 41-5 2
2-1 9 33-11 8
7-3 12 38-8 15
2-3 1 41-6 4
7-4 10 31-6 5
10-13 14 33-13 11
12-4 4 33-8 10
9-2 7 41-3 6
5-4 11 36-4 9
7-6 16 33-7 16
12-1 6 41-2 7
4-1 15 30-10 12
cExperiment 2 were all gilts (n=15)
1
L. reuteri WB-75
L. acidophilus L-23
Table B2. Swine assignments for study 1 feeding lactobacilli cultures
Control
L. reuteri DS-33
L. reuteri WB-74
aAll treatments were fed 10 mL twice a day; Lactobacilli concentrations 
fed were 1 x 109 cfu/mL
bExperiment 1 were all barrows (n=15)
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 12.43 16.60 19.87 24.58
8 9.98 13.15 18.14 20.68
13 11.25 16.33 16.87 20.23
11.22 15.36 18.29 21.83
1 11.52 15.15 18.60 24.63
3 10.07 13.15 16.51 21.50
14 9.03 11.52 14.42 19.28
10.21 13.28 16.51 21.80
10.78 14.47 17.53 21.82
2 12.34 16.51 22.50 26.67
9 10.89 13.43 18.05 21.41
12 10.80 14.97 20.96 26.49
11.34 14.97 20.50 24.86
2 11.70 15.51 19.05 24.40
8 10.30 14.51 17.87 22.41
15 8.44 10.98 14.24 18.73
10.15 13.67 17.06 21.85
10.83 14.41 19.02 23.57
1 12.79 17.24 21.68 24.68
10 10.80 15.06 20.32 25.04
14 10.34 12.25 15.69 18.51
11.31 14.85 19.23 22.74
4 11.43 14.61 17.06 22.00
5 10.07 13.52 16.83 20.87
11 8.71 12.25 15.69 21.05
10.07 13.46 16.53 21.30
10.78 14.25 18.07 22.12
4 11.61 15.79 20.41 24.58
7 11.34 14.97 19.32 22.23
11 10.07 14.51 19.32 22.86
11.01 15.09 19.69 23.22
6 10.43 12.52 15.42 19.64
9 9.80 13.34 16.01 20.68
10 11.34 15.06 17.60 22.14
10.52 13.64 16.34 20.82
10.80 14.47 18.25 22.19
5 13.15 16.96 23.22 27.31
6 11.79 14.70 18.87 22.95
15 10.70 14.15 18.05 21.32
11.88 15.27 20.05 23.86
7 10.80 13.43 16.96 21.86
12 7.89 11.34 14.88 19.14
13 12.25 16.15 18.87 25.04
10.31 13.64 16.90 22.01
11.21 14.57 18.70 23.07
Table B3 . Study 1 weekly swine weights (kg)
Control
1b
2c
Overall Mean
L. acidophilus L-23
2c
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
1b
2c
Overall Mean
L. reuteri WB-75
bExperiment 1 were barrows
Overall Mean
L. reuteri DS-33
1b
2c
Overall Mean
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-74
1b
2c
cExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1b
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
3 0.60 0.47 0.79
8 0.45 0.71 0.42
13 0.73 0.08 0.56
0.59 0.42 0.59
1 0.52 0.49 0.75
3 0.44 0.48 0.62
14 0.36 0.41 0.61
0.44 0.46 0.66
0.52 0.44 0.63
2 0.60 0.86 0.70
9 0.36 0.66 0.56
12 0.60 0.86 0.92
0.52 0.79 0.73
2 0.54 0.51 0.67
8 0.60 0.48 0.57
15 0.36 0.47 0.56
0.50 0.48 0.60
0.51 0.64 0.66
1 0.64 0.64 0.50
10 0.61 0.75 0.79
14 0.27 0.49 0.47
0.51 0.63 0.58
4 0.45 0.35 0.62
5 0.49 0.47 0.50
11 0.51 0.49 0.67
0.48 0.44 0.60
0.49 0.53 0.59
4 0.60 0.66 0.70
7 0.52 0.62 0.48
11 0.64 0.69 0.59
0.58 0.66 0.59
6 0.30 0.41 0.53
9 0.51 0.38 0.58
10 0.53 0.36 0.57
0.44 0.39 0.56
0.51 0.52 0.57
5 0.54 0.89 0.68
6 0.41 0.60 0.68
15 0.49 0.56 0.54
0.48 0.68 0.64
7 0.38 0.51 0.61
12 0.49 0.51 0.53
13 0.56 0.39 0.77
0.48 0.47 0.64
0.48 0.57 0.64
bDescription of treatments, experiments, and pigs - see Table B2
aADG - average daily gain
cExperiment 1 were barrows
dExperiment 2 were gilts
L. acidophilus L-23
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-75
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-74
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-33
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Table B4. Study 1 weekly ADGa (kg)
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
3 0.69 0.96 1.54
8 0.58 1.00 1.03
13 0.76 0.84 0.98
0.68 0.93 1.18
1 0.75 0.98 1.23
3 0.68 0.88 1.01
14 0.54 0.74 1.11
0.66 0.87 1.12
0.67 0.90 1.15
2 0.86 1.10 1.45
9 0.50 0.85 1.16
12 0.95 1.21 1.69
0.77 1.05 1.43
2 0.86 0.94 1.19
8 0.85 0.95 1.08
15 0.62 0.84 1.06
0.78 0.91 1.11
0.77 0.98 1.27
1 0.95 1.03 1.34
10 0.83 1.02 1.59
14 0.51 0.85 1.08
0.76 0.97 1.34
4 0.74 0.92 1.10
5 0.82 0.89 1.04
11 0.75 0.92 1.19
0.77 0.91 1.11
0.77 0.94 1.22
4 0.80 1.02 1.23
7 0.74 1.00 1.10
11 0.65 1.09 1.48
0.73 1.04 1.27
6 0.62 0.85 0.96
9 0.78 0.80 1.05
10 0.84 0.83 1.16
0.75 0.83 1.06
0.74 0.93 1.16
5 0.80 1.24 1.47
6 0.63 0.91 1.13
15 0.78 0.99 0.87
0.74 1.04 1.16
7 0.67 0.94 1.16
12 0.70 0.92 1.06
13 0.79 0.93 1.24
0.72 0.93 1.15
0.73 0.99 1.16
aADFI - average daily feed intake
bDescription of treatments, experiments, and pigs - see Table B2
cExperiment 1 were barrows
dExperiment 2 were gilts
L. acidophilus L-23
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-75
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-74
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-33
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Table B5. Study 1 weekly ADFIa (kg)
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
3 1.16 2.05 1.96
8 1.29 1.40 2.43
13 1.04 10.75 1.75
1.16 4.73 2.05
1 1.45 1.99 1.63
3 1.54 1.83 1.62
14 1.53 1.78 1.83
1.51 1.87 1.69
1.34 3.30 1.87
2 1.44 1.29 2.08
9 1.38 1.29 2.07
12 1.59 1.41 1.83
1.47 1.33 1.99
2 1.58 1.86 1.78
8 1.42 1.97 1.91
15 1.71 1.80 1.89
1.57 1.88 1.86
1.52 1.60 1.93
1 1.50 1.62 2.68
10 1.37 1.36 2.02
14 1.86 1.72 2.30
1.58 1.57 2.33
4 1.63 2.62 1.79
5 1.66 1.87 2.06
11 1.49 1.86 1.78
1.59 2.12 1.88
1.59 1.84 2.11
4 1.34 1.55 1.77
7 1.42 1.61 2.28
11 1.03 1.59 2.51
1.26 1.58 2.19
6 2.08 2.05 1.83
9 1.54 2.10 1.80
10 1.58 2.28 2.04
1.73 2.14 1.89
1.50 1.86 2.04
5 1.48 1.38 2.16
6 1.51 1.53 1.65
15 1.58 1.77 1.60
1.52 1.56 1.80
7 1.79 1.85 1.90
12 1.42 1.83 1.99
13 1.41 2.40 1.61
1.54 2.03 1.83
1.53 1.79 1.82
aF:G - feed to gain
bDescription of treatments, experiments, and pigs - see Table B2
cExperiment 1 were barrows
dExperiment 2 were gilts
L. acidophilus L-23
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-75
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-74
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-33
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Table B6. Study 1 weekly F:G ratioa 
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga ADGb ADFIc F:Gd
3 0.62 1.06 1.64
8 0.53 0.87 1.57
13 0.45 0.86 1.84
0.53 0.93 1.68
1 0.59 0.99 1.68
3 0.51 0.86 1.66
14 0.46 0.80 1.74
0.52 0.88 1.69
0.53 0.91 1.69
2 0.72 1.14 1.51
9 0.53 0.84 1.51
12 0.79 1.28 1.55
0.68 1.08 1.52
2 0.57 1.00 1.74
8 0.55 0.96 1.76
15 0.46 0.84 1.82
0.53 0.93 1.77
0.60 1.01 1.65
1 0.59 1.11 1.84
10 0.72 1.15 1.53
14 0.41 0.81 1.89
0.57 1.02 1.75
4 0.47 0.92 1.93
5 0.49 0.91 1.88
11 0.56 0.95 1.72
0.51 0.93 1.84
0.54 0.98 1.80
4 0.65 1.02 1.50
7 0.54 0.95 1.68
11 0.64 1.08 1.59
0.61 1.01 1.59
6 0.41 0.81 1.96
9 0.49 0.88 1.79
10 0.49 0.94 1.94
0.46 0.88 1.90
0.54 0.95 1.74
5 0.71 1.17 1.58
6 0.56 0.89 1.52
15 0.53 0.88 1.62
0.60 0.98 1.57
7 0.50 0.92 1.86
12 0.51 0.89 1.76
13 0.57 0.99 1.72
0.53 0.93 1.78
0.56 0.96 1.68
L. reuteri WB-75
1e
2f
Overall Mean
eExperiment 1 were barrows
fExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table B2
dF:G - feed to gain ratio
L. acidophilus L-23
1e
2f
Overall Mean
bADG - average daily gain
cADFI - average daily feed intake
Exp. 2 Mean
Exp. 2 Mean
L. reuteri DS-33
1e
2f
L. reuteri WB-74
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
Exp. 2 Mean
1e
2f
Table B7. Study 1 overall growth and performance (kg)
Control
1e
2f
Overall Mean
Exp. 1 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 5.80 7.18 6.43 8.59
8 8.54 6.74 7.34 6.40
13 5.86 6.56 7.11 5.76
6.74 6.82 6.96 6.91
1 8.18 6.85 5.54 6.75
3 7.30 6.32 5.87 5.86
14 7.65 7.51 6.76 5.20
7.71 6.89 6.06 5.94
7.22 6.86 6.51 6.43
2 6.78 5.91 5.86 7.11
9 7.26 5.83 7.70 6.15
12 5.73 5.94 5.76 4.08
6.59 5.89 6.44 5.78
2 6.69 5.83 6.36 6.20
8 8.90 7.53 7.32 6.57
15 6.40 7.26 8.30 6.52
7.33 6.87 7.33 6.43
6.96 6.38 6.88 6.11
1 5.04 7.73 7.72 5.41
10 6.04 7.36 7.74 6.04
14 4.88 4.73 5.45 6.04
5.32 6.61 6.97 5.83
4 6.43 5.92 7.89 6.78
5 7.52 8.00 7.73 7.86
11 8.20 7.69 7.26 5.94
7.38 7.20 7.62 6.86
6.35 6.91 7.30 6.35
4 6.28 6.74 7.94 7.08
7 5.98 6.30 5.91 6.11
11 7.15 7.26 6.90 7.11
6.47 6.77 6.92 6.77
6 7.46 6.76 5.65 4.69
9 6.30 6.23 6.88 5.97
10 7.08 4.93 8.08 5.15
6.95 5.97 6.87 5.27
6.71 6.37 6.89 6.02
5 5.96 5.81 6.62 7.64
6 8.08 5.61 6.26 5.94
15 7.34 5.53 6.15 6.79
7.13 5.65 6.34 6.79
7 6.88 7.20 7.20 7.63
12 6.67 6.95 6.76 7.23
13 7.80 7.95 6.48 5.99
7.12 7.37 6.81 6.95
7.12 6.51 6.58 6.87
bDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-74
1c
2d
Overall Mean
L. acidophilus L-23
Overall Mean
L. reuteri DS-33
1c
2d
Overall Mean
Table B8. Study 1 weekly fecal counts of coliformsa (Log10 cfu/mL)
Control
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aPlated on violet red bile agar (VRBA)
2d
Overall Mean
L. reuteri WB-75
1c
2d
dExperiment 2 were gilts
cExperiment 1 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
1c
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 9.60 9.92 7.82 8.11
8 10.00 9.60 9.15 9.40
13 9.83 9.18 9.59 9.11
9.81 9.57 8.85 8.88
1 9.88 9.65 9.78 9.63
3 9.08 9.04 9.38 9.45
14 9.54 9.71 9.26 9.51
9.50 9.47 9.47 9.53
9.65 9.52 9.16 9.20
2 9.84 9.51 7.34 8.08
9 9.72 8.93 9.30 8.99
12 9.85 9.00 9.23 9.62
9.80 9.14 8.62 8.90
2 9.81 9.30 9.36 9.11
8 9.93 9.15 9.57 9.00
15 9.46 10.08 9.18 9.43
9.73 9.51 9.37 9.18
9.77 9.33 9.00 9.04
1 9.80 9.49 9.30 8.63
10 9.72 7.20 8.15 9.28
14 8.87 7.89 8.98 9.18
9.46 8.19 8.81 9.03
4 9.46 9.08 8.87 9.15
5 9.83 9.32 8.08 9.43
11 9.63 9.26 9.58 9.57
9.64 9.22 8.84 9.38
9.55 8.71 8.83 9.21
4 9.51 9.85 8.23 8.28
7 9.34 9.53 8.26 8.90
11 8.98 8.32 8.98 9.36
9.28 9.23 8.49 8.85
6 9.67 9.34 9.61 9.65
9 9.59 8.58 9.34 9.56
10 9.34 9.41 9.69 9.87
9.54 9.11 9.55 9.69
9.41 9.17 9.02 9.27
5 9.45 9.28 9.11 9.61
6 9.08 9.45 7.67 9.41
15 9.74 9.72 7.94 10.11
9.42 9.48 8.24 9.71
7 9.00 8.77 8.57 9.00
12 9.08 9.00 9.11 9.08
13 9.53 9.11 7.91 9.32
9.20 8.96 8.53 9.13
9.31 9.22 8.39 9.42
Table B9. Study 1 weekly fecal counts of lactobacillia (Log10 cfu/mL)
Control
1c
2d
Overall Mean
L. reuteri DS-33
1c
2d
Overall Mean
Exp. 1 Mean
2d
Overall Mean
L. reuteri WB-75
1c
2d
Overall Mean
Exp. 1 Mean
L. reuteri WB-74
1c
L. acidophilus L-23
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
aPlated on Lactobacillus selection agar (LBSA)
bDescription of treatments, experiments, and pigs - see Table B2
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Treatmentb Exp.b Pigb Day 0c Week 1 Week 2 Week 3
3 NA 4.00 4.00 4.69
8 NA 4.54 4.00 4.59
13 NA 4.00 4.00 4.00
NA 4.18 4.00 4.43
1 4.00 4.00 4.00 4.00
3 6.30 4.34 4.00 4.54
14 5.45 4.65 4.53 4.54
5.25 4.33 4.18 4.36
5.25 4.26 4.09 4.39
2 NA 4.00 4.00 4.00
9 NA 4.59 4.00 4.00
12 NA 4.00 4.00 4.00
NA 4.20 4.00 4.00
2 4.48 4.00 4.79 4.00
8 4.00 4.57 4.00 4.00
15 4.00 4.00 4.00 4.56
4.16 4.19 4.26 4.19
4.16 4.19 4.13 4.09
1 NA 4.40 4.00 4.00
10 NA 6.90 6.46 4.54
14 NA 4.71 4.00 4.48
NA 4.79 4.56 4.19
4 4.00 4.00 4.00 4.41
5 4.00 4.00 4.00 4.00
11 5.76 4.64 4.18 4.43
4.37 4.10 4.81 4.19
4.37 4.45 4.69 4.19
4 NA 4.45 4.57 4.00
7 NA 4.57 4.60 5.51
11 NA 4.46 4.38 4.00
NA 4.49 4.52 4.50
6 5.94 4.00 4.00 4.41
9 4.00 4.00 4.00 4.00
10 4.00 4.48 4.04 4.74
4.65 4.16 4.01 4.38
4.65 4.33 4.27 4.44
5 NA 4.00 4.61 4.56
6 NA 4.49 4.43 4.00
15 NA 5.88 4.64 4.00
NA 4.79 4.56 4.19
7 4.41 4.30 5.90 4.58
12 4.00 4.00 4.53 4.00
13 4.71 4.00 4.00 4.00
4.37 4.10 4.81 4.19
4.37 4.45 4.69 4.19
Table B10. Study 1 weekly fecal counts of Campylobacter a (Log10 cfu/mL)
Control
1d
Exp. 1 Mean
2e
Exp. 2 Mean
Overall Mean
L. reuteri DS-33
1d
Exp. 1 Mean
2e
Exp. 2 Mean
Overall Mean
L. reuteri WB-74
1d
Exp. 1 Mean
2e
Exp. 2 Mean
Overall Mean
Overall Mean
L. reuteri WB-75
1d
Exp. 1 Mean
2e
Exp. 2 Mean
Overall Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table B2
dExperiment 1 were barrows
eExperiment 2 were gilts
cNA - not analyzed
L. acidophilus L-23
1d
Exp. 1 Mean
2e
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0c Week 1 Week 2 Week 3
3 NA - - +
8 NA + - +
13 NA - - -
NA 1 0 2
1 - - - -
3 + + - +
14 + + + +
2 2 1 2
2 3 1 4
2 NA - - -
9 NA + - -
12 NA - - -
NA 1 0 0
2 + - + -
8 - + - -
15 - - - +
1 1 1 1
1 2 1 1
1 NA + - -
10 NA + + +
14 NA + - +
NA 3 1 2
4 - - - +
5 - - - -
11 + + + +
1 1 1 2
1 4 2 4
4 NA + + -
7 NA + + +
11 NA + + -
NA 3 3 1
6 + - - +
9 - - - -
10 - + + +
1 1 1 2
1 4 4 3
5 NA - + +
6 NA + + -
15 NA + + -
NA 2 3 1
7 + + + +
12 - - + -
13 + - - -
2 1 2 1
2 3 5 2
Table B11. Study 1 testing of weekly fecal cultures of Campylobacter positivesa
1d
2e
Overall Mean
Control
Exp. 2 Mean
2e
1d
1d
2e
2e
Overall Mean
Overall Mean
L. reuteri DS-33
Overall Mean
L. reuteri WB-74
cNA - not analyzed
1d
L. acidophilus L-23
1d
2e
Overall Mean
aTesting was done on the Bax® system
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-75
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 + + + +
8 + + + +
13 + + + +
3 3 3 3
1 - - - -
3 + + + +
14 + + + +
2 2 2 2
5 5 5 5
2 + + + +
9 + + + +
12 + + + +
3 3 3 3
2 + + + +
8 - + + +
15 + + + -
2 3 3 2
5 6 6 5
1 + + + -
10 + + + +
14 + + + +
3 3 3 2
4 + + + +
5 - - - -
11 + + + -
2 2 2 1
5 5 5 3
4 + + - +
7 + + + +
11 + + + +
3 3 2 3
6 + + + +
9 + + + -
10 + + + +
3 3 3 2
6 6 5 5
5 + + + +
6 + + + +
15 + + - +
3 3 2 3
7 + + + +
12 - + + -
13 + + - -
2 3 2 1
5 6 4 4
L. reuteri WB-75
1c
2d
Overall Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table B2
L. acidophilus L-23
1c
2d
Overall Mean
1c
2d
Overall Mean
Exp. 1 Mean
L. reuteri WB-74
1c
2d
Overall Mean
Exp. 1 Mean
Table B12. Study 1 testing of weekly fecal enrichment cultures of Campylobacter 
positivesa
Control
1c
2d
Overall Mean
Exp. 1 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-33
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 - - - -
8 - - - -
13 - - - -
0 0 0 0
1 - - - -
3 - - - -
14 - - - -
0 0 0 0
0 0 0 0
2 - - - -
9 - - - -
12 - - - -
0 0 0 0
2 - - - -
8 - - - -
15 - - - -
0 0 0 0
0 0 0 0
1 - - - -
10 - - - -
14 - - - -
0 0 0 0
4 - - - -
5 - - - -
11 - - - -
0 0 0 0
0 0 0 0
4 - - - -
7 - - - -
11 - - - -
0 0 0 0
6 - - - -
9 - - - -
10 - - - -
0 0 0 0
0 0 0 0
5 - - - -
6 - - - -
15 - - - -
0 0 0 0
7 - - - -
12 - - - -
13 - - - -
0 0 0 0
0 0 0 0
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table B2
L. acidophilus L-23
1c
2d
Overall Mean
2d
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri WB-75
1c
2d
Overall Mean
Exp. 1 Mean
Table B13. Study 1 testing of weekly fecal enrichment cultures of Salmonella 
positivesa  
Control
Exp. 2 Mean
Exp. 1 Mean
L. reuteri WB-74
1c
2d
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1c
2d
Overall Mean
L. reuteri DS-33
1c
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 135 117 116 123
8 122 112 109 120
13 126 111 95 113
128 113 107 119
1 111 117 103 133
3 131 112 119 140
14 110 111 107 116
117 113 110 130
123 113 108 124
2 124 127 117 130
9 129 120 144 142
12 110 86 105 124
120 111 122 132
2 124 127 111 122
8 99 120 114 106
15 96 86 133 104
106 111 119 111
112 111 121 121
1 126 131 121 113
10 133 141 135 133
14 106 105 101 90
120 126 119 112
4 105 131 108 152
5 103 141 101 136
11 124 105 125 128
111 126 111 139
114 126 115 125
4 126 112 114 128
7 123 116 117 121
11 104 101 109 118
118 110 113 122
6 109 112 104 111
9 119 116 102 127
10 119 101 108 145
116 110 105 128
117 110 109 125
5 123 120 118 118
6 132 112 103 115
15 116 131 106 125
124 121 109 119
7 99 120 126 131
12 101 112 97 140
13 109 131 105 176
103 121 109 149
113 121 109 134
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-75
Overall Mean
L. reuteri DS-33
Overall Mean
1b
2c
2c
cExperiment 2 were gilts
bExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
1b
2c
1b
Exp. 2 Mean
Overall Mean
Table B14. Study 1 weekly glucose levels (mg/dL)
1b
2c
Overall Mean
Control
L. acidophilus L-23
L. reuteri WB-74
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
2c
1b
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 9 8 9 9
8 12 8 9 7
13 9 15 6 8
10 10 8 8
1 11 8 6 7
3 10 8 6 8
14 8 15 8 10
10 10 7 8
10 10 7 8
2 7 8 8 9
9 9 13 10 9
12 10 8 9 9
9 10 9 9
2 7 8 8 9
8 7 13 7 9
15 7 8 6 9
7 10 7 9
8 10 8 9
1 6 5 7 8
10 9 8 7 7
14 11 16 10 12
9 10 8 9
4 10 5 7 14
5 7 8 7 8
11 13 16 7 9
10 10 7 10
9 10 8 10
4 7 11 10 8
7 6 6 7 7
11 6 6 8 6
6 8 8 7
6 8 11 10 11
9 7 6 8 8
10 7 6 9 7
7 8 9 9
7 8 9 8
5 9 9 12 11
6 9 10 7 6
15 7 7 6 5
8 9 8 7
7 14 9 9 9
12 11 10 8 10
13 9 7 5 10
11 9 7 10
10 9 8 9
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table B2
aBUN - blood urea nitrogen
Table B15. Study 1 weekly BUNa levels (mg/dL)
1c
2d
1c
2d
L. reuteri WB-75
Control
L. reuteri DS-33
L. acidophilus L-23
2d
1c
Overall Mean
2d
1c
L. reuteri WB-74
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 1.0 0.9 1.0 1.0
8 0.9 0.9 0.9 1.0
13 0.8 1.1 0.9 1.1
0.9 1.0 0.9 1.0
1 1.2 0.9 1.0 1.1
3 1.0 0.9 1.1 1.0
14 1.0 1.1 1.1 1.1
1.1 1.0 1.1 1.1
1.0 1.0 1.0 1.1
2 0.9 1.0 1.1 1.1
9 1.0 1.2 1.0 1.0
12 0.8 0.8 0.9 0.9
0.9 1.0 1.0 1.0
2 0.9 1.0 1.2 1.3
8 0.9 1.2 1.2 1.0
15 1.0 0.8 0.9 0.9
0.9 1.0 1.1 1.1
0.9 1.0 1.1 1.0
1 0.9 0.8 0.9 0.9
10 0.9 1.0 1.0 1.0
14 0.9 1.2 1.0 1.0
0.9 1.0 1.0 1.0
4 1.0 0.8 1.3 1.7
5 1.0 1.0 1.0 1.2
11 1.1 1.2 1.1 1.1
1.0 1.0 1.1 1.3
1.0 1.0 1.1 1.2
4 0.9 0.9 1.1 1.1
7 0.9 0.9 0.9 1.1
11 0.9 1.0 0.9 1.0
0.9 0.9 1.0 1.1
6 1.0 0.9 1.2 1.2
9 1.0 0.9 1.1 1.2
10 0.9 1.0 1.3 1.2
1.0 0.9 1.2 1.2
0.9 0.9 1.1 1.1
5 1.0 1.2 1.2 1.1
6 0.9 1.1 1.0 1.0
15 0.7 0.8 0.9 0.9
0.9 1.0 1.0 1.0
7 1.4 1.2 1.2 1.2
12 1.2 1.1 1.0 1.4
13 1.1 0.8 1.0 1.4
1.2 1.0 1.1 1.3
1.1 1.0 1.1 1.2
cExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bExperiment 1 were barrows
Overall Mean
Overall Mean
2c
L. acidophilus L-23
L. reuteri WB-75
L. reuteri DS-33
2c
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aDescription of treatments, experiments, and pigs - see Table B2
1b
1b
2c
1b
2c
Overall Mean
Overall Mean
L. reuteri WB-74
Exp. 1 Mean
Table B16. Study 1 weekly creatinine levels (mg/dL)
1b
2c
1b
Overall Mean
Control
Exp. 1 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 9.8 9.3 9.0 8.6
8 13.6 8.9 10.7 6.4
13 11.3 13.4 6.8 7.4
11.6 10.5 8.8 7.5
1 8.9 9.3 6.1 6.3
3 10.7 8.9 5.9 8.1
14 7.6 13.4 6.9 8.9
9.1 10.5 6.3 7.8
10.3 10.5 7.6 7.6
2 7.9 7.8 7.1 8.3
9 9.1 11.3 9.5 8.7
12 12.1 9.6 10.1 9.7
9.7 9.6 8.9 8.9
2 7.3 7.8 6.4 6.6
8 8.1 11.3 6.4 8.8
15 7.0 9.6 6.8 10.0
7.5 9.6 6.5 8.5
8.6 9.6 7.7 8.7
1 7.0 6.7 8.0 8.8
10 10.5 7.6 6.7 6.8
14 11.9 12.9 10.3 12.0
9.8 9.1 8.3 9.2
4 9.7 6.7 5.6 8.4
5 6.6 7.6 7.0 6.2
11 12.0 12.9 6.5 7.8
9.4 9.1 6.4 7.5
9.6 9.1 7.4 8.3
4 7.3 11.7 9.1 7.2
7 6.9 6.8 7.4 6.0
11 6.6 6.7 8.7 5.7
6.9 8.4 8.4 6.3
6 8.4 11.7 8.3 8.9
9 7.3 6.8 7.2 6.6
10 7.3 6.7 7.4 5.8
7.7 8.4 7.6 7.1
7.3 8.4 8.0 6.7
5 8.5 8.0 10.3 9.7
6 10.0 9.2 7.0 5.4
15 10.1 8.5 6.4 5.6
9.5 8.6 7.9 6.9
7 9.5 8.0 7.6 7.1
12 9.1 9.2 8.0 7.0
13 8.7 8.5 4.9 6.7
9.1 8.6 6.8 6.9
9.3 8.6 7.4 6.9
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table B2
aBUN - blood urea nitrogen
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
L. reuteri WB-74
2d
Table B17. Study 1 weekly BUNa:creatinine ratio levels
1c
2d
1c
Control
L. reuteri DS-33
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 151 137 143 144
8 140 140 140 143
13 135 137 142 145
142 138 142 144
1 139 137 135 147
3 132 140 147 136
14 137 137 138 137
136 138 140 140
139 138 141 142
2 151 141 144 145
9 142 140 140 141
12 139 139 142 142
144 140 142 143
2 135 141 144 154
8 134 140 142 129
15 134 139 138 125
134 140 141 136
139 140 142 139
1 142 140 143 143
10 142 140 142 150
14 138 137 140 144
141 139 142 146
4 136 140 141 152
5 137 140 134 149
11 133 137 144 139
135 139 140 147
138 139 141 146
4 145 142 143 146
7 146 142 142 145
11 140 137 137 143
144 140 141 145
6 139 142 143 148
9 138 142 131 143
10 137 137 140 144
138 140 138 145
141 140 139 145
5 152 139 143 143
6 146 142 143 144
15 136 138 140 142
145 140 142 143
7 138 139 151 146
12 140 142 134 142
13 137 138 136 149
138 140 140 146
142 140 141 144
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
2c
Control
L. reuteri DS-33
Overall Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-75
2c
1b
2c
L. reuteri WB-74
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
2c
1b
Exp. 2 Mean
1b
L. acidophilus L-23
Exp. 1 Mean
Exp. 1 Mean
Table B18. Study 1 weekly sodium levels (mEq/L)
1b
2c
1b
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 10.6 8.8 9.7 12.3
8 10.1 8.8 9.0 10.8
13 9.3 10.0 8.7 10.4
10.0 9.2 9.1 11.2
1 9.6 8.8 9.2 10.0
3 11.5 8.8 9.9 9.9
14 9.9 10.0 9.3 9.6
10.3 9.2 9.5 9.8
10.2 9.2 9.3 10.5
2 9.9 7.9 9.0 10.4
9 9.7 9.7 9.7 11.7
12 7.5 8.0 8.3 9.3
9.0 8.5 9.0 10.5
2 9.1 7.9 9.2 10.2
8 9.7 9.7 7.6 8.1
15 9.2 8.0 9.1 8.8
9.3 8.5 8.6 9.0
9.2 8.5 8.8 9.8
1 11.0 9.3 9.0 11.0
10 9.6 10.4 9.9 13.0
14 8.7 8.4 8.7 10.5
9.8 9.4 9.2 11.5
4 8.6 9.3 9.1 10.0
5 9.4 10.4 8.0 9.7
11 9.6 8.4 9.3 9.9
9.2 9.4 8.8 9.9
9.5 9.4 9.0 10.7
4 9.3 10.0 8.6 10.8
7 10.0 9.3 9.2 11.5
11 8.2 8.1 9.4 9.6
9.2 9.1 9.1 10.6
6 8.9 10.0 8.5 10.5
9 10.8 9.3 9.5 9.1
10 9.5 8.1 9.7 10.2
9.7 9.1 9.2 9.9
9.5 9.1 9.2 10.3
5 9.7 9.0 9.5 10.6
6 9.0 9.1 9.3 10.9
15 8.0 8.4 8.8 10.0
8.9 8.8 9.2 10.5
7 9.6 9.0 10.2 10.4
12 9.8 9.1 9.5 9.0
13 10.0 8.4 8.6 10.9
9.8 8.8 9.4 10.1
9.4 8.8 9.3 10.3
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
2c
Exp. 2 Mean
Control
L. reuteri DS-33
Overall Mean
Exp. 2 Mean
2c
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-75
2c
1b
2c
L. reuteri WB-74
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
1b
Overall Mean
Exp. 2 Mean
1b
L. acidophilus L-23
Exp. 1 Mean
Exp. 1 Mean
Table B19. Study 1 weekly potassium levels (mEq/L)
1b
2c
1b
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 111 103 106 106
8 107 104 105 107
13 102 105 107 107
107 104 106 107
1 105 103 101 110
3 101 104 107 104
14 103 105 100 102
103 104 103 105
105 104 104 106
2 113 105 105 106
9 108 110 108 109
12 102 105 106 104
108 107 106 106
2 102 105 106 111
8 101 110 102 96
15 100 105 103 97
101 107 104 101
104 107 105 104
1 108 106 103 103
10 106 109 107 109
14 102 104 104 103
105 106 105 105
4 102 106 104 111
5 106 109 102 113
11 103 104 107 106
104 106 104 110
105 106 105 108
4 106 105 104 105
7 106 107 107 109
11 103 107 107 104
105 106 106 106
6 105 105 104 109
9 102 107 98 104
10 103 107 100 105
103 106 101 106
104 106 103 106
5 114 104 106 105
6 107 105 107 107
15 101 101 106 107
107 103 106 106
7 104 104 109 108
12 105 105 101 106
13 102 101 103 112
104 103 104 109
106 103 105 108
cExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bExperiment 1 were barrows
aDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Control
L. reuteri WB-74
L. reuteri DS-33
L. reuteri WB-75
L. acidophilus L-23
1b
2c
2c
1b
2c
1b
Table B20. Study 1 weekly chloride levels (mEq/L)
1b
2c
1b
Exp. 1 Mean
Exp. 1 Mean
2c
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
Overall Mean
Exp. 1 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 25 23 24 23
8 20 25 26 20
13 20 16 20 21
22 21 23 21
1 21 23 20 24
3 16 25 28 20
14 28 16 28 23
22 21 25 22
22 21 24 22
2 25 21 22 24
9 22 18 20 16
12 26 23 23 24
24 21 22 21
2 27 21 27 29
8 24 18 27 23
15 24 23 24 21
25 21 26 24
25 21 24 23
1 16 20 27 27
10 24 16 25 21
14 26 24 22 25
22 20 25 24
4 22 20 23 24
5 19 16 21 18
11 18 24 23 17
20 20 22 20
21 20 24 22
4 25 26 24 21
7 21 23 22 19
11 26 19 20 21
24 23 22 20
6 25 26 28 27
9 21 23 19 23
10 25 19 23 21
24 23 23 24
24 23 23 22
5 26 25 24 22
6 26 24 23 21
15 24 23 21 19
25 24 23 21
7 22 25 23 24
12 22 24 21 18
13 22 23 19 15
22 24 21 19
24 24 22 20
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
1b
bExperiment 1 were barrows
cExperiment 2 were gilts
aDescription of treatments, experiments, and pigs - see Table B2
Exp. 2 Mean
Exp. 2 Mean
1b
Overall Mean
Overall Mean
2c
Table B21. Study 1 weekly carbon dioxide levels (mEq/L)
1b
2c
1b
2c
Control
L. reuteri DS-33
Overall Mean
Overall Mean
Exp. 1 Mean
L. acidophilus L-23
Exp. 2 Mean
L. reuteri WB-75
2c
1b
2c
L. reuteri WB-74
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 25.1 19.6 22.7 27.4
8 22.7 19.6 18.1 26.0
13 22.4 26.2 23.2 26.8
23.4 21.8 21.3 26.7
1 22.4 19.6 23.4 24.1
3 26.1 19.6 21.3 22.3
14 16.0 26.2 18.8 21.3
21.5 21.8 21.2 22.6
22.5 21.8 21.3 24.7
2 23.2 23.1 25.8 25.8
9 21.8 22.4 22.0 27.4
12 17.2 19.3 21.5 22.6
20.7 21.6 23.1 25.3
2 15.8 23.1 20.3 24.7
8 17.8 22.4 20.0 18.1
15 19.2 19.3 20.8 16.1
17.6 21.6 20.4 19.6
19.2 21.6 21.7 22.5
1 28.9 23.9 21.5 23.9
10 21.8 25.2 19.7 32.4
14 17.6 17.5 22.9 25.9
22.8 22.2 21.4 27.4
4 20.6 23.9 22.6 27.6
5 21.9 25.2 18.9 27.2
11 21.8 17.5 22.8 26.6
21.4 22.2 21.4 27.1
22.1 22.2 21.4 27.3
4 23.8 21.7 23.6 30.5
7 28.4 20.9 21.5 28.7
11 18.9 19.7 19.9 27.9
23.7 20.8 21.7 29.0
6 18.9 21.7 18.7 21.9
9 26.2 20.9 23.0 25.7
10 18.8 19.7 26.0 27.8
21.3 20.8 22.6 25.1
22.5 20.8 22.1 27.1
5 22.0 19.3 23.1 26.6
6 21.9 22.6 21.4 27.6
15 18.9 22.4 22.0 26.3
20.9 21.4 22.2 26.8
7 21.4 19.3 28.5 23.2
12 22.8 22.6 21.3 26.0
13 22.3 22.4 23.1 33.2
22.2 21.4 24.3 27.5
21.6 21.4 23.2 27.2
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
2c
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aDescription of treatments, experiments, and pigs - see Table B2
Table B22. Study 1 weekly anion gap levels
1b
2c
1b
L. reuteri WB-75
2c
L. reuteri WB-74
Control
L. reuteri DS-33
L. acidophilus L-23
Exp. 1 Mean
1b
Overall Mean
Overall Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
1b
2c
1b
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2c
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 11.2 10.7 10.0 10.4
8 10.8 11.7 10.2 10.0
13 10.8 10.2 9.6 11.0
10.9 10.9 9.9 10.5
1 10.9 10.7 10.1 11.1
3 10.1 11.7 10.7 9.2
14 9.8 10.2 10.0 9.6
10.3 10.9 10.3 10.0
10.6 10.9 10.1 10.2
2 11.7 10.6 11.0 10.9
9 11.0 10.3 10.5 11.1
12 12.8 10.2 10.6 10.7
11.8 10.4 10.7 10.9
2 10.1 10.6 10.7 11.1
8 9.9 10.3 10.5 8.5
15 10.2 10.2 9.8 8.3
10.1 10.4 10.3 9.3
11.0 10.4 10.5 10.1
1 10.6 10.7 10.4 10.6
10 10.2 10.2 10.3 11.5
14 9.9 9.9 10.0 11.0
10.2 10.3 10.2 11.0
4 9.8 10.7 10.0 11.6
5 11.0 10.2 9.4 10.3
11 9.3 9.9 10.6 9.7
10.0 10.3 10.0 10.5
10.1 10.3 10.1 10.8
4 11.8 10.8 10.5 10.8
7 11.7 10.8 10.5 11.3
11 10.5 9.7 10.3 11.1
11.3 10.4 10.4 11.1
6 9.8 10.8 10.1 10.5
9 10.4 10.8 9.7 10.6
10 10.0 9.7 10.3 10.4
10.1 10.4 10.0 10.5
10.7 10.4 10.2 10.8
5 12.9 11.1 11.5 11.0
6 11.4 10.9 10.3 10.7
15 10.5 10.1 9.9 10.6
11.6 10.7 10.6 10.8
7 9.9 11.1 11.4 10.6
12 10.5 10.9 9.3 9.8
13 9.9 10.1 9.4 10.8
10.1 10.7 10.0 10.4
10.9 10.7 10.3 10.6
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
2c
Control
L. reuteri DS-33
Overall Mean
Overall Mean
Exp. 2 Mean
2c
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-75
2c
1b
2c
L. reuteri WB-74
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
1b
L. acidophilus L-23
Exp. 2 Mean
Exp. 2 Mean
1b
Exp. 2 Mean
Table B23. Study 1 weekly calcium levels (mEq/L)
1b
2c
1b
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 5.1 3.9 4.8 5.3
8 5.2 4.6 4.3 5.1
13 4.9 4.8 4.3 5.6
5.1 4.4 4.5 5.3
1 4.4 3.9 4.6 5.5
3 5.1 4.6 5.5 4.8
14 4.3 4.8 4.3 4.8
4.6 4.4 4.8 5.0
4.8 4.4 4.6 5.2
2 5.1 4.6 5.1 5.6
9 4.5 4.1 4.0 4.9
12 4.7 4.7 4.9 5.3
4.8 4.5 4.7 5.3
2 3.9 4.6 4.9 5.9
8 4.2 4.1 5.2 3.9
15 3.8 4.7 4.9 3.6
4.0 4.5 5.0 4.5
4.4 4.5 4.8 4.9
1 4.9 4.8 5.1 5.6
10 4.5 4.4 4.6 5.8
14 4.5 4.3 4.7 5.7
4.5 4.5 4.8 5.7
4 4.5 4.8 5.3 6.2
5 4.6 4.4 4.6 5.5
11 4.5 4.3 5.1 4.6
4.5 4.5 5.0 5.4
4.5 4.5 4.9 5.6
4 4.9 4.9 4.6 5.2
7 4.9 4.1 4.5 5.2
11 4.8 4.4 4.7 5.6
4.9 4.5 4.6 5.3
6 4.5 4.9 5.0 5.4
9 4.9 4.1 4.4 4.7
10 4.3 4.4 4.8 5.0
4.6 4.5 4.7 5.0
4.7 4.5 4.7 5.2
5 5.2 4.6 5.1 5.8
6 4.9 5.1 4.8 5.3
15 4.7 5.1 5.0 5.4
4.9 4.9 5.0 5.5
7 4.6 4.6 5.6 5.6
12 4.7 5.1 4.8 5.3
13 4.3 5.1 4.5 6.3
4.5 4.9 5.0 5.7
4.7 4.9 5.0 5.6
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
2c
L. acidophilus L-23
1b
aDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
2c
1b
2c
1b
2c
Overall Mean
L. reuteri WB-75
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-74
Table B24. Study 1 weekly total protein levels (g/dL)
1b
2c
1b
L. reuteri DS-33
Control
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 3.2 2.3 2.8 3.5
8 2.9 2.4 2.4 3.2
13 2.3 2.3 2.2 3.2
2.8 2.3 2.5 3.3
1 2.7 2.3 2.9 3.8
3 2.7 2.4 3.2 2.7
14 2.3 2.3 2.3 2.6
2.6 2.3 2.8 3.0
2.7 2.3 2.6 3.2
2 3.3 2.9 3.3 3.8
9 2.6 2.3 2.4 3.4
12 3.0 3.2 3.3 3.8
3.0 2.8 3.0 3.7
2 2.1 2.9 3.1 3.8
8 2.4 2.3 3.3 2.3
15 1.9 3.2 2.7 2.0
2.1 2.8 3.0 2.7
2.6 2.8 3.0 3.2
1 3.0 3.2 3.3 3.8
10 2.7 2.7 2.9 4.3
14 2.5 2.3 2.5 3.2
2.6 2.7 2.9 3.8
4 2.4 3.2 2.8 3.5
5 2.3 2.7 2.4 3.0
11 2.4 2.3 3.2 3.0
2.4 2.7 2.8 3.2
2.5 2.7 2.9 3.5
4 3.0 3.0 3.0 3.6
7 3.2 2.5 2.7 3.4
11 2.6 2.3 2.7 3.7
2.9 2.6 2.8 3.6
6 2.5 3.0 2.9 3.4
9 3.0 2.5 2.8 3.2
10 2.6 2.3 2.8 2.9
2.7 2.6 2.8 3.2
2.8 2.6 2.8 3.4
5 3.5 3.0 3.6 4.2
6 2.7 2.9 2.6 3.2
15 2.7 2.9 3.0 3.4
3.0 2.9 3.1 3.6
7 2.3 3.0 3.4 3.5
12 2.1 2.9 2.5 2.9
13 2.7 2.9 2.8 4.2
2.4 2.9 2.9 3.5
2.7 2.9 3.0 3.6
Overall Mean
2c
L. acidophilus L-23
1b
1b
L. reuteri WB-74
bExperiment 1 were barrows
cExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2c
Overall Mean
L. reuteri DS-33
1b
2c
Overall Mean
aDescription of treatments, experiments, and pigs - see Table B2
Table B25. Study 1 weekly albumin levels (g/dL)
1b
2c
1b
2c
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri WB-75
Exp. 1 Mean
Exp. 1 Mean
Control
Overall Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 1.9 1.6 1.9 1.7
8 2.4 2.2 1.9 2.0
13 2.6 2.5 2.1 2.4
2.3 2.1 2.0 2.0
1 1.7 1.6 1.7 1.7
3 2.3 2.2 2.3 2.1
14 2.0 2.5 2.0 2.2
2.0 2.1 2.0 2.0
2.2 2.1 2.0 2.0
2 1.9 1.7 1.8 1.8
9 1.9 1.9 1.6 1.5
12 1.8 1.5 1.6 1.5
1.9 1.7 1.7 1.6
2 1.8 1.7 1.9 2.1
8 1.8 1.9 1.9 1.6
15 1.9 1.5 2.1 1.6
1.8 1.7 2.0 1.8
1.8 1.7 1.8 1.7
1 1.9 1.6 1.7 1.8
10 1.8 1.7 1.7 1.5
14 2.0 2.0 2.1 2.4
1.9 1.8 1.8 1.9
4 2.2 1.6 2.5 2.7
5 2.3 1.7 2.2 2.5
11 2.0 2.0 1.9 1.5
2.2 1.8 2.2 2.2
2.0 1.8 2.0 2.1
4 1.9 1.9 1.7 1.6
7 1.7 1.5 1.8 1.8
11 2.2 2.1 1.9 1.9
1.9 1.8 1.8 1.8
6 2.0 1.9 2.1 2.1
9 1.9 1.5 1.6 1.5
10 1.7 2.1 2.0 2.1
1.9 1.8 1.9 1.9
1.9 1.8 1.9 1.8
5 1.7 1.6 1.5 1.6
6 2.2 2.2 2.2 2.1
15 2.0 2.2 2.0 2.0
2.0 2.0 1.9 1.9
7 2.3 1.6 2.2 2.1
12 2.6 2.2 2.3 2.4
13 1.7 2.2 1.7 2.1
2.2 2.0 2.1 2.2
2.1 2.0 2.0 2.1
2c
L. reuteri WB-74
L. acidophilus L-23
Exp. 2 Mean
2c
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
bExperiment 1 were barrows
cExperiment 2 were gilts
Overall Mean
Overall Mean
Overall Mean
1b
aDescription of treatments, experiments, and pigs - see Table B2
2c
1b
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1b
2c
Exp. 2 Mean
Table B26. Study 1 weekly globulin levels (g/dL)
1b
2c
1b
Exp. 2 Mean
Control
L. reuteri DS-33
L. reuteri WB-75
Overall Mean
Exp. 1 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 1.7 1.4 1.5 2.0
8 1.2 1.1 1.2 1.6
13 0.9 0.9 1.0 1.4
1.3 1.1 1.2 1.7
1 1.6 1.4 1.7 2.3
3 1.2 1.1 1.4 1.3
14 1.1 0.9 1.1 1.2
1.3 1.1 1.4 1.6
1.3 1.1 1.3 1.6
2 1.7 1.4 1.5 2.0
9 1.2 1.1 1.2 1.6
12 0.9 0.9 1.0 1.4
1.3 1.1 1.2 1.7
2 1.6 1.4 1.7 2.3
8 1.2 1.1 1.4 1.3
15 1.1 0.9 1.1 1.2
1.3 1.1 1.4 1.6
1.3 1.1 1.3 1.6
1 1.5 2.0 1.9 2.1
10 1.5 1.6 1.7 2.8
14 1.2 1.1 1.2 1.3
1.4 1.6 1.6 2.1
4 1.1 2.0 1.1 1.3
5 1.0 1.6 1.1 1.2
11 1.2 1.1 1.6 2.0
1.1 1.6 1.3 1.5
1.3 1.6 1.4 1.8
4 1.6 1.6 1.8 2.2
7 1.9 1.7 1.5 1.9
11 1.2 1.1 1.4 1.9
1.6 1.5 1.6 2.0
6 1.2 1.6 1.4 1.6
9 1.6 1.7 1.8 2.2
10 1.5 1.1 1.4 1.4
1.4 1.5 1.5 1.7
1.5 1.5 1.6 1.9
5 2.0 1.9 2.4 2.7
6 1.2 1.3 1.2 1.5
15 1.4 1.3 1.5 1.7
1.5 1.5 1.7 2.0
7 1.0 1.9 1.5 1.7
12 0.8 1.3 1.1 1.2
13 1.6 1.3 1.7 2.0
1.1 1.5 1.4 1.6
1.3 1.5 1.6 1.8
Overall Mean
2c
L. acidophilus L-23
1b
1b
L. reuteri WB-74
bExperiment 1 were barrows
cExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2c
Overall Mean
L. reuteri DS-33
1b
2c
Overall Mean
aDescription of treatments, experiments, and pigs - see Table B2
Table B27. Study 1 weekly albumin:globulin ratio levels
1b
2c
1b
2c
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri WB-75
Exp. 1 Mean
Exp. 1 Mean
Control
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 74 62 50 52
8 84 82 62 55
13 68 70 45 54
75 71 52 54
1 55 62 38 43
3 64 82 42 39
14 65 70 57 62
61 71 46 48
68 71 49 51
2 67 51 59 50
9 73 57 41 46
12 40 41 66 53
60 50 55 50
2 43 51 34 38
8 57 57 46 43
15 46 41 67 37
49 50 49 39
54 50 52 45
1 67 55 59 57
10 41 49 50 50
14 60 70 41 53
56 58 50 53
4 58 55 34 56
5 55 49 35 60
11 88 70 60 52
67 58 43 56
62 58 47 55
4 53 51 38 41
7 87 67 55 59
11 68 122 66 62
69 80 53 54
6 50 51 52 59
9 76 67 44 47
10 52 122 56 44
59 80 51 50
64 80 52 52
5 53 64 55 70
6 57 67 48 45
15 105 101 66 77
72 77 56 64
7 72 64 45 45
12 97 67 59 65
13 56 101 41 72
75 77 48 61
73 77 52 62
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
2d
Overall Mean
1c
aAST - aspartate aminotransferase
bDescription of treatments, experiments, and pigs - see Table B2
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
1c
2d
Overall Mean
L. reuteri WB-75
Overall Mean
2d
L. acidophilus L-23
1c
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Table B28. Experiment 1 weekly ASTa levels (U/L)
1c
2d
L. reuteri WB-74
Control
Overall Mean
L. reuteri DS-33
Exp. 1 Mean
Exp. 1 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 69 54 54 59
8 66 54 54 59
13 47 44 49 66
61 51 52 61
1 45 54 31 34
3 30 54 40 25
14 51 44 63 59
42 51 45 39
51 51 49 50
2 41 34 37 45
9 71 75 51 58
12 51 57 75 81
54 55 54 61
2 34 34 39 34
8 37 75 36 28
15 26 57 39 29
32 55 38 30
43 55 46 46
1 57 64 55 65
10 43 45 38 53
14 53 51 49 53
51 53 47 57
4 40 64 39 50
5 38 45 33 34
11 56 51 54 41
45 53 42 42
48 53 45 49
4 53 51 43 46
7 61 53 45 50
11 48 49 38 52
54 51 42 49
6 41 51 53 54
9 43 53 50 55
10 40 49 33 30
41 51 45 46
48 51 44 48
5 49 46 47 60
6 50 49 43 42
15 53 59 67 71
51 51 52 58
7 53 46 46 41
12 39 49 37 30
13 45 59 43 41
46 51 42 37
48 51 47 48
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
2d
2d
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
Exp. 2 Mean
Table B29. Experiment 1 weekly ALTa levels (U/L)
1c
2d
1c
Control
L. reuteri DS-33
2d
Exp. 1 Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table B2
aALT - alanine aminotransferase 
L. reuteri WB-74
L. reuteri WB-75
1c
2d
Overall Mean
L. acidophilus L-23
1c
1c
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 392 220 179 226
8 331 220 270 291
13 280 213 196 247
334 218 215 255
1 225 220 179 204
3 151 220 246 156
14 231 213 203 198
202 218 209 186
268 218 212 220
2 411 249 254 263
9 311 208 195 230
12 409 232 231 257
377 230 227 250
2 253 249 224 188
8 166 208 175 114
15 103 232 155 93
174 230 185 132
276 230 206 191
1 392 310 247 263
10 440 319 290 336
14 322 204 273 315
385 278 270 305
4 252 310 218 247
5 197 319 151 161
11 318 204 301 231
256 278 223 213
320 278 247 259
4 448 277 269 278
7 297 185 178 207
11 364 182 213 262
370 215 220 249
6 272 277 239 252
9 308 185 225 199
10 264 182 259 212
281 215 241 221
326 215 231 235
5 341 223 205 229
6 412 250 238 289
15 319 214 218 166
357 229 220 228
7 208 223 236 197
12 250 250 158 152
13 216 214 206 196
225 229 200 182
291 229 210 205
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table B2
aALKPhos - alkaline phosphatase
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
L. reuteri WB-74
2d
Table B30. Experiment 1 weekly ALKPhosa levels (U/L)
1c
2d
1c
Control
L. reuteri DS-33
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Treatmenta Exp.a Piga Day 0b Week 1b Week 2b Week 3b
3 0.2 0.1 0.1 0.2
8 0.4 0.1 0.1 0.1
13 0.3 0.3 0.1 0.1
0.3 0.2 0.1 0.1
1 0.1 0.1 0.1 0.2
3 0.5 0.1 0.2 0.2
14 0.2 0.3 0.1 0.1
0.3 0.2 0.1 0.2
0.3 0.2 0.1 0.2
2 0.4 0.2 0.3 0.2
9 0.1 0.1 0.1 0.3
12 0.3 0.1 0.2 0.2
0.3 0.1 0.2 0.2
2 0.1 0.2 0.1 0.2
8 0.1 0.1 0.1 0.1
15 0.1 0.1 0.3 0.1
0.1 0.1 0.2 0.1
0.2 0.1 0.2 0.2
1 0.2 0.1 0.2 0.2
10 0.2 0.1 0.2 0.3
14 0.1 0.1 0.1 0.1
0.2 0.1 0.2 0.2
4 0.2 0.1 0.1 0.1
5 0.2 0.1 0.2 0.2
11 0.4 0.1 0.1 0.1
0.3 0.1 0.1 0.1
0.2 0.1 0.2 0.2
4 0.1 0.3 0.1 0.3
7 0.3 0.1 0.1 0.2
11 0.2 0.2 0.3 0.1
0.2 0.2 0.2 0.2
6 0.1 0.3 0.1 0.3
9 0.3 0.1 0.2 0.1
10 0.1 0.2 0.1 0.1
0.2 0.2 0.1 0.2
0.2 0.2 0.2 0.2
5 0.2 0.2 0.2 0.3
6 0.2 0.2 0.1 0.2
15 0.2 0.2 0.2 0.1
0.2 0.2 0.2 0.2
7 0.1 0.2 0.2 0.1
12 0.1 0.2 0.1 0.3
13 0.2 0.2 0.1 0.4
0.1 0.2 0.1 0.3
0.2 0.2 0.2 0.2
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1c
2d
L. reuteri WB-75
L. reuteri WB-74
Overall Mean
Overall Mean
1c
2d
Control
Overall Mean
Overall Mean
Table B31. Study 1 weekly bili, total levels (mg/dL)
1c
2d
1c
2d
L. reuteri DS-33
Exp. 1 Mean
bAll 0.1 individual pig values were equal to <0.1
aDescription of treatments, experiments, and pigs - see Table B2
1c
2d
L. acidophilus L-23
Overall Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0b Week 1b Week 2b Week 3b
3 50 50 69 65
8 100 88 80 88
13 55 74 64 70
68 71 71 74
1 70 50 88 95
3 77 88 107 82
14 77 74 82 83
75 71 92 87
72 71 82 81
2 63 55 62 71
9 50 50 50 59
12 69 65 76 82
60 57 63 71
2 51 55 72 97
8 95 50 96 81
15 53 65 66 50
66 57 78 76
64 57 70 73
1 50 50 50 51
10 50 67 71 83
14 50 59 50 60
50 59 57 65
4 67 50 92 101
5 84 67 80 76
11 73 59 81 72
75 59 84 83
62 59 71 74
4 50 59 65 81
7 50 60 66 82
11 73 80 83 104
58 66 71 89
6 62 59 79 84
9 69 60 56 52
10 100 80 116 82
77 66 84 73
67 66 78 81
5 76 67 74 89
6 62 69 64 81
15 51 59 64 79
63 65 67 83
7 67 67 88 85
12 78 69 78 86
13 82 59 78 109
76 65 81 93
69 65 74 88
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bAll 50 individual pig values were equal to <50
Table B32. Study 1 weekly cholesterol levels (mg/dL)
1c
2d
1c
Control
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-74
L. reuteri DS-33
1c
2d
L. reuteri WB-75
2d
Overall Mean
Overall Mean
Overall Mean
L. acidophilus L-23
2d
1c
2d
1c
Overall Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
3 27 19 26 15
8 36 16 24 30
13 25 31 25 26
29 22 25 24
1 32 19 45 28
3 42 16 57 40
14 56 31 38 42
43 22 47 37
36 22 36 30
1b 2 30 21 38 21
9 45 38 39 37
12 23 20 28 24
33 26 35 27
2 24 21 41 44
8 41 38 39 35
15 25 20 27 15
30 26 36 31
31 26 35 29
1b 1 35 25 24 23
10 17 53 29 36
14 26 23 15 52
22 34 23 37
4 38 25 29 36
5 22 53 25 28
11 76 23 46 31
45 34 33 32
36 34 28 34
1b 4 23 17 21 19
7 39 28 29 28
11 25 36 31 36
29 27 27 28
6 54 17 24 41
9 42 28 29 28
10 40 36 84 68
45 27 46 46
37 27 36 37
1b 5 32 19 22 31
6 22 24 15 20
15 25 19 24 25
26 21 20 25
7 40 19 49 44
12 46 24 21 77
13 54 19 27 79
47 21 32 67
37 21 26 46
bExperiment 1 were barrows
cExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table B2
2c
Overall Mean
Exp. 2 Mean
L. reuteri WB-74
Overall Mean
2c
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
2c
Control
Overall Mean
L. acidophilus L-23
L. reuteri WB-75
2c
Table B33. Study 1 weekly triglyceride levels (mg/dL)
1b
2c
L. reuteri DS-33
Overall Mean
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 19 21 20 24
8 38 33 28 33
13 21 22 25 24
26 25 24 27
1 28 21 27 28
3 24 33 33 25
14 27 22 28 25
26 25 29 26
26 25 27 27
2 25 26 27 30
9 20 16 17 25
12 30 29 28 34
25 24 24 30
2 21 26 27 35
8 30 16 30 28
15 26 29 28 18
26 24 28 27
25 24 26 28
1 17 16 17 18
10 17 22 24 30
14 19 19 13 18
18 19 18 22
4 24 16 32 35
5 35 22 30 22
11 27 19 30 28
29 19 31 28
23 19 24 25
4 20 21 22 30
7 21 28 28 34
11 30 26 29 38
24 25 26 34
6 21 21 30 31
9 23 28 20 19
10 35 26 36 25
26 25 29 25
25 25 28 30
5 28 23 28 34
6 25 26 23 31
15 23 25 26 31
25 25 26 32
7 22 23 30 30
12 27 26 26 30
13 29 25 27 35
26 25 28 32
26 25 27 32
cExperiment 1 were barrows
dExperiment 2 were gilts
bDescription of treatments, experiments, and pigs - see Table B2
aHDL - high-density lipoprotein
2d
2d
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Exp. 2 Mean
L. reuteri WB-74
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
2d
Overall Mean
1c
Table B34. Experiment 1 weekly HDLa levels (mg/dL)
1c
2d
1c
Control
2d
L. reuteri DS-33
Overall Mean
Exp. 1 Mean
Overall Mean
Exp. 1 Mean
Overall Mean
1c
Exp. 2 Mean
Exp. 2 Mean
1c
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 5 4 5 3
8 7 3 5 6
13 5 6 5 5
6 4 5 5
1 6 4 9 6
3 8 3 11 8
14 11 6 8 8
8 4 9 7
7 4 7 6
2 7 4 8 4
9 9 8 8 7
12 5 4 6 5
7 5 7 5
2 5 4 8 9
8 8 8 8 7
15 5 4 5 3
6 5 7 6
7 5 7 6
1 7 5 5 5
10 3 11 6 7
14 5 5 3 10
5 7 5 7
4 8 5 6 7
5 4 11 5 6
11 15 5 9 6
9 7 7 6
7 7 6 7
4 5 3 4 4
7 8 6 6 6
11 5 7 6 7
6 5 5 6
6 11 3 5 8
9 8 6 6 6
10 8 7 17 14
9 5 9 9
8 5 7 8
5 6 4 4 6
6 4 5 3 4
15 5 4 5 5
5 4 4 5
7 8 4 10 9
12 9 5 4 15
13 11 4 5 16
9 4 6 13
7 4 5 9
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. acidophilus L-23
1c
2d
Overall Mean
Exp. 2 Mean
2d
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table B2
aVLDL - very low-density lipoprotein
Overall Mean
Overall Mean
L. reuteri WB-74
L. reuteri WB-75
1c
Table B35. Study 1 weekly VLDLa levels (mg/dL)
1c
2d
1c
Control
Overall Mean
L. reuteri DS-33
Overall Mean
2d
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 0.534 0.585 0.708 0.775
8 0.324 0.374 0.373 0.313
13 0.328 0.412 0.388 0.591
0.395 0.457 0.490 0.560
1 0.379 0.345 0.334 0.370
3 0.481 0.358 0.317 0.358
14 0.674 0.386 0.441 0.784
0.511 0.363 0.364 0.504
0.453 0.410 0.427 0.532
2 0.357 0.442 0.378 0.445
9 0.345 0.343 0.349 0.442
12 0.623 0.530 0.829 0.903
0.441 0.438 0.519 0.597
2 0.956 0.980 0.894 0.999
8 0.812 0.800 0.725 0.502
15 0.738 0.338 0.378 0.526
0.835 0.706 0.666 0.676
0.638 0.572 0.592 0.636
1 0.326 0.524 0.284 0.561
10 0.552 0.685 0.585 0.534
14 0.720 0.628 0.627 0.896
0.533 0.612 0.499 0.664
4 0.348 0.551 0.379 0.358
5 0.373 0.579 1.353 0.619
11 0.978 1.289 0.674 1.414
0.566 0.806 0.802 0.797
0.549 0.709 0.650 0.730
4 0.428 0.449 0.458 0.620
7 0.716 0.870 0.680 0.955
11 0.285 0.291 0.411 0.524
0.476 0.537 0.516 0.700
6 0.447 0.575 0.251 0.312
9 0.367 0.346 0.323 0.250
10 0.303 0.351 0.357 0.494
0.372 0.424 0.310 0.352
0.424 0.480 0.413 0.526
5 0.531 0.420 0.287 0.516
6 0.347 0.468 0.450 0.532
15 0.324 0.517 0.337 0.330
0.400 0.469 0.358 0.459
7 0.842 0.593 0.732 0.898
12 0.213 0.257 0.326 0.248
13 0.236 0.189 0.199 0.332
0.430 0.346 0.419 0.493
0.415 0.407 0.389 0.476
bDescription of treatments, experiments, and pigs - see Table B2
1c
2d
L. reuteri WB-75
Overall Mean
Overall Mean
Overall Mean
L. acidophilus L-23
aIgA - immunoglobulin A
L. reuteri WB-74
Table B36. Study 1 weekly IgAa levels (mg/mL)
1c
2d
Overall Mean
Control
L. reuteri DS-33
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
dExperiment 2 were gilts
cExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
1c
2d
1c
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
2d
1c
2d
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 4.447 8.336 7.110 7.098
8 4.255 7.552 6.267 4.553
13 6.107 3.990 5.283 9.335
4.936 6.626 6.220 6.995
1 12.300 9.677 10.570 9.195
3 8.888 7.760 9.989 12.260
14 12.370 11.600 16.240 7.057
11.186 9.679 12.266 9.504
8.061 8.153 9.243 8.250
2 3.354 6.783 4.734 4.075
9 6.687 5.692 6.274 5.112
12 12.430 15.140 10.830 9.920
7.490 9.205 7.279 6.369
2 10.920 7.985 10.330 11.470
8 15.480 14.230 12.940 13.720
15 9.515 13.080 11.830 4.178
11.972 11.765 11.700 9.789
9.731 10.485 9.490 8.079
1 4.289 6.648 8.324 5.113
10 4.528 8.136 6.692 5.970
14 10.440 9.317 7.416 9.550
6.419 8.034 7.477 6.878
4 9.837 9.342 8.771 9.874
5 5.927 7.914 8.738 10.640
11 12.130 12.240 9.198 9.277
9.298 9.832 8.902 9.930
7.859 8.933 8.190 8.404
4 3.733 8.142 11.890 7.555
7 3.925 10.610 7.406 6.725
11 6.373 5.591 5.974 5.317
4.677 8.114 8.423 6.532
6 11.410 10.650 12.320 14.080
9 9.292 9.231 10.800 8.451
10 10.020 7.416 7.549 7.629
10.241 9.099 10.223 10.053
7.459 8.607 9.323 8.293
5 3.141 8.967 7.679 8.947
6 8.110 9.651 6.711 6.532
15 5.907 9.068 7.339 9.013
5.719 9.229 7.243 8.164
7 10.460 9.412 8.522 12.690
12 6.832 6.062 8.399 6.234
13 10.420 13.210 12.780 16.300
9.237 9.561 9.900 11.741
7.478 9.395 8.572 9.953
L. acidophilus L-23
2d
1c
Overall Mean
2d
1c
L. reuteri WB-74
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
aIgG - immunoglobulin G
Table B37. Study 1 weekly IgGa levels (mg/mL)
1c
2d
1c
2d
L. reuteri WB-75
Control
L. reuteri DS-33
Exp. 2 Mean
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
3 0.990 1.296 1.313 1.756
8 1.292 1.394 0.958 1.463
13 1.172 0.963 0.907 1.434
1.151 1.218 1.059 1.551
1 1.588 1.741 2.053 1.808
3 3.237 2.908 2.696 2.513
14 5.528 5.776 5.604 4.837
3.451 3.475 3.451 3.053
2.301 2.346 2.255 2.302
2 1.813 1.312 1.242 1.072
9 1.044 1.065 1.272 1.452
12 1.953 1.516 1.143 1.544
1.603 1.298 1.219 1.356
2 4.073 2.859 2.303 2.348
8 4.248 2.570 2.333 2.298
15 3.905 2.617 2.426 2.242
4.075 2.682 2.354 2.296
2.839 1.990 1.787 1.826
1 1.039 1.562 1.235 0.856
10 0.779 0.851 1.559 1.808
14 1.986 2.968 1.523 2.044
1.268 1.794 1.439 1.569
4 1.996 1.879 2.411 2.710
5 1.522 2.249 2.025 2.552
11 4.461 3.263 3.016 2.749
2.660 2.464 2.484 2.670
1.964 2.129 1.962 2.120
4 1.459 1.683 1.312 1.645
7 2.037 1.255 1.156 1.643
11 1.196 0.993 0.921 1.786
1.564 1.310 1.130 1.691
6 2.386 2.838 2.828 2.954
9 3.821 2.152 2.342 2.085
10 3.046 3.677 2.863 3.380
3.084 2.889 2.678 2.806
2.324 2.100 1.904 2.249
5 1.607 1.859 1.165 2.073
6 1.872 1.395 1.285 1.621
15 1.220 0.973 0.849 1.279
1.566 1.409 1.100 1.658
7 2.507 1.738 1.609 1.746
12 3.232 1.947 2.749 3.222
13 2.036 1.711 1.652 2.585
2.592 1.799 2.003 2.518
2.079 1.604 1.552 2.088
Table B38. Study 1 weekly IgMa levels (mg/mL)
1c
2d
1c
Overall Mean
Control
Exp. 1 Mean
L. reuteri DS-33
2d
Exp. 1 Mean
dExperiment 2 were gilts
aIgM - immunoglobulin M
1c
L. reuteri WB-74
Exp. 1 Mean
L. acidophilus L-23
L. reuteri WB-75
1c
cExperiment 1 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
Overall Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Overall Mean
2d
Exp. 1 Mean
Exp. 1 Mean
1c
2d
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Treatmentb Exp.b Pigb FIc
3 0.73
8 0.75
13 0.84
0.77
1 0.89
3 0.85
14 0.88
0.88
0.82
2 0.24
9 0.62
12 0.71
0.52
2 0.43
8 0.90
15 0.83
0.72
0.62
1 0.47
10 0.01
14 0.76
0.41
4 0.72
5 0.79
11 0.90
0.81
0.61
4 0.38
7 0.47
11 0.77
0.54
6 0.75
9 0.82
10 0.85
0.81
0.67
5 0.31
6 0.58
15 0.67
0.52
7 0.80
12 0.75
13 0.85
0.80
0.66
Exp. 1 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri DS-33
1d
2e
Overall Mean
Table B39. Study 1 overall LPSa challenge feed 
intake (kg)
Control
Overall Mean
1d
2e
Exp. 2 Mean
L. reuteri WB-75
1d
2e
Overall Mean
L. reuteri WB-74
1d
2e
Overall Mean
cFI - feed intake
L. acidophilus L-23
1d
2e
Overall Mean
bDescription of treatments, experiments, and pigs - 
see Table B2
aLPS - Escherichia coli  O111:B4 
lipopolysaccharide
Exp. 2 Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 6.0 Hour 12 Hour 24
3 24.58 24.13 23.68 24.31
8 20.68 20.28 19.96 21.68
13 20.23 19.87 20.18 21.64
21.83 21.42 21.27 22.54
1 24.63 23.77 23.95 24.58
3 21.50 20.87 20.23 21.32
14 19.28 18.78 18.42 19.46
21.80 21.14 20.87 21.79
21.82 21.28 21.07 22.17
2 26.67 25.67 25.13 25.40
9 21.41 21.23 20.77 21.77
12 26.49 25.40 25.13 26.31
24.86 24.10 23.68 24.49
2 24.40 23.95 23.22 23.50
8 22.41 21.59 21.41 22.59
15 18.73 18.33 17.60 19.14
21.85 21.29 20.74 21.74
23.35 22.69 22.21 23.12
1 24.68 25.49 25.08 25.31
10 25.04 24.77 23.90 23.68
14 18.51 18.01 17.69 18.82
22.74 22.76 22.23 22.60
4 22.00 21.14 21.05 22.04
5 20.87 20.59 20.00 21.23
11 21.05 20.46 19.60 20.68
21.30 20.73 20.22 21.32
22.02 21.74 21.22 21.96
4 24.58 24.13 23.72 23.59
7 22.23 21.86 21.77 22.59
11 22.86 22.50 21.95 23.86
23.22 22.83 22.48 23.34
6 19.64 19.23 18.82 20.23
9 20.68 20.32 20.05 21.32
10 22.14 21.77 21.41 22.41
20.82 20.44 20.09 21.32
22.02 21.64 21.29 22.33
5 27.31 26.94 26.40 26.72
6 22.95 22.32 22.04 22.95
15 21.32 20.68 20.09 21.50
23.86 23.31 22.85 23.72
7 21.86 21.23 21.59 22.23
12 19.14 18.33 18.23 18.73
13 25.04 24.58 23.77 25.08
22.01 21.38 21.20 22.01
22.94 22.35 22.02 22.87
cExperiment 1 were barrows
1c
2d
Overall Mean
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table B2
2d
1c
2d
Exp. 2 Mean
1c
Exp. 1 Mean
Exp. 2 Mean
Table B40. Study 1 LPSa challenge swine weights (kg)
L. reuteri WB-74
1c
2d
Overall Mean
L. reuteri WB-75
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. acidophilus L-23
Overall Mean
Control
1c
2d
L. reuteri DS-33
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 39.63 39.41 40.18 39.63 39.68 39.46
8 39.07 39.41 39.74 39.90 39.18 39.46
13 38.91 39.18 40.24 40.40 39.74 39.18
39.20 39.33 40.05 39.98 39.53 39.37
1 39.79 40.13 40.63 40.13 39.68 39.79
3 39.41 39.07 40.24 39.46 39.68 39.18
14 39.52 40.13 40.35 40.40 40.02 39.46
39.57 39.78 40.40 40.00 39.79 39.48
39.39 39.55 40.23 39.99 39.66 39.42
2 39.02 39.57 40.35 40.63 40.68 39.96
9 38.85 39.35 40.40 39.90 39.90 39.07
12 39.35 39.63 41.18 40.46 39.24 39.35
39.07 39.52 40.64 40.33 39.94 39.46
2 39.52 39.85 40.90 40.52 40.96 40.29
8 39.63 39.79 40.68 39.63 39.68 39.29
15 39.68 39.57 40.07 40.29 39.68 39.18
39.61 39.74 40.55 40.15 40.11 39.59
39.34 39.63 40.60 40.24 40.02 39.53
1 39.29 39.35 39.90 40.40 39.90 41.24
10 39.41 39.46 40.35 40.35 41.24 39.02
14 39.35 39.13 40.40 40.07 39.79 39.90
39.35 39.31 40.22 40.27 40.31 40.05
4 39.57 40.13 40.79 39.79 40.13 39.68
5 39.57 40.90 41.01 39.57 39.63 39.24
11 39.18 39.85 40.57 39.63 40.18 39.35
39.44 40.29 40.79 39.66 39.98 39.42
39.40 39.80 40.51 39.97 40.15 39.74
4 39.35 39.13 39.96 39.79 39.41 39.74
7 39.57 39.46 40.57 40.29 40.02 39.41
11 39.68 39.35 39.96 40.13 39.85 39.52
39.53 39.31 40.16 40.07 39.76 39.55
6 39.35 39.18 39.57 39.41 39.35 39.24
9 39.46 39.68 40.29 40.68 39.46 39.41
10 39.57 40.74 40.90 39.85 40.02 39.79
39.46 39.87 40.26 39.98 39.61 39.48
39.50 39.59 40.21 40.02 39.68 39.52
5 39.13 39.18 40.18 40.63 40.07 39.96
6 39.35 39.52 40.40 40.57 40.07 39.57
15 39.07 39.02 40.57 40.96 40.46 39.85
39.18 39.24 40.39 40.72 40.20 39.79
7 39.63 39.41 40.46 40.74 39.46 39.07
12 39.85 40.13 41.07 40.46 40.02 39.29
13 39.18 39.29 40.29 39.41 39.52 39.46
39.55 39.61 40.61 40.20 39.66 39.28
39.37 39.42 40.50 40.46 39.93 39.53
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Exp. 2 Mean
L. reuteri WB-75
dExperiment 2 were gilts
cExperiment 1 were barrows
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1c
2d
Exp. 1 Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table B2
L. reuteri WB-74
1c
2d
Overall Mean
L. acidophilus L-23
1c
2d
Overall Mean
L. reuteri DS-33
Table B41. Study 1 hourly LPSa challenge rectal temperatures (°C)
1c
2d
Overall Mean
Control
1c
2d
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 123 123 103 80 71 125
8 120 100 89 78 55 86
13 113 116 121 117 115 115
119 113 104 92 80 109
1 133 115 115 103 81 125
3 140 103 78 99 74 101
14 116 90 85 110 73 114
130 103 93 104 76 113
124 108 99 98 78 111
2 130 126 111 64 102 139
9 142 127 145 106 72 127
12 124 116 93 47 70 90
132 123 116 72 81 119
2 122 128 74 96 79 120
8 106 113 93 105 103 106
15 104 101 85 109 99 109
111 114 84 103 94 112
121 119 100 88 88 115
1 113 116 150 84 74 128
10 133 134 97 75 70 99
14 90 89 80 58 56 105
112 113 109 72 67 111
4 152 138 76 96 80 107
5 136 120 76 98 88 96
11 128 118 98 96 80 142
139 125 83 97 83 115
125 119 96 85 75 113
4 128 129 123 73 79 124
7 121 119 121 70 62 124
11 118 106 94 49 52 111
122 118 113 64 64 120
6 111 78 88 102 76 113
9 127 123 94 103 90 107
10 145 120 91 114 110 121
128 107 91 106 92 114
125 113 102 85 78 117
5 118 119 123 46 83 114
6 115 123 126 72 64 133
15 125 110 118 93 72 93
119 117 122 70 73 113
7 131 92 91 116 62 113
12 140 106 82 98 103 113
13 176 117 77 108 71 100
149 105 83 107 79 109
134 111 103 89 76 111
dExperiment 2 were gilts
cExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri DS-33
bDescription of treatments, experiments, and pigs - see Table B2
Table B42. Study 1 hourly LPSa challenge glucose levels (mg/dL)
1c
1c
2d
1c
2d
L. reuteri WB-74
1c
L. reuteri WB-75
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
L. acidophilus L-23
2d
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Control
2d
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 9 8 7 8 12 11
8 7 7 7 9 11 11
13 8 8 8 7 8 10
8 8 7 8 10 11
1 7 7 7 7 11 11
3 8 8 6 7 9 12
14 10 9 8 10 10 10
8 8 7 8 10 11
8 8 7 8 10 11
2 9 9 8 10 17 12
9 9 9 11 11 14 12
12 9 8 7 11 15 13
9 9 9 11 15 12
2 9 9 7 9 13 16
8 9 10 9 9 8 7
15 9 9 8 10 8 8
9 9 8 9 10 10
9 9 8 10 13 11
1 8 7 9 9 11 9
10 7 7 7 10 13 13
14 12 12 12 14 14 11
9 9 9 11 13 11
4 14 15 10 11 11 12
5 8 8 7 8 7 7
11 9 9 9 10 14 12
10 11 9 10 11 10
10 10 9 10 12 11
4 8 9 9 11 16 13
7 7 6 8 8 9 8
11 6 6 8 12 14 10
7 7 8 10 13 10
6 11 9 9 9 9 13
9 8 8 8 9 9 9
10 7 7 6 8 7 7
9 8 8 9 8 10
8 8 8 10 11 10
5 11 11 12 15 19 16
6 6 6 7 9 14 12
15 5 5 6 8 11 10
7 7 8 11 15 13
7 9 8 8 9 11 12
12 10 9 9 10 9 8
13 10 9 8 9 12 11
10 9 8 9 11 10
9 8 8 10 13 12
Exp. 2 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1d
2e
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
bDescription of treatments, experiments, and pigs - see Table B2
bBUN - blood urea nitrogen
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
L. acidophilus L-23
1d
2e
1d
2e
Overall Mean
Overall Mean
Table B43. Study 1 hourly LPSa challenge BUNb levels (mg/dL)
L. reuteri WB-75
Control
L. reuteri DS-33
L. reuteri WB-74
Overall Mean
Overall Mean
1d
2e
1d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 1.0 1.0 0.9 1.0 1.4 1.2
8 1.0 1.0 1.0 1.2 1.3 1.0
13 1.1 1.1 1.1 1.2 1.5 1.2
1.0 1.0 1.0 1.1 1.4 1.1
1 1.1 1.0 1.2 1.2 1.4 1.2
3 1.0 1.0 1.1 1.0 1.2 1.2
14 1.1 0.9 0.8 1.2 1.4 1.2
1.1 1.0 1.0 1.1 1.3 1.2
1.1 1.0 1.0 1.1 1.4 1.2
2 1.1 1.1 1.2 1.3 1.6 1.6
9 1.0 1.0 1.2 1.1 1.3 1.2
12 0.9 0.9 0.8 1.2 1.3 1.0
1.0 1.0 1.1 1.2 1.4 1.3
2 1.3 1.3 0.8 1.2 1.6 1.7
8 1.0 1.1 1.1 1.3 1.2 1.1
15 0.9 0.9 0.8 1.2 1.1 1.0
1.1 1.1 0.9 1.2 1.3 1.3
1.0 1.1 1.0 1.2 1.4 1.3
1 0.9 1.0 1.3 1.0 1.4 1.1
10 1.0 1.0 0.9 1.3 1.3 1.3
14 1.0 1.0 1.0 1.1 1.4 1.0
1.0 1.0 1.1 1.1 1.4 1.1
4 1.7 1.6 0.9 1.5 1.5 1.4
5 1.2 1.2 1.0 1.1 1.1 1.1
11 1.1 1.1 1.0 1.3 1.6 1.2
1.3 1.3 1.0 1.3 1.4 1.2
1.2 1.2 1.0 1.2 1.4 1.2
4 1.1 1.1 1.1 1.1 1.3 1.5
7 1.1 1.1 1.3 1.3 1.5 1.1
11 1.0 1.0 1.2 1.2 1.5 1.0
1.1 1.1 1.2 1.2 1.4 1.2
6 1.2 1.0 1.0 1.2 1.3 1.3
9 1.2 1.3 1.0 1.2 1.4 1.3
10 1.2 1.2 1.0 1.3 1.4 1.2
1.2 1.2 1.0 1.2 1.4 1.3
1.1 1.1 1.1 1.2 1.4 1.2
5 1.1 1.2 1.3 1.4 1.5 1.2
6 1.0 1.1 1.1 1.2 1.6 1.2
15 0.9 0.9 1.0 1.2 1.3 1.0
1.0 1.1 1.1 1.3 1.5 1.1
7 1.2 1.0 1.0 1.2 1.4 1.3
12 1.4 1.2 1.1 1.4 1.5 1.1
13 1.4 1.1 1.0 1.4 1.5 1.3
1.3 1.1 1.0 1.3 1.5 1.2
1.2 1.1 1.1 1.3 1.5 1.2
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
L. reuteri DS-33
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1c
2d
1c
2d
Overall Mean
Exp. 2 Mean
L. acidophilus L-23
L. reuteri WB-74
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
Table B44. Study 1 hourly LPSa challenge creatinine levels (mg/dL)
Overall Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Overall Mean
Control
1c
2d
1c
2d
Overall Mean
L. reuteri WB-75
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 8.6 8.8 8.0 8.0 8.6 9.1
8 6.4 6.6 7.1 7.7 8.4 11.3
13 7.4 6.9 6.9 6.1 5.0 8.6
7.5 7.4 7.3 7.3 7.3 9.7
1 6.3 6.7 5.5 5.5 8.0 8.8
3 8.1 8.3 7.3 6.9 7.1 9.6
14 8.9 10.3 9.3 8.1 7.1 8.6
7.8 8.4 7.4 6.8 7.4 9.0
7.6 7.9 7.4 7.1 7.4 9.3
2 8.3 7.9 7.2 8.2 10.7 7.2
9 8.7 9.1 9.1 10.0 10.2 10.4
12 9.7 9.0 8.9 9.7 11.3 12.5
8.9 8.7 8.4 9.3 10.7 10.0
2 6.6 7.1 7.7 7.3 8.1 9.5
8 8.8 9.4 8.8 7.3 6.6 6.7
15 10.0 10.1 10.5 7.8 7.7 8.0
8.5 8.9 9.0 7.5 7.5 8.1
8.7 8.8 8.7 8.4 9.1 9.1
1 8.8 7.7 7.2 8.8 7.7 7.9
10 6.8 7.0 7.7 7.7 10.4 10.3
14 12.0 12.0 12.1 12.5 10.4 10.5
9.2 8.9 9.0 9.7 9.5 9.6
4 8.4 9.0 9.1 7.4 7.3 8.8
5 6.2 7.1 7.3 7.2 6.6 7.0
11 7.8 8.5 8.5 7.6 8.5 9.8
7.5 8.2 8.3 7.4 7.5 8.5
8.3 8.6 8.7 8.5 8.5 9.1
4 7.2 7.7 8.0 9.5 12.0 9.1
7 6.0 5.9 6.0 6.0 6.2 7.4
11 5.7 6.1 6.9 10.1 9.5 10.1
6.3 6.6 7.0 8.5 9.2 8.9
6 8.9 9.2 9.1 7.8 7.2 10.3
9 6.6 6.7 7.5 7.0 6.5 7.3
10 5.8 6.2 6.6 5.8 5.3 5.7
7.1 7.4 7.7 6.9 6.3 7.8
6.7 7.0 7.4 7.7 7.8 8.3
5 9.7 9.2 9.4 10.5 13.1 12.9
6 5.4 5.8 6.6 8.0 8.8 10.1
15 5.6 5.6 5.6 6.6 8.1 10.3
6.9 6.9 7.2 8.4 10.0 11.1
7 7.1 8.5 8.0 7.8 7.9 9.9
12 7.0 7.8 8.2 7.2 5.7 7.1
13 6.7 8.5 8.3 6.8 7.6 8.5
6.9 8.3 8.2 7.3 7.1 8.5
6.9 7.6 7.7 7.8 8.5 9.8
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cDescription of treatments, experiments, and pigs - see Table B2
bBUN - blood urea nitrogen
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
L. reuteri DS-33
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
1d
2e
1d
2e
Overall Mean
Overall Mean
1d
2e
1d
2e
Exp. 1 Mean
Table B45. Study 1 hourly LPSa challenge BUNb:creatinine ratio levels
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Overall Mean
Control
Overall Mean
1d
2e
L. reuteri WB-74
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 144 141 136 141 139 146
8 143 141 137 139 129 130
13 145 142 146 143 143 138
144 141 140 141 137 138
1 147 135 143 142 143 146
3 136 131 111 138 140 144
14 137 117 105 140 140 143
140 128 120 140 141 144
142 135 130 141 139 141
2 145 143 140 143 141 150
9 141 138 156 141 134 144
12 142 139 128 141 136 134
143 140 141 142 137 143
2 154 149 105 139 140 144
8 129 132 125 140 141 144
15 125 126 110 140 140 141
136 136 113 140 140 143
139 138 127 141 139 143
1 143 142 168 141 139 141
10 150 141 129 142 131 136
14 144 140 136 141 134 134
146 141 144 141 135 137
4 152 151 106 139 141 142
5 149 142 117 140 140 145
11 139 130 120 141 143 143
147 141 114 140 141 143
146 141 129 141 138 140
4 146 144 146 142 140 152
7 145 143 155 140 139 145
11 143 139 157 139 135 137
145 142 153 140 138 145
6 148 122 129 141 143 144
9 143 141 126 140 143 146
10 144 137 116 142 144 147
145 133 124 141 143 146
145 138 138 141 141 145
5 143 144 153 142 140 140
6 144 141 146 139 144 145
15 142 139 145 144 136 134
143 141 148 142 140 140
7 146 129 127 144 146 145
12 142 130 124 142 143 143
13 149 125 113 142 142 145
146 128 121 143 144 144
144 135 135 142 142 142
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
Overall Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Exp. 1 Mean
1c
Exp. 2 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
1c
2d
L. acidophilus L-23
Exp. 1 Mean
Overall Mean
2d
1c
Table B46. Study 1 hourly LPSa challenge sodium levels (mEq/L)
L. reuteri WB-75
2d
1c
Control
L. reuteri DS-33
L. reuteri WB-74
1c
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 12.3 11.4 9.8 9.6 8.1 10.3
8 10.8 10.2 11.4 10.0 8.8 9.8
13 10.4 9.6 9.9 9.1 8.2 8.8
11.2 10.4 10.4 9.6 8.4 9.6
1 10.0 9.2 9.5 10.1 9.2 9.8
3 9.9 8.9 7.3 9.8 9.6 9.5
14 9.6 8.4 8.5 8.9 8.5 8.9
9.8 8.8 8.4 9.6 9.1 9.4
10.5 9.6 9.4 9.6 8.7 9.5
2 10.4 10.2 9.7 9.1 7.6 10.2
9 11.7 9.9 10.0 9.0 7.5 9.3
12 9.3 8.3 8.3 8.6 7.3 7.8
10.5 9.5 9.3 8.9 7.5 9.1
2 10.2 10.2 7.2 9.0 9.7 7.9
8 8.1 8.9 8.2 7.8 8.5 8.3
15 8.8 8.4 7.6 9.0 9.2 8.3
9.0 9.2 7.7 8.6 9.1 8.2
9.8 9.3 8.5 8.8 8.3 8.6
1 11.0 10.4 11.1 9.8 8.5 9.8
10 13.0 10.7 9.9 10.0 9.0 9.1
14 10.5 9.6 8.6 9.0 7.2 8.9
11.5 10.2 9.9 9.6 8.2 9.3
4 10.0 9.1 8.1 8.4 8.9 8.0
5 9.7 8.6 7.9 8.6 8.4 8.3
11 9.9 8.5 8.2 9.2 9.5 8.2
9.9 8.7 8.1 8.7 8.9 8.2
10.7 9.5 9.0 9.2 8.6 8.7
4 10.8 9.5 9.9 9.4 8.0 9.5
7 11.5 11.2 11.5 10.7 8.3 9.4
11 9.6 9.0 10.1 10.5 7.4 8.7
10.6 9.9 10.5 10.2 7.9 9.2
6 10.5 8.1 8.8 8.4 9.2 8.3
9 9.1 9.1 8.6 9.3 9.4 9.2
10 10.2 9.9 8.6 9.7 11.0 10.1
9.9 9.0 8.7 9.1 9.9 9.2
10.3 9.5 9.6 9.7 8.9 9.2
5 10.6 9.9 9.7 9.3 8.1 9.1
6 10.9 9.9 9.7 9.8 8.7 9.0
15 10.0 9.8 9.7 9.9 7.7 8.5
10.5 9.9 9.7 9.7 8.2 8.9
7 10.4 8.8 9.2 9.5 9.8 9.2
12 9.0 8.9 9.9 10.0 9.9 8.3
13 10.9 8.6 8.6 9.7 8.7 8.7
10.1 8.8 9.2 9.7 9.5 8.7
10.3 9.3 9.5 9.7 8.8 8.8
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
Overall Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Exp. 1 Mean
1c
Exp. 2 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
1c
2d
L. acidophilus L-23
Exp. 1 Mean
Overall Mean
2d
1c
Table B47. Study 1 hourly LPSa challenge potassium levels (mEq/L)
L. reuteri WB-75
2d
1c
Control
L. reuteri DS-33
L. reuteri WB-74
1c
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
 
 151
Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 106 106 101 102 103 112
8 107 105 105 103 99 101
13 107 106 109 104 105 103
107 106 105 103 102 105
1 110 104 105 104 105 110
3 104 99 84 103 104 109
14 102 90 79 100 100 106
105 98 89 102 103 108
106 102 97 103 103 107
2 106 104 107 103 102 112
9 109 105 113 103 100 110
12 104 102 96 102 102 103
106 104 105 103 101 108
2 111 109 78 103 105 104
8 96 97 92 100 104 107
15 97 95 84 102 105 104
101 100 85 102 105 105
104 102 95 102 103 107
1 103 101 116 101 101 110
10 109 103 97 103 102 106
14 103 101 99 102 99 105
105 102 104 102 101 107
4 111 111 80 100 103 107
5 113 106 88 104 105 109
11 106 98 88 103 103 107
110 105 85 102 104 108
108 103 95 102 102 107
4 105 104 106 102 102 111
7 109 110 115 108 103 109
11 104 102 113 104 99 109
106 105 111 105 101 110
6 109 93 99 102 103 106
9 104 102 94 103 104 111
10 105 102 86 102 105 108
106 99 93 102 104 108
106 102 102 104 103 109
5 105 105 112 103 103 106
6 107 104 108 104 102 108
15 107 105 106 103 98 102
106 105 109 103 101 105
7 108 97 96 103 104 110
12 106 98 93 102 102 108
13 112 95 86 101 102 105
109 97 92 102 103 108
108 101 100 103 102 107
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
Table B48. Study 1 hourly LPSa challenge chloride levels (mEq/L)
Overall Mean
Overall Mean
Overall Mean
Control
L. reuteri WB-74
1c
1c
2d
L. reuteri DS-33
1c
2d
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
L. acidophilus L-23
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table B2
2d
1c
2d
L. reuteri WB-75
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 23 26 26 29 27 26
8 20 25 24 29 22 22
13 21 25 23 23 23 23
21 25 24 27 24 24
1 24 23 27 27 25 24
3 20 22 21 23 26 27
14 23 21 20 31 30 28
22 22 23 27 27 26
22 24 24 27 26 25
2 24 26 22 28 26 21
9 16 25 30 29 25 20
12 24 27 23 26 24 21
21 26 25 28 25 21
2 29 29 20 26 26 29
8 23 25 26 28 24 26
15 21 25 23 27 26 27
24 26 23 27 25 27
23 26 24 27 25 24
1 27 28 37 29 27 18
10 21 27 22 27 20 20
14 25 30 22 30 26 23
24 28 27 29 24 20
4 24 27 18 28 26 24
5 18 23 23 27 25 27
11 17 21 25 28 24 24
20 24 22 28 25 25
22 26 25 28 25 23
4 21 29 29 30 26 24
7 19 19 27 20 23 20
11 21 26 30 20 24 16
20 25 29 23 24 20
6 27 23 26 30 29 28
9 23 24 27 26 30 22
10 21 21 22 28 24 24
24 23 25 28 28 25
22 24 27 26 26 22
5 22 25 29 27 24 23
6 21 25 28 24 27 23
15 19 24 27 23 26 24
21 25 28 25 26 23
7 24 23 24 26 25 24
12 18 19 21 28 24 22
13 15 17 19 26 26 25
19 20 21 27 25 24
20 22 25 26 25 24
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Control
L. reuteri DS-33
L. reuteri WB-74
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
1c
2d
2d
Table B49. Study 1 hourly LPSa challenge carbon dioxide levels (mEq/L)
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Overall Mean
2d
1c
Overall Mean
2d
1c
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 27.4 20.6 18.7 18.9 17.6 18.6
8 26.0 21.1 20.0 16.8 17.2 17.3
13 26.8 21.1 23.3 25.3 23.7 20.6
26.7 20.9 20.7 20.3 19.5 18.8
1 24.1 17.8 20.6 21.3 22.2 22.2
3 22.3 18.5 13.0 21.2 19.6 17.8
14 21.3 14.7 14.2 17.4 18.9 18.6
22.6 17.0 15.9 20.0 20.2 19.5
24.7 19.0 18.3 20.2 19.9 19.2
2 25.8 23.3 21.6 21.3 21.2 26.8
9 27.4 18.0 23.3 18.2 16.2 24.0
12 22.6 18.9 17.0 21.5 17.4 17.0
25.3 20.1 20.6 20.3 18.3 22.6
2 24.7 21.4 14.3 18.8 18.4 19.2
8 18.1 19.2 15.3 19.5 21.4 19.4
15 16.1 14.6 11.3 19.6 17.8 18.0
19.6 18.4 13.6 19.3 19.2 18.9
22.5 19.2 17.1 19.8 18.7 20.7
1 23.9 23.6 25.6 20.2 19.3 22.6
10 32.4 21.7 20.2 22.0 18.3 19.1
14 25.9 18.7 22.9 17.7 16.6 15.4
27.4 21.3 22.9 20.0 18.1 19.0
4 27.6 22.4 16.6 19.0 20.4 19.5
5 27.2 21.3 14.4 17.8 18.0 17.8
11 26.6 19.9 14.7 19.0 25.3 21.3
27.1 21.2 15.2 18.6 21.2 19.5
27.3 21.3 19.1 19.3 19.7 19.3
4 30.5 20.9 21.2 19.6 19.6 26.8
7 28.7 24.6 24.0 21.4 21.1 25.0
11 27.9 20.7 24.0 26.1 20.1 21.2
29.0 22.1 23.1 22.4 20.3 24.3
6 21.9 13.9 13.7 17.5 20.4 18.2
9 25.7 24.0 14.6 20.2 18.9 21.6
10 27.8 24.0 16.1 21.4 25.4 24.5
25.1 20.6 14.8 19.7 21.6 21.4
27.1 21.4 18.9 21.0 20.9 22.9
5 26.6 23.4 22.4 21.9 21.3 20.6
6 27.6 22.5 19.9 21.2 23.4 21.7
15 26.3 19.9 21.8 27.4 20.0 17.1
26.8 21.9 21.4 23.5 21.6 19.8
7 23.2 17.1 16.1 23.9 26.6 20.7
12 26.0 22.0 19.8 21.6 26.1 22.1
13 33.2 21.4 16.8 23.8 22.7 23.3
27.5 20.2 17.6 23.1 25.1 22.0
27.2 21.1 19.5 23.3 23.4 20.9
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Control
L. reuteri DS-33
L. reuteri WB-74
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
1c
2d
2d
Table B50. Study 1 hourly LPSa challenge anion gap levels
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Overall Mean
2d
1c
Overall Mean
2d
1c
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 10.4 9.9 8.4 8.7 9.3 10.1
8 10.0 9.5 8.1 8.7 6.7 6.6
13 11.0 10.5 10.4 9.7 10.5 9.5
10.5 10.0 9.0 9.0 8.8 8.7
1 11.1 9.9 10.6 9.7 9.8 10.5
3 9.2 8.7 7.3 9.0 9.4 10.5
14 9.6 7.0 7.0 9.4 8.8 10.2
10.0 8.5 8.3 9.4 9.3 10.4
10.2 9.3 8.6 9.2 9.1 9.6
2 10.9 10.6 9.2 9.3 10.8 11.3
9 11.1 10.1 10.7 9.4 7.7 10.2
12 10.7 10.4 8.1 9.3 8.2 7.8
10.9 10.4 9.3 9.3 8.9 9.8
2 11.1 10.7 6.4 9.2 8.6 8.7
8 8.5 9.2 8.3 9.2 9.4 10.3
15 8.3 8.4 7.1 9.5 9.0 10.2
9.3 9.4 7.3 9.3 9.0 9.7
10.1 9.9 8.3 9.3 9.0 9.8
1 10.6 10.5 12.6 9.4 9.1 9.0
10 11.5 10.3 7.4 9.5 6.3 8.5
14 11.0 10.2 9.1 8.8 7.3 8.6
11.0 10.3 9.7 9.2 7.6 8.7
4 11.6 11.5 6.8 8.9 8.6 9.8
5 10.3 9.7 7.5 9.2 8.9 10.4
11 9.7 8.9 8.1 9.5 9.0 10.4
10.5 10.0 7.5 9.2 8.8 10.2
10.8 10.2 8.6 9.2 8.2 9.5
4 10.8 10.2 9.3 9.3 9.2 9.8
7 11.3 10.8 11.3 9.3 8.9 9.5
11 11.1 10.2 11.1 9.4 8.5 7.9
11.1 10.4 10.6 9.3 8.9 9.1
6 10.5 8.0 8.8 9.7 9.7 10.1
9 10.6 10.1 8.4 9.6 9.6 11.1
10 10.4 9.9 7.8 10.0 9.9 11.1
10.5 9.3 8.3 9.8 9.7 10.8
10.8 9.9 9.5 9.6 9.3 9.9
5 11.0 10.7 10.3 9.4 8.6 9.1
6 10.7 10.4 9.8 9.2 9.8 9.3
15 10.6 10.1 9.7 9.4 7.9 7.9
10.8 10.4 9.9 9.3 8.8 8.8
7 10.6 8.3 8.4 9.7 8.9 9.7
12 9.8 8.6 8.3 8.9 8.7 9.7
13 10.8 8.1 7.6 9.7 9.3 10.0
10.4 8.3 8.1 9.4 9.0 9.8
10.6 9.4 9.0 9.4 8.9 9.3
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Control
L. reuteri DS-33
L. reuteri WB-74
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
1c
2d
2d
Table B51. Study 1 hourly LPSa challenge calcium levels (mEq/L)
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Overall Mean
2d
1c
Overall Mean
2d
1c
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 5.3 4.7 3.8 4.8 5.1 5.1
8 5.1 4.7 4.2 4.4 3.3 2.7
13 5.6 5.2 5.2 5.1 5.6 4.5
5.3 4.9 4.4 4.8 4.7 4.1
1 5.5 4.3 5.1 5.0 5.2 5.3
3 4.8 4.0 3.2 4.7 5.0 5.3
14 4.8 3.3 3.3 4.7 4.9 5.1
5.0 3.9 3.9 4.8 5.0 5.2
5.2 4.4 4.1 4.8 4.9 4.7
2 5.6 5.1 3.9 5.0 6.5 6.2
9 4.9 4.3 4.9 4.4 3.7 4.7
12 5.3 5.0 3.8 5.2 4.4 3.7
5.3 4.8 4.2 4.9 4.9 4.9
2 5.9 4.9 3.2 4.9 4.8 4.8
8 3.9 3.8 3.7 4.5 4.8 4.9
15 3.6 3.9 3.2 5.1 5.1 5.0
4.5 4.2 3.4 4.8 4.9 4.9
4.9 4.5 3.8 4.9 4.9 4.9
1 5.6 5.3 6.6 5.2 5.3 5.3
10 5.8 4.9 3.2 5.1 3.0 4.8
14 5.7 5.2 4.5 5.1 4.5 4.2
5.7 5.1 4.8 5.1 4.3 4.8
4 6.2 5.5 3.4 4.9 5.1 5.3
5 5.5 4.9 3.9 5.0 5.0 5.2
11 4.6 3.9 3.7 5.0 5.4 5.2
5.4 4.8 3.7 5.0 5.2 5.2
5.6 5.0 4.2 5.1 4.7 5.0
4 5.2 4.5 4.2 4.8 4.6 5.6
7 5.2 4.8 5.1 4.4 4.2 4.4
11 5.6 5.1 5.8 5.2 4.7 3.4
5.3 4.8 5.0 4.8 4.5 4.5
6 5.4 3.5 4.2 4.8 4.9 4.9
9 4.7 4.5 3.9 4.8 4.9 5.1
10 5.0 4.4 3.5 4.7 5.3 5.4
5.0 4.1 3.9 4.8 5.0 5.1
5.2 4.5 4.5 4.8 4.8 4.8
5 5.8 5.2 5.0 5.5 5.1 4.4
6 5.3 4.9 4.7 4.8 5.7 4.4
15 5.4 5.2 5.3 5.6 4.8 3.7
5.5 5.1 5.0 5.3 5.2 4.2
7 5.6 4.2 4.1 5.5 5.4 5.4
12 5.3 4.2 4.6 5.1 5.3 5.1
13 6.3 4.3 3.8 5.4 5.5 5.7
5.7 4.2 4.2 5.3 5.4 5.4
5.6 4.7 4.6 5.3 5.3 4.8
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table B2
1c
2d
L. acidophilus L-23
1c
2d
1c
Exp. 1 Mean
Table B52. Study 1 hourly LPSa challenge total protein levels (g/dL)
L. reuteri WB-75
L. reuteri WB-74
L. reuteri DS-33
Control
Overall Mean
Overall Mean
2d
Overall Mean
Overall Mean
1c
2d
1c
2d
Exp. 1 Mean
Exp. 1 Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 3.5 2.9 2.3 3.0 3.1 3.2
8 3.2 2.8 2.4 2.6 1.8 1.4
13 3.2 2.9 2.8 2.9 3.1 2.4
3.3 2.9 2.5 2.8 2.7 2.3
1 3.8 2.8 3.5 3.4 3.5 3.5
3 2.7 2.2 1.7 2.7 2.8 2.8
14 2.6 1.7 1.6 2.5 2.7 2.7
3.0 2.2 2.3 2.9 3.0 3.0
3.2 2.6 2.4 2.9 2.8 2.7
2 3.8 3.5 2.5 3.3 4.3 4.0
9 3.4 2.7 3.2 2.9 2.2 3.0
12 3.8 3.5 2.5 3.6 2.9 2.3
3.7 3.2 2.7 3.3 3.1 3.1
2 3.8 3.2 1.8 3.1 2.9 2.8
8 2.3 2.3 2.2 2.7 3.0 3.0
15 2.0 2.2 1.7 3.1 3.1 2.9
2.7 2.6 1.9 3.0 3.0 2.9
3.2 2.9 2.3 3.1 3.1 3.0
1 3.8 3.5 4.4 3.4 3.3 3.3
10 4.3 3.4 2.0 3.5 1.8 3.0
14 3.2 2.8 2.4 2.8 2.3 2.2
3.8 3.2 2.9 3.2 2.5 2.8
4 3.5 3.0 1.7 2.6 2.7 2.7
5 3.0 2.6 1.9 2.6 2.6 2.6
11 3.0 2.5 2.3 3.4 3.7 3.3
3.2 2.7 2.0 2.9 3.0 2.9
3.5 3.0 2.5 3.1 2.7 2.9
4 3.6 3.1 2.8 3.1 3.0 3.7
7 3.4 3.0 3.2 2.8 2.6 2.6
11 3.7 3.2 3.8 3.3 2.9 2.0
3.6 3.1 3.3 3.1 2.8 2.8
6 3.4 2.0 2.5 2.9 3.1 2.9
9 3.2 3.1 2.5 3.2 3.1 3.3
10 2.9 2.6 2.0 2.7 3.1 3.1
3.2 2.6 2.3 2.9 3.1 3.1
3.4 2.8 2.8 3.0 3.0 2.9
5 4.2 3.7 3.6 3.8 3.5 2.9
6 3.2 2.9 2.7 2.8 3.4 2.6
15 3.4 3.2 3.3 3.7 2.9 2.1
3.6 3.3 3.2 3.4 3.3 2.5
7 3.5 2.5 2.6 3.5 3.4 3.3
12 2.9 2.1 2.4 2.8 3.0 2.7
13 4.2 2.7 2.4 3.7 3.6 3.6
3.5 2.4 2.5 3.3 3.3 3.2
3.6 2.9 2.8 3.4 3.3 2.9
dExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cExperiment 1 were barrows
Overall Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table B2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
2d
Table B53. Study 1 hourly LPSa challenge albumin levels (g/dL)
Control
Overall Mean
L. reuteri DS-33
1c
2d
Exp. 1 Mean
Exp. 1 Mean
L. acidophilus L-23
1c
Overall Mean
1c
2d
L. reuteri WB-74
2d
Overall Mean
1c
L. reuteri WB-75
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 1.7 1.7 1.5 1.8 2.0 1.9
8 2.0 2.0 1.7 1.8 1.5 1.3
13 2.4 2.4 2.4 2.2 2.5 2.1
2.0 2.0 1.9 1.9 2.0 1.8
1 1.7 1.5 1.6 1.6 1.7 1.9
3 2.1 1.8 1.5 2.0 2.2 2.4
14 2.2 1.6 1.6 2.2 2.2 2.4
2.0 1.6 1.6 1.9 2.0 2.2
2.0 1.8 1.7 1.9 2.0 2.0
2 1.8 1.6 1.4 1.7 2.1 2.2
9 1.5 1.6 1.7 1.5 1.5 1.7
12 1.5 1.6 1.3 1.6 1.5 1.4
1.6 1.6 1.5 1.6 1.7 1.8
2 2.1 1.8 1.4 1.8 1.9 2.0
8 1.6 1.5 1.6 1.7 1.8 1.9
15 1.6 1.7 1.5 2.0 2.0 2.1
1.8 1.7 1.5 1.8 1.9 2.0
1.7 1.6 1.5 1.7 1.8 1.9
1 1.8 1.8 2.3 1.8 2.0 2.0
10 1.5 1.4 1.1 1.6 1.2 1.8
14 2.4 2.3 2.1 2.3 2.2 2.0
1.9 1.8 1.8 1.9 1.8 1.9
4 2.7 2.5 1.7 2.3 2.3 2.6
5 2.5 2.3 2.0 2.4 2.4 2.5
11 1.5 1.4 1.4 1.6 1.7 1.9
2.2 2.1 1.7 2.1 2.1 2.3
2.1 2.0 1.8 2.0 2.0 2.1
4 1.6 1.4 1.4 1.6 1.6 1.9
7 1.8 1.8 1.9 1.6 1.6 1.8
11 1.9 1.8 2.1 1.9 1.8 1.4
1.8 1.7 1.8 1.7 1.7 1.7
6 2.1 1.5 1.8 1.9 1.8 2.0
9 1.5 1.4 1.5 1.6 1.7 1.8
10 2.1 1.8 1.5 1.9 2.2 2.3
1.9 1.6 1.6 1.8 1.9 2.0
1.8 1.6 1.7 1.8 1.8 1.9
5 1.6 1.5 1.4 1.7 1.6 1.5
6 2.1 2.0 2.0 2.0 2.3 1.8
15 2.0 2.0 2.0 1.9 2.0 1.6
1.9 1.8 1.8 1.9 2.0 1.6
7 2.1 1.8 1.6 2.0 2.0 2.2
12 2.4 2.1 2.2 2.3 2.4 2.4
13 2.1 1.7 1.5 1.7 1.9 2.1
2.2 1.9 1.8 2.0 2.1 2.2
2.1 1.9 1.8 1.9 2.0 1.9
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table B2
2d
Overall Mean
cExperiment 1 were barrows
Exp. 2 Mean
L. acidophilus L-23
Overall Mean
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Table B54. Study 1 hourly LPSa challenge globulin levels (g/dL)
2d
L. reuteri WB-74
2d
1c
Overall Mean
L. reuteri DS-33
2d
Control
1c
L. reuteri WB-75
Exp. 1 Mean
1c
Exp. 2 Mean
1c
Overall Mean
1c
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 2.0 1.7 1.6 1.7 1.6 1.7
8 1.6 1.4 1.4 1.5 1.2 1.1
13 1.4 1.2 1.1 1.3 1.3 1.2
1.7 1.4 1.4 1.5 1.4 1.3
1 2.3 2.0 2.2 2.1 2.0 1.9
3 1.3 1.2 1.2 1.3 1.2 1.2
14 1.2 1.0 1.0 1.1 1.2 1.1
1.6 1.4 1.5 1.5 1.5 1.4
1.6 1.4 1.4 1.5 1.4 1.4
2 2.2 2.2 1.8 1.9 2.0 1.8
9 2.2 1.7 1.9 1.9 1.5 1.7
12 2.4 2.2 1.9 2.2 1.9 1.7
2.3 2.0 1.9 2.0 1.8 1.7
2 1.8 1.8 1.2 1.7 1.6 1.5
8 1.5 1.5 1.4 1.6 1.7 1.6
15 1.2 1.3 1.2 1.5 1.5 1.4
1.5 1.5 1.3 1.6 1.6 1.5
1.9 1.8 1.6 1.8 1.7 1.6
1 2.1 2.0 1.9 1.9 1.6 1.6
10 2.8 2.4 1.9 2.2 1.6 1.7
14 1.3 1.2 1.1 1.2 1.1 1.1
2.1 1.9 1.6 1.8 1.4 1.5
4 1.3 1.2 1.0 1.1 1.2 1.1
5 1.2 1.2 1.0 1.1 1.1 1.0
11 2.0 1.8 1.7 2.1 2.2 1.8
1.5 1.4 1.2 1.4 1.5 1.3
1.8 1.6 1.4 1.6 1.5 1.4
4 2.2 2.1 2.0 1.9 1.8 2.0
7 1.9 1.7 1.6 1.7 1.6 1.5
11 1.9 1.7 1.8 1.7 1.6 1.4
2.0 1.8 1.8 1.8 1.7 1.6
6 1.6 1.4 1.4 1.6 1.7 1.5
9 2.2 2.2 1.7 1.9 1.8 1.9
10 1.4 1.4 1.3 1.4 1.5 1.3
1.7 1.7 1.5 1.6 1.7 1.6
1.9 1.8 1.6 1.7 1.7 1.6
5 2.7 2.6 2.5 2.3 2.3 1.9
6 1.5 1.4 1.4 1.4 1.5 1.5
15 1.7 1.6 1.6 2.0 1.5 1.3
2.0 1.9 1.8 1.9 1.8 1.6
7 1.7 1.4 1.6 1.7 1.7 1.5
12 1.2 1.0 1.1 1.2 1.3 1.1
13 2.0 1.6 1.6 2.1 1.9 1.7
1.6 1.3 1.4 1.7 1.6 1.4
1.8 1.6 1.6 1.8 1.7 1.5
cExperiment 1 were barrows
Overall Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table B2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-75
dExperiment 2 were gilts
Exp. 2 Mean
1c
Exp. 2 Mean
Table B55. Study 1 hourly LPSa challenge albumin:globulin ratio levels
Control
Overall Mean
L. reuteri DS-33
1c
Exp. 2 Mean
2d
Exp. 1 Mean
Exp. 1 Mean
1c
2d
Exp. 1 Mean
2d
L. acidophilus L-23
1c
Overall Mean
L. reuteri WB-74
2d
Overall Mean
Exp. 2 Mean
Overall Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 52 57 53 81 94 50
8 55 62 75 73 72 31
13 54 56 59 68 76 38
54 58 62 74 81 40
1 43 53 66 86 123 63
3 39 33 32 62 70 54
14 62 46 49 92 127 83
48 44 49 80 107 67
51 51 56 77 94 53
2 50 65 47 81 140 77
9 46 48 54 54 46 59
12 53 60 49 90 80 37
50 58 50 75 89 58
2 38 40 27 58 67 76
8 43 44 56 79 86 72
15 37 40 33 55 84 44
39 41 39 64 79 64
45 50 44 70 84 61
1 57 60 88 77 85 62
10 50 57 50 86 62 73
14 53 57 49 60 58 37
53 58 62 74 68 57
4 56 52 43 100 176 102
5 60 43 42 63 76 52
11 52 72 81 143 161 108
56 56 55 102 138 87
55 57 59 88 103 72
4 41 48 53 58 66 66
7 59 75 87 91 105 87
11 62 76 40 104 146 72
54 66 60 84 106 75
6 59 36 49 51 55 44
9 47 56 59 89 146 69
10 44 56 56 96 126 79
50 49 55 79 109 64
52 58 57 82 107 70
5 70 71 77 83 79 65
6 45 56 61 70 102 53
15 77 83 90 104 97 48
64 70 76 86 93 55
7 45 34 42 49 64 45
12 65 52 76 108 140 87
13 72 68 74 124 187 98
61 51 64 94 130 77
62 61 70 90 112 66
dExperiment 1 were barrows
eExperiment 2 were gilts
cDescription of treatments, experiments, and pigs - see Table B2
bAST - aspartate aminotransferase
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1d
2e
L. reuteri WB-75
Overall Mean
2e
L. acidophilus L-23
Table B56. Study 1 hourly LPSa challenge ASTb levels (U/L)
Control
Overall Mean
L. reuteri DS-33
1d
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-74
1d
2e
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
1d
1d
2e
Overall Mean
2e
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 59 57 52 65 69 63
8 59 57 53 61 49 39
13 66 67 65 71 79 54
61 60 57 66 66 52
1 34 34 35 39 49 40
3 25 33 25 29 35 32
14 59 48 47 62 72 70
39 38 36 43 52 47
50 49 46 55 59 50
2 45 50 37 49 64 54
9 58 54 56 60 55 52
12 81 80 66 94 81 60
61 61 53 68 67 55
2 34 33 29 36 42 37
8 28 31 33 35 41 37
15 29 31 29 34 42 34
30 32 30 35 42 36
46 47 42 51 54 46
1 65 65 74 68 73 63
10 53 52 40 58 42 49
14 53 51 45 57 52 44
57 56 53 61 56 52
4 50 46 37 48 58 54
5 34 34 31 36 40 36
11 41 40 40 55 63 56
42 40 36 46 54 49
49 48 45 54 55 50
4 46 46 44 54 55 56
7 50 51 58 56 54 49
11 52 56 66 70 62 46
49 51 56 60 57 50
6 54 42 47 50 57 49
9 55 53 49 55 61 56
10 30 31 31 37 43 39
46 42 42 47 54 48
48 47 49 54 55 49
5 60 59 56 66 64 55
6 42 46 44 50 57 45
15 71 76 70 82 76 56
58 60 57 66 66 52
7 41 37 37 44 48 43
12 30 27 31 35 40 40
13 41 36 37 45 58 52
37 33 35 41 49 45
48 47 46 54 57 49
Exp. 2 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cDescription of treatments, experiments, and pigs - see Table B2
bALT - alanine aminotransferase 
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
1d
2e
Overall Mean
L. reuteri DS-33
Overall Mean
Overall Mean
1d
2e
1d
2e
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Table B57. Study 1 hourly LPSa challenge ALTb levels (U/L)
L. reuteri WB-74
L. reuteri WB-75
L. acidophilus L-23
Overall Mean
Overall Mean
1d
2e
1d
Control
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 226 210 179 210 289 206
8 291 273 221 244 197 133
13 247 247 239 220 289 186
255 243 213 225 258 175
1 204 164 231 183 250 224
3 156 138 112 150 195 195
14 198 130 120 180 224 208
186 144 154 171 223 209
220 194 184 198 241 192
2 263 264 188 263 383 268
9 230 208 236 200 195 196
12 257 238 168 210 183 149
250 237 197 224 254 204
2 188 172 99 152 233 284
8 114 116 111 129 154 145
15 93 96 84 124 118 119
132 128 98 135 168 183
191 182 148 180 211 194
1 263 265 321 230 293 206
10 336 306 178 320 176 312
14 315 301 259 279 237 190
305 291 253 276 235 236
4 247 232 127 199 222 200
5 161 150 105 134 152 140
11 231 193 174 229 273 255
213 192 135 187 216 198
259 241 194 232 226 217
4 278 260 235 263 293 257
7 207 219 226 191 246 199
11 262 257 294 272 324 170
249 245 252 242 288 209
6 252 169 198 224 262 233
9 199 207 168 214 234 199
10 212 194 139 195 228 214
221 190 168 211 241 215
235 218 210 227 265 212
5 229 209 188 205 242 176
6 289 297 273 256 420 247
15 166 184 196 194 176 105
228 230 219 218 279 176
7 197 153 148 188 232 208
12 152 121 122 128 164 141
13 196 135 113 175 224 216
182 136 128 164 207 188
205 183 173 191 243 182
eExperiment 2 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
dExperiment 1 were barrows
1d
2e
L. reuteri DS-33
Overall Mean
Exp. 1 Mean
cDescription of treatments, experiments, and pigs - see Table B2
bALKPhos - alkaline phosphatase
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
Overall Mean
Overall Mean
1d
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Table B58. Study 1 hourly LPSa challenge ALKPhosb levels (U/L)
Overall Mean
1d
2e
Control
Exp. 1 Mean
L. reuteri WB-74
L. reuteri WB-75
L. acidophilus L-23
2e
Overall Mean
1d
2e
1d
Exp. 1 Mean
Exp. 1 Mean
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Treatmentb Exp.b Pigb Hour 0c Hour 1.5c Hour 3.0c Hour 6.0c Hour 12 Hour 24c
3 0.2 0.3 0.3 0.6 1.0 0.1
8 0.1 0.3 0.6 0.6 0.7 0.1
13 0.1 0.1 0.2 0.2 0.8 0.1
0.1 0.2 0.4 0.5 0.8 0.1
1 0.2 0.2 0.2 0.2 0.9 0.1
3 0.2 0.1 0.1 0.2 0.5 0.1
14 0.1 0.1 0.1 0.2 0.8 0.1
0.2 0.1 0.1 0.2 0.7 0.1
0.2 0.2 0.3 0.3 0.8 0.1
2 0.2 0.3 0.3 0.6 0.8 0.3
9 0.3 0.2 0.1 0.3 0.9 0.1
12 0.2 0.2 0.1 0.5 0.5 0.1
0.2 0.2 0.2 0.5 0.7 0.2
2 0.2 0.1 0.1 0.1 0.6 0.1
8 0.1 0.1 0.1 0.1 0.3 0.1
15 0.1 0.2 0.1 0.1 0.3 0.1
0.1 0.1 0.1 0.1 0.4 0.1
0.2 0.2 0.1 0.3 0.6 0.1
1 0.2 0.2 0.4 0.7 1.5 0.2
10 0.3 0.2 0.1 0.5 0.4 0.9
14 0.1 0.2 0.1 0.3 0.6 0.1
0.2 0.2 0.2 0.5 0.8 0.4
4 0.1 0.3 0.3 0.3 0.6 0.1
5 0.2 0.1 0.1 0.2 0.4 0.1
11 0.1 0.1 0.1 0.3 1.3 0.1
0.1 0.2 0.2 0.3 0.8 0.1
0.2 0.2 0.2 0.4 0.8 0.3
4 0.3 0.1 0.1 0.3 0.8 0.2
7 0.2 0.4 0.5 0.8 1.0 0.1
11 0.1 0.2 0.3 0.9 1.1 0.1
0.2 0.2 0.3 0.7 1.0 0.1
6 0.3 0.1 0.1 0.1 0.5 0.1
9 0.1 0.1 0.1 0.3 0.2 0.1
10 0.1 0.1 0.1 0.1 0.2 0.1
0.2 0.1 0.1 0.2 0.3 0.1
0.2 0.2 0.2 0.4 0.6 0.1
5 0.3 0.2 0.2 0.3 0.6 0.1
6 0.2 0.2 0.2 0.5 1.1 0.1
15 0.1 0.2 0.2 0.3 0.7 0.1
0.2 0.2 0.2 0.4 0.8 0.1
7 0.1 0.1 0.1 0.1 0.5 0.1
12 0.3 0.1 0.3 0.3 0.3 0.1
13 0.4 0.4 0.3 0.3 0.8 0.1
0.3 0.2 0.2 0.2 0.5 0.1
0.2 0.2 0.2 0.3 0.7 0.1
Exp. 2 Mean
Exp. 2 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
cAll 0.1 individual pig values were equal to <0.1
bDescription of treatments, experiments, and pigs - see Table B2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
1d
2e
L. acidophilus L-23
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
1d
2e
L. reuteri WB-75
L. reuteri WB-74
Overall Mean
Overall Mean
Table B59. Study 1 hourly LPSa challenge bili, total levels (mg/dL)
1d
2e
1d
L. reuteri DS-33
Control
Overall Mean
Overall Mean
1d
2e
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 65 54 50 58 73 68
8 88 76 62 65 50e 50e
13 70 64 59 54 65 53
74 65 57 59 63 57
1 95 67 85 75 79 89
3 82 67 50e 71 80 89
14 83 52 50e 63 77 87
87 62 62 70 79 88
81 63 59 64 71 73
2 71 66 50 61 80 97
9 59 50e 50 50e 50e 59
12 82 74 52 70 59 53
71 63 51 60 63 70
2 97 80 50e 62 58 65
8 81 77 69 83 91 101
15 50e 50 50e 52 57 66
76 69 56 66 69 77
73 66 54 63 66 74
1 51 50e 64 50 50e 50e
10 83 65 50 62 50e 70
14 60 56 50 57 53 50e
65 57 55 56 51 57
4 101 87 50e 67 79 76
5 76 66 50e 63 71 76
11 72 57 51 73 78 72
83 70 50 68 76 75
74 64 53 62 64 66
4 81 68 58 65 60 86
7 82 72 74 61 71 71
11 104 93 101 86 89 55
89 78 78 71 73 71
6 84 50e 58 61 57 64
9 52 50e 50e 50e 50e 53
10 82 69 50e 69 89 98
73 56 53 60 65 72
81 67 65 65 69 71
5 89 81 71 74 72 72
6 81 74 66 62 84 67
15 79 76 70 69 58 50e
83 77 69 68 71 63
7 85 61 59 73 69 83
12 86 68 66 68 81 84
13 109 70 57 85 90 102
93 66 61 75 80 90
88 72 65 72 76 76
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Table B60. Study 1 hourly LPSa challenge cholesterol levels (mg/dL)
L. reuteri DS-33
Control
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-75
1c
2d
1c
2d
L. reuteri WB-74
Overall Mean
Overall Mean
1c
2d
1c
2d
Exp. 1 Mean
Exp. 1 Mean
1c
2d
L. acidophilus L-23
Overall Mean
eValues were equal to <50
bDescription of treatments, experiments, and pigs - see Table B2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 15 25 16 27 120 29
8 30 26 21 18 55 25
13 26 26 32 19 39 20
24 26 23 21 71 25
1 28 23 23 15 46 57
3 40 25 16 27 55 33
14 42 23 27 18 41 32
37 24 22 20 47 41
30 25 23 21 59 33
2 21 33 18 25 67 50
9 37 31 23 19 65 36
12 24 19 17 29 112 32
27 28 19 24 81 39
2 44 38 27 21 28 53
8 35 51 27 24 35 49
15 15 16 12 11 30 27
31 35 22 19 31 43
29 31 21 22 56 41
1 23 34 45 26 76 22
10 36 46 15 30 29 166
14 52 52 53 69 155 31
37 44 38 42 87 73
4 36 41 27 17 31 32
5 28 13 10e 13 19 18
11 31 27 28 27 70 35
32 27 22 19 40 28
34 36 30 30 63 51
4 19 26 13 23 65 23
7 28 42 39 35 142 33
11 36 34 40 48 198 44
28 34 31 35 135 33
6 41 14 18 18 29 33
9 28 30 15 24 27 40
10 68 32 17 19 32 55
46 25 17 20 29 43
37 30 24 28 82 38
5 31 28 27 27 76 28
6 20 25 21 22 143 25
15 25 20 16 15 31 14
25 24 21 21 83 22
7 44 25 26 24 34 40
12 77 39 27 23 58 67
13 79 35 34 36 75 64
67 33 29 28 56 57
46 29 25 25 70 40
Exp. 2 Mean
cExperiment 1 were barrows
dExperiment 2 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
L. acidophilus L-23
1c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1c
2d
1c
2d
Exp. 1 Mean
Exp. 1 Mean
eValue was equal to <10
Table B61. Study 1 hourly LPSa challenge triglyceride levels (mg/dL)
Control
Overall Mean
Overall Mean
L. reuteri WB-75
2d
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table B2
Overall Mean
L. reuteri DS-33
Overall Mean
Overall Mean
L. reuteri WB-74
1c
2d
1c
2d
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 24 21 17 18 22 18
8 33 29 23 19 13 12
13 24 22 21 14 13 14
27 24 20 17 16 15
1 28 21 27 19 16 19
3 25 20 16 19 18 21
14 25 16 15 14 15 20
26 19 19 17 16 20
27 22 20 17 16 17
2 30 28 20 20 16 15
9 25 21 21 13 11 16
12 34 31 21 20 15 17
30 27 21 18 14 16
2 35 29 17 18 11 10
8 28 27 23 22 20 26
15 18 20 15 18 16 22
27 25 18 19 16 19
28 26 20 19 15 18
1 18 17 21 11 10 7
10 30 25 14 17 7 10
14 18 17 14 13 10 12
22 20 16 14 9 10
4 35 31 16 19 25 23
5 22 19 13 16 19 21
11 28 23 20 23 21 21
28 24 16 19 22 22
25 22 16 17 15 16
4 30 25 22 19 15 13
7 34 31 31 21 20 14
11 38 34 36 23 19 12
34 30 30 21 18 13
6 31 20 24 20 13 17
9 19 19 14 13 12 15
10 25 21 15 18 21 25
25 20 18 17 15 19
30 25 24 19 17 16
5 34 31 28 20 14 10
6 31 28 26 17 20 16
15 31 30 29 21 14 10
32 30 28 19 16 12
7 30 21 20 22 13 19
12 30 24 22 18 18 22
13 35 22 18 23 22 19
32 22 20 21 18 20
32 26 24 20 17 16
Exp. 2 Mean
Exp. 2 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
cDescription of treatments, experiments, and pigs - see Table B2
bHDL - high-density lipoprotein
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
1d
Overall Mean
Table B62. Study 1 hourly LPSa challenge HDLb levels (mg/dL)
1d
2e
2e
L. reuteri WB-74
L. reuteri WB-75
1d
Control
L. reuteri DS-33
L. acidophilus L-23
Overall Mean
1d
2e
2e
1d
2e
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 3 5 3 5 24 6
8 6 5 4 4 11 5
13 5 5 6 4 8 4
5 5 4 4 14 5
1 6 5 5 3 9 11
3 8 5 3 5 11 7
14 8 5 5 4 8 6
7 5 4 4 9 8
6 5 4 4 12 7
2 4 7 4 5 13 10
9 7 6 5 4 13 7
12 5 4 3 6 22 6
5 6 4 5 16 8
2 9 8 5 4 6 11
8 7 10 5 5 7 10
15 3 3 2 2 6 5
6 7 4 4 6 9
6 6 4 4 11 8
1 5 7 9 5 15 4
10 7 9 3 6 6 33
14 10 10 11 14 31 6
7 9 8 8 17 14
4 7 8 5 3 6 6
5 6 3 NAf 3 4 4
11 6 5 3 5 14 7
6 5 4 4 8 6
7 7 6 6 13 10
4 4 5 3 5 13 5
7 6 8 8 7 28 7
11 7 7 8 10 40 9
6 7 6 7 27 7
6 8 3 4 4 6 7
9 6 6 3 5 5 8
10 14 6 3 4 6 11
9 5 3 4 6 9
8 6 5 6 16 8
5 6 6 5 5 15 6
6 4 5 4 4 29 5
15 5 4 3 3 6 3
5 5 4 4 17 5
7 9 5 5 5 13 8
12 15 8 5 5 12 13
13 16 7 5 7 15 19
13 7 5 6 13 13
9 6 5 5 15 9
eExperiment 2 were gilts
fNA - not analyzed
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
dExperiment 1 were barrows
cDescription of treatments, experiments, and pigs - see Table B2
bVLDL - very low-density lipoprotein
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
Table B63. Study 1 hourly LPSa challenge VLDLb levels (mg/dL)
2e
1d
2e
Overall Mean
Overall Mean
1d
L. reuteri DS-33
Overall Mean
2e
Exp. 1 Mean
Exp. 2 Mean
2e
1d
L. acidophilus L-23
1d
2e
Exp. 1 Mean
L. reuteri WB-74
L. reuteri WB-75
Control
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
1d
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 0.775 0.722 0.513 0.276 0.148 0.407
8 0.313 0.326 0.387 0.145 0.196 0.160
13 0.591 0.510 0.416 0.197 0.181 0.262
0.560 0.519 0.438 0.206 0.175 0.276
1 0.370 0.379 0.327 0.327 0.449 0.366
3 0.358 0.345 0.299 0.250 0.289 0.522
14 0.784 0.717 0.644 0.443 0.453 0.409
0.504 0.480 0.423 0.340 0.397 0.432
0.532 0.500 0.431 0.273 0.286 0.354
2 0.445 0.418 0.385 0.191 0.178 0.221
9 0.442 0.385 0.439 0.155 0.255 0.317
12 0.903 0.787 0.836 0.257 0.245 0.331
0.597 0.530 0.553 0.201 0.226 0.290
2 0.999 0.706 0.611 0.369 0.711 0.692
8 0.502 0.615 0.321 0.659 0.504 0.528
15 0.526 0.369 0.601 0.374 0.380 0.360
0.676 0.564 0.511 0.467 0.532 0.527
0.636 0.547 0.532 0.334 0.379 0.408
1 0.561 0.406 0.326 0.186 0.238 0.364
10 0.534 0.513 0.510 0.258 0.200 0.258
14 0.896 0.516 0.134 0.244 0.266 0.320
0.664 0.478 0.323 0.229 0.234 0.314
4 0.358 0.293 0.270 0.236 0.273 0.275
5 0.619 0.921 0.941 0.811 0.691 0.482
11 1.414 0.736 0.672 1.003 0.601 1.101
0.797 0.650 0.628 0.684 0.522 0.619
0.730 0.564 0.475 0.456 0.378 0.467
4 0.620 0.528 0.371 0.234 0.229 0.400
7 0.955 0.886 1.335 0.248 0.307 0.309
11 0.524 0.371 0.467 0.224 0.188 0.208
0.700 0.595 0.724 0.235 0.241 0.306
6 0.312 0.303 0.189 0.309 0.229 0.209
9 0.250 0.227 0.197 0.352 0.270 0.282
10 0.494 0.502 0.298 0.421 0.556 0.483
0.352 0.344 0.228 0.361 0.351 0.324
0.526 0.469 0.476 0.298 0.296 0.315
5 0.516 0.503 0.787 0.202 0.201 0.239
6 0.532 0.516 0.617 0.261 0.271 0.271
15 0.330 0.886 0.126 0.157 0.158 0.203
0.459 0.635 0.510 0.207 0.210 0.238
7 0.898 0.689 0.662 0.889 0.648 0.527
12 0.248 0.307 0.461 0.335 0.293 0.259
13 0.332 0.210 0.457 0.216 0.225 0.228
0.493 0.402 0.527 0.480 0.389 0.338
0.476 0.519 0.518 0.343 0.299 0.288
bIgA - immunoglobulin A
Exp. 1 Mean
Exp. 1 Mean
Control
2e
1d
2e
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
L. acidophilus L-23
2e
Overall Mean
Exp. 2 Mean
Table B64. Study 1 hourly LPSa challenge IgAb levels (mg/mL)
1d
1d
2e
1d
2e
L. reuteri WB-74
1d
L. reuteri WB-75
Overall Mean
eExperiment 2 were gilts
dExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri DS-33
cDescription of treatments, experiments, and pigs - see Table B2
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 7.098 4.851 5.984 5.690 5.391 4.415
8 4.553 4.389 5.342 5.943 3.495 4.430
13 9.335 6.526 5.452 3.331 2.914 3.783
6.995 5.255 5.593 4.988 3.933 4.209
1 9.195 3.158 2.574 2.713 2.903 2.791
3 12.260 2.667 2.901 2.484 2.678 4.861
14 7.057 6.119 11.460 5.604 5.559 4.444
9.504 3.981 5.645 3.600 3.713 4.032
8.250 4.618 5.619 4.294 3.823 4.121
2 4.075 2.871 6.292 3.031 2.652 1.373
9 5.112 4.343 4.516 2.298 3.571 3.090
12 9.920 9.851 7.329 9.218 5.706 6.114
6.369 5.688 6.046 4.849 3.976 3.526
2 11.470 4.250 2.900 4.082 3.122 3.803
8 13.720 4.315 2.944 12.710 4.368 3.185
15 4.178 4.111 9.400 3.185 2.759 3.171
9.789 4.225 5.081 6.659 3.416 3.386
8.079 4.957 5.564 5.754 3.696 3.456
1 5.113 7.037 6.290 5.249 4.465 3.579
10 5.970 5.942 5.181 3.548 2.878 4.428
14 9.550 9.666 6.159 6.689 3.719 4.932
6.878 7.548 5.877 5.162 3.687 4.313
4 9.874 2.450 2.349 3.358 2.403 2.671
5 10.640 2.676 2.597 7.979 2.634 2.403
11 9.277 2.610 2.745 3.538 2.421 2.805
9.930 2.579 2.564 4.958 2.486 2.626
8.404 5.064 4.220 5.060 3.087 3.470
4 7.555 7.019 6.795 6.269 4.919 5.771
7 6.725 8.659 5.192 8.857 9.453 5.219
11 5.317 6.509 7.466 3.188 3.479 2.574
6.532 7.396 6.484 6.105 5.950 4.521
6 14.080 3.889 2.906 7.718 2.934 2.602
9 8.451 2.484 2.152 2.416 2.572 1.928
10 7.629 2.586 2.067 2.088 2.448 2.083
10.053 2.986 2.375 4.074 2.651 2.204
8.293 5.191 4.430 5.089 4.301 3.363
5 8.947 9.675 8.350 8.342 6.768 6.286
6 6.532 6.101 5.932 7.125 5.255 4.158
15 9.013 6.703 5.899 6.526 5.144 3.841
8.164 7.493 6.727 7.331 5.722 4.762
7 12.690 5.148 4.895 9.644 4.312 3.655
12 6.234 1.849 5.219 1.682 2.433 2.798
13 16.300 2.794 9.928 9.909 2.401 2.889
11.741 3.264 6.681 7.078 3.049 3.114
9.953 5.378 6.704 7.205 4.386 3.938
Table B65. Study 1 hourly LPSa challenge IgGb levels (mg/mL)
L. reuteri WB-75
Control
L. reuteri DS-33
L. reuteri WB-74
Overall Mean
Overall Mean
1d
2e
1d
1d
2e
1d
2e
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
cDescription of treatments, experiments, and pigs - see Table B2
bIgG - immunoglobulin G
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
L. acidophilus L-23
Exp. 2 Mean
dExperiment 1 were barrows
eExperiment 2 were gilts
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1d
2e
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
3 1.756 1.755 1.829 1.125 1.294 1.561
8 1.463 1.384 1.463 1.281 1.368 1.079
13 1.434 1.964 1.840 0.682 0.689 1.058
1.551 1.701 1.711 1.029 1.117 1.233
1 0.920 0.316 0.257 0.271 0.290 0.279
3 1.226 0.267 0.290 0.248 0.268 0.486
14 0.706 0.612 1.146 0.560 0.556 0.444
0.950 0.398 0.565 0.360 0.371 0.403
1.251 1.050 1.138 0.695 0.744 0.818
2 1.072 1.064 1.094 0.987 0.956 0.865
9 1.452 1.194 0.998 0.837 1.110 0.816
12 1.544 2.020 1.550 0.808 0.969 0.915
1.356 1.426 1.214 0.877 1.012 0.865
2 1.147 0.425 0.290 0.408 0.312 0.380
8 1.372 0.432 0.294 1.271 0.437 0.319
15 0.418 0.411 0.940 0.319 0.276 0.317
0.979 0.423 0.508 0.666 0.342 0.339
1.167 0.924 0.861 0.772 0.677 0.602
1 0.856 1.329 1.552 1.147 1.177 1.235
10 1.808 1.751 1.633 1.056 1.152 1.723
14 2.044 1.869 1.940 1.150 0.821 1.652
1.569 1.650 1.708 1.118 1.050 1.537
4 0.987 0.245 0.235 0.336 0.240 0.267
5 1.064 0.268 0.260 0.798 0.263 0.240
11 0.928 0.261 0.275 0.354 0.242 0.281
0.993 0.258 0.256 0.496 0.249 0.263
1.281 0.954 0.982 0.807 0.649 0.900
4 1.645 1.366 1.712 0.766 0.776 0.947
7 1.643 1.319 1.111 1.811 1.109 0.904
11 1.786 1.308 1.064 0.645 0.808 1.161
1.691 1.331 1.296 1.074 0.897 1.004
6 1.408 0.389 0.291 0.772 0.293 0.260
9 0.845 0.248 0.215 0.242 0.257 0.193
10 0.763 0.259 0.207 0.209 0.245 0.208
1.005 0.299 0.238 0.407 0.265 0.220
1.348 0.815 0.767 0.741 0.581 0.612
5 2.073 2.528 4.021 1.415 1.343 1.485
6 1.621 1.621 2.240 0.883 0.841 0.783
15 1.279 1.583 1.167 1.312 0.655 0.726
1.658 1.911 2.476 1.203 0.946 0.998
7 1.269 0.515 0.490 0.964 0.431 0.366
12 0.623 0.185 0.522 0.168 0.243 0.280
13 1.630 0.279 0.993 0.991 0.240 0.289
1.174 0.326 0.668 0.708 0.305 0.311
1.416 1.119 1.572 0.956 0.626 0.655
eExperiment 2 were gilts
1d
bIgM - immunoglobulin M
Overall Mean
Overall Mean
Control
1d
2e
1d
2e
Overall Mean
Overall Mean
Exp. 2 Mean
L. acidophilus L-23
L. reuteri WB-75
L. reuteri WB-74
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Table B66. Study 1 hourly LPSa challenge IgMb levels (mg/mL)
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1d
2e
1d
2e
cDescription of treatments, experiments, and pigs - see Table B2
dExperiment 1 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2e
L. reuteri DS-33
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Treatmentb Exp. Day 0 Day 3 or 4
1 0.92 1.20
2 1.27 1.45
1 8.02 7.94
2 7.96 7.83
1 8.14 8.19
2 7.95 7.91
1 7.98 7.60
2 7.95 6.63
1 8.04 7.59
2 8.04 6.62
aPlated on deMan, Rogasa, Sharpe agar (MRSA)
bIdeal count for treatments was 8.00 log10 cfu/mL
Table C1. Study 2 treatment counts of lactobacillia 
(Log10 cfu/mL)
Control
L. reuteri DS-36
L. reuteri DS-37
L. reuteri WB-72
L. reuteri WB-76
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Study Treatmenta
Exp. 1 
Pigb
Crate 
Number
Exp. 2 
Pigc
Crate 
Number
7-6 3 22-10 13
17-4 15 28-10 10
1-8 1 17-4 5
4-6 2 26-10 14
7-4 4 17-13 8
11-1 10 27-13 2
1-2 5 21-12 11
4-2 11 28-11 6
5-1 6 27-11 4
7-3 7 25-8 15
14-3 8 21-11 7
21-6 9 17-8 3
1-3 12 17-6 12
7-1 13 13-10 9
14-4 14 25-13 1
aAll treatments were fed 10 mL twice a day; Lactobacilli concentrations 
fed were 1 x 109 cfu/mL
bExperiment 1 were all gilts (n=15)
cExperiment 2 were all barrows (n=15)
Table C2. Swine assignments for study 2 feeding lactobacilli cultures
2
Control
L. reuteri DS-36
L. reuteri DS-37
L. reuteri WB-72
L. reuteri WB-76
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 8.26 10.43 13.34 17.33
10 8.62 11.34 15.24 18.51
13 10.80 13.52 16.69 19.96
9.22 11.76 15.09 18.60
1 7.71 9.80 13.15 16.24
3 11.88 12.88 16.06 19.78
15 7.80 8.53 11.70 15.33
9.13 10.40 13.64 17.12
9.18 11.18 14.47 17.96
2 7.53 9.89 12.97 15.88
8 8.44 11.61 15.24 19.32
14 10.43 14.33 18.51 22.41
8.80 11.94 15.57 19.20
2 11.43 13.88 17.33 20.50
4 10.52 12.25 15.88 20.23
10 5.90 7.17 9.98 13.79
9.28 11.10 14.39 18.17
9.01 11.58 15.07 18.76
4 7.94 11.79 15.42 18.42
6 9.16 12.34 15.33 19.78
11 9.71 12.88 15.51 19.05
8.94 12.34 15.42 19.08
5 11.07 11.79 13.88 16.87
6 7.80 8.44 11.88 14.61
11 9.25 10.66 13.34 16.24
9.37 10.30 13.03 15.91
9.12 11.46 14.40 17.72
3 8.89 11.79 14.97 18.60
7 8.89 12.25 15.69 19.50
15 8.71 10.89 14.06 16.51
8.83 11.64 14.91 18.20
7 11.25 13.20 16.87 19.96
8 7.17 8.16 10.98 14.61
9 9.07 10.52 13.43 16.51
9.16 10.63 13.76 17.02
8.97 11.21 14.42 17.70
1 8.26 10.80 13.97 17.69
9 8.98 11.61 14.79 17.51
12 10.07 14.06 17.24 20.96
9.10 12.16 15.33 18.72
12 10.52 11.70 14.97 17.96
13 9.98 11.34 14.83 18.51
14 7.80 9.53 13.52 17.33
9.43 10.86 14.44 17.93
9.24 11.60 14.95 18.38Overall Mean
L. reuteri WB-72
Table C3. Study 2 weekly swine weights (kg)
Control
1b
2c
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
1b
2c
Overall Mean
L. reuteri DS-36
1b
2c
Overall Mean
L. reuteri WB-76
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-37
1b
Exp. 2 Mean
Exp. 2 Mean
1b
2c
Overall Mean
cExperiment 2 were barrows
bExperiment 1 were gilts
aDescription of treatments, experiments, and pigs - see Table C2
2c
Overall Mean
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
5 0.27 0.41 0.80
10 0.34 0.56 0.65
13 0.34 0.45 0.65
0.32 0.48 0.70
1 0.30 0.48 0.39
3 0.14 0.45 0.46
15 0.10 0.45 0.45
0.18 0.46 0.43
0.25 0.47 0.57
2 0.29 0.44 0.58
8 0.40 0.52 0.82
14 0.49 0.60 0.78
0.39 0.52 0.73
2 0.35 0.49 0.40
4 0.25 0.52 0.54
10 0.18 0.40 0.48
0.26 0.47 0.47
0.33 0.49 0.60
4 0.48 0.52 0.60
6 0.40 0.43 0.89
11 0.40 0.38 0.71
0.43 0.44 0.73
5 0.10 0.30 0.37
6 0.09 0.49 0.34
11 0.20 0.38 0.36
0.13 0.39 0.36
0.28 0.42 0.55
3 0.36 0.45 0.73
7 0.42 0.49 0.76
15 0.27 0.45 0.49
0.35 0.47 0.66
7 0.28 0.52 0.39
8 0.14 0.40 0.45
9 0.21 0.41 0.39
0.21 0.45 0.41
0.28 0.46 0.53
1 0.32 0.45 0.74
9 0.33 0.45 0.54
12 0.50 0.45 0.74
0.38 0.45 0.68
12 0.17 0.47 0.37
13 0.19 0.50 0.46
14 0.25 0.57 0.48
0.20 0.51 0.44
0.29 0.48 0.56
Table C4. Study 2 weekly ADGa (kg)
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-36
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-37
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-72
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table C2
aADG - average daily gain
cExperiment 1 were gilts
dExperiment 2 were barrows
L. reuteri WB-76
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
5 0.46 0.74 1.20
10 0.58 0.89 1.20
13 0.56 0.76 1.19
0.53 0.79 1.20
1 0.42 0.68 0.69
3 0.36 0.69 0.73
15 0.26 0.63 0.69
0.35 0.67 0.70
0.44 0.73 0.95
2 0.55 0.71 1.02
8 0.72 0.86 1.38
14 0.82 0.95 1.34
0.70 0.84 1.25
2 0.55 0.80 0.72
4 0.48 0.71 0.71
10 0.34 0.63 0.72
0.46 0.72 0.72
0.58 0.78 0.98
4 0.70 0.85 1.07
6 0.63 0.78 1.30
11 0.71 0.72 1.14
0.68 0.78 1.17
5 0.33 0.55 0.57
6 0.38 0.54 0.66
11 0.44 0.60 0.64
0.38 0.56 0.62
0.53 0.67 0.90
3 0.70 0.81 1.23
7 0.74 0.82 1.25
15 0.47 0.73 1.03
0.63 0.79 1.17
7 0.52 0.70 0.69
8 0.22 0.58 0.70
9 0.36 0.52 0.70
0.37 0.60 0.70
0.50 0.69 0.93
1 0.62 0.73 1.30
9 0.66 0.76 1.07
12 0.73 0.86 1.17
0.67 0.79 1.18
12 0.32 0.69 0.69
13 0.37 0.72 0.69
14 0.41 0.71 0.71
0.37 0.71 0.70
0.52 0.75 0.94
Table C5. Study 2 weekly ADFIa (kg)
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-36
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-37
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-72
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
aADFI - average daily feed intake
bDescription of treatments, experiments, and pigs - see Table C2
cExperiment 1 were gilts
dExperiment 2 were barrows
L. reuteri WB-76
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Week 1 Week 2 Week 3
5 1.67 1.77 1.50
10 1.70 1.60 1.84
13 1.66 1.67 1.83
1.68 1.68 1.72
1 1.42 1.41 1.79
3 2.55 1.52 1.57
15 2.46 1.39 1.52
2.14 1.44 1.63
1.91 1.56 1.68
2 1.88 1.61 1.76
8 1.82 1.66 1.69
14 1.68 1.59 1.72
1.79 1.62 1.72
2 1.57 1.63 1.82
4 1.95 1.37 1.30
10 1.86 1.57 1.51
1.79 1.52 1.54
1.79 1.57 1.63
4 1.44 1.65 1.79
6 1.59 1.81 1.46
11 1.79 1.92 1.61
1.61 1.79 1.62
5 3.17 1.83 1.51
6 4.20 1.10 1.93
11 2.20 1.56 1.75
3.19 1.50 1.73
2.40 1.65 1.68
3 1.92 1.79 1.69
7 1.75 1.67 1.64
15 1.73 1.61 2.09
1.80 1.69 1.81
7 1.88 1.33 1.78
8 1.52 1.44 1.55
9 1.71 1.61 2.09
1.70 1.46 1.81
1.75 1.58 1.81
1 1.94 1.61 1.74
9 2.00 1.68 1.96
12 1.45 1.90 1.57
1.80 1.73 1.76
12 1.88 1.49 1.86
13 1.88 1.45 1.51
14 1.68 1.25 1.49
1.81 1.40 1.62
1.81 1.56 1.69
Table C6. Study 2 weekly F:G ratioa 
Control
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-36
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri DS-37
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
L. reuteri WB-72
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
aF:G - feed to gain
bDescription of treatments, experiments, and pigs - see Table C2
cExperiment 1 were gilts
dExperiment 2 were barrows
L. reuteri WB-76
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga ADGb ADFIc F:Gd
5 0.50 0.80 1.63
10 0.52 0.89 1.71
13 0.48 0.84 1.72
0.50 0.84 1.69
1 0.39 0.60 1.55
3 0.35 0.59 1.67
15 0.34 0.53 1.56
0.36 0.57 1.59
0.43 0.71 1.64
2 0.44 0.76 1.74
8 0.58 0.99 1.72
14 0.62 1.03 1.66
0.55 0.93 1.71
2 0.41 0.69 1.68
4 0.44 0.63 1.44
10 0.35 0.56 1.59
0.40 0.63 1.57
0.47 0.78 1.64
4 0.53 0.87 1.61
6 0.57 0.90 1.60
11 0.49 0.86 1.76
0.53 0.88 1.66
5 0.26 0.48 1.83
6 0.31 0.53 1.72
11 0.32 0.56 1.77
0.29 0.52 1.77
0.41 0.70 1.72
3 0.51 0.91 1.79
7 0.56 0.93 1.68
15 0.41 0.74 1.80
0.49 0.86 1.76
7 0.40 0.64 1.61
8 0.33 0.50 1.51
9 0.34 0.52 1.57
0.35 0.55 1.56
0.42 0.71 1.66
1 0.50 0.88 1.75
9 0.44 0.83 1.87
12 0.57 0.92 1.62
0.50 0.88 1.75
12 0.34 0.57 1.70
13 0.38 0.59 1.55
14 0.43 0.61 1.42
0.38 0.59 1.56
0.44 0.73 1.65
Table C7. Study 2 overall growth and performance (kg)
Control
1e
2f
Overall Mean
Exp. 2 Mean
L. reuteri DS-36
1e
2f
Overall Mean
Exp. 2 Mean
L. reuteri DS-37
1e
2f
Overall Mean
L. reuteri WB-72
1e
2f
Overall Mean
bADG - average daily gain
cADFI - average daily feed intake
dF:G - feed to gain ratio
L. reuteri WB-76
1e
2f
Overall Mean
aDescription of treatments, experiments, and pigs - see Table C2
eExperiment 1 were gilts
fExperiment 2 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 7.65 5.76 3.85 5.53
10 7.23 5.49 6.49 6.28
13 6.80 7.38 6.08 4.43
7.23 6.21 5.47 5.41
1 4.20 4.20 4.00 5.28
3 7.20 6.78 8.60 6.34
15 8.04 6.96 6.43 6.68
6.48 5.98 6.34 6.10
6.86 6.10 5.91 5.76
2 7.20 6.59 5.95 4.38
8 8.65 6.20 5.52 6.87
14 6.80 6.52 7.46 5.83
7.55 6.44 6.31 5.69
2 6.77 4.95 5.71 7.11
4 7.89 7.75 6.58 5.78
10 8.18 7.40 7.34 7.79
7.61 6.70 6.54 6.89
7.58 6.57 6.43 6.29
4 6.18 6.00 5.23 7.36
6 6.18 5.53 6.85 4.54
11 7.30 7.53 5.53 6.11
6.55 6.35 5.87 6.01
5 5.73 7.71 7.62 8.65
6 7.96 7.76 6.08 8.26
11 6.60 6.72 6.80 6.81
6.76 7.40 6.83 7.91
6.66 6.88 6.35 6.96
3 8.79 6.32 7.59 5.48
7 5.53 7.79 6.36 3.45
15 6.08 6.71 4.61 6.38
6.80 6.94 6.19 5.10
7 8.23 6.85 6.15 6.41
8 6.91 9.04 7.08 8.18
9 7.00 8.15 6.08 5.81
7.38 8.01 6.43 6.80
7.09 7.47 6.31 5.95
1 6.59 8.11 7.57 6.38
9 7.57 5.75 5.11 7.54
12 7.49 5.48 6.08 6.45
7.22 6.45 6.25 6.79
12 5.72 6.71 4.20 6.58
13 7.89 7.04 6.49 7.85
14 5.85 6.61 6.28 5.89
6.49 6.79 5.66 6.77
6.85 6.62 5.96 6.78
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
Overall Mean
1c
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
L. reuteri DS-36
1c
2d
Overall Mean
aPlated on violet red bile agar (VRBA)
2d
Overall Mean
L. reuteri WB-72
1c
Exp. 2 Mean
Table C8. Study 2 weekly fecal counts of coliformsa (Log10 cfu/mL)
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri DS-37
1c
2d
Overall Mean
L. reuteri WB-76
Control
1c
2d
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 9.72 9.40 10.23 9.59
10 9.98 9.40 9.74 9.53
13 9.72 9.58 9.96 9.97
9.81 9.46 9.98 9.70
1 8.11 9.53 9.72 10.00
3 9.75 9.70 10.11 9.72
15 9.76 9.68 10.04 9.38
9.21 9.64 9.96 9.70
9.51 9.55 9.97 9.70
2 8.99 9.11 8.93 9.04
8 9.57 9.11 9.92 9.43
14 9.81 9.36 9.11 9.41
9.46 9.20 9.32 9.30
2 9.83 9.51 9.99 9.28
4 9.15 9.65 9.93 9.67
10 9.64 9.15 9.79 8.62
9.54 9.43 9.90 9.19
9.50 9.32 9.61 9.24
4 9.04 9.40 9.59 9.89
6 9.54 9.40 9.86 9.64
11 9.76 8.94 9.56 9.41
9.45 9.25 9.67 9.65
5 9.81 9.54 9.74 8.41
6 9.49 9.08 9.65 9.79
11 9.89 9.56 10.00 9.58
9.73 9.39 9.80 9.26
9.59 9.32 9.73 9.45
3 9.81 9.51 9.36 9.40
7 9.28 8.89 9.49 9.11
15 9.48 9.04 9.51 9.72
9.52 9.14 9.45 9.41
7 9.92 10.11 9.76 9.45
8 10.15 9.88 9.86 9.58
9 9.65 9.69 9.26 9.89
9.91 9.89 9.62 9.64
9.71 9.52 9.54 9.52
1 9.77 9.66 8.15 9.38
9 10.00 9.68 9.89 9.52
12 9.40 9.15 9.53 9.51
9.72 9.50 9.19 9.47
12 10.18 9.38 9.26 9.89
13 9.38 9.34 9.11 9.97
14 9.98 9.43 9.98 9.60
9.84 9.38 9.45 9.82
9.78 9.44 9.32 9.64
dExperiment 2 were barrows
cExperiment 1 were gilts
L. reuteri WB-76
1c
2d
Overall Mean
aPlated on Lactobacillus selection agar (LBSA)
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri DS-37
1c
2d
Overall Mean
L. reuteri WB-72
1c
2d
Overall Mean
L. reuteri DS-36
1c
2d
Overall Mean
Table C9. Study 2 weekly fecal counts of lactobacillia (Log10 cfu/mL)
Control
1c
2d
Overall Mean
Exp. 1 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 4.08 5.74 4.59 4.53
10 4.41 4.34 4.80 5.49
13 5.66 6.04 5.81 5.68
5.37 5.07 5.07 5.23
1 4.00 4.46 4.00 4.00
3 4.00 4.48 4.00 4.00
15 4.45 4.00 4.48 4.43
4.15 4.31 4.16 4.14
4.43 4.84 4.61 4.69
2 4.00 4.00 4.45 4.00
8 4.38 4.67 4.00 4.38
14 4.38 4.00 4.74 4.00
4.25 4.22 4.40 4.13
2 4.00 4.00 4.00 4.00
4 4.59 4.00 4.00 4.00
10 6.04 4.51 6.08 4.57
4.88 4.17 4.69 4.19
4.57 4.20 4.55 4.16
4 4.00 4.41 5.34 4.00
6 4.74 4.00 4.00 4.00
11 4.00 5.69 4.67 4.66
4.56 4.25 4.18 4.85
5 4.00 4.00 4.38 4.77
6 4.00 4.00 4.30 4.64
11 4.00 4.00 4.74 5.48
4.32 4.23 4.56 5.15
4.44 4.24 4.37 5.00
3 4.00 4.00 4.67 5.54
7 5.90 5.58 4.45 4.54
15 4.00 4.11 4.79 5.79
4.63 4.56 4.64 5.29
7 4.00 4.00 4.00 4.00
8 4.00 4.51 4.00 4.53
9 7.34 4.00 4.34 4.38
5.11 4.17 4.11 4.30
4.87 4.37 4.38 4.80
1 4.64 4.00 4.00 4.00
9 4.45 4.00 4.00 6.08
12 4.58 4.75 4.54 4.46
4.56 4.25 4.18 4.85
12 4.41 4.00 5.68 6.18
13 4.48 4.68 4.00 4.68
14 4.08 4.00 4.00 4.59
4.32 4.23 4.56 5.15
4.44 4.24 4.37 5.00
Table C10. Study 2 weekly fecal counts of Campylobacter a (Log10 cfu/mL)
Control
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
L. reuteri DS-36
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
L. reuteri DS-37
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
L. reuteri WB-72
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table C2
cExperiment 1 were gilts
dExperiment 2 were barrows
L. reuteri WB-76
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 + + + +
10 + + + +
13 + + + +
3 3 3 3
1 - + - -
3 - + - -
15 + - + +
1 1 1 1
4 5 4 4
2 - - + -
8 + + - +
14 + - + -
2 1 2 1
2 - - - -
4 + - - -
10 + + + +
2 1 1 1
4 2 3 2
4 - + + -
6 + - - -
11 - + + +
1 2 2 1
5 - - + +
6 - - + +
11 - + + +
0 1 3 3
1 3 5 4
3 - + + +
7 + + + +
15 - + + +
1 3 3 3
7 + - - -
8 - + - +
9 + - + +
2 1 1 2
3 4 4 5
1 + - - -
9 + - - +
12 + + + +
3 1 1 2
12 + - + +
13 + + - +
14 + - - +
3 1 1 3
6 2 2 5
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table C2
1c
L. reuteri WB-76
1c
2d
Overall Mean
aTesting was done on the Bax® system
L. reuteri WB-72
2d
Table C11. Study 2 testing of weekly fecal cultures of Campylobacter positivesa
1c
2d
Overall Mean
Control
Exp. 1 Mean
Exp. 2 Mean
1c
1c
2d
dExperiment 2 were barrows
Exp. 2 Mean
Overall Mean
L. reuteri DS-36
Overall Mean
L. reuteri DS-37
2d
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
cExperiment 1 were gilts
Exp. 1 Mean
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 + + + +
10 + + + +
13 + + + +
3 3 3 3
1 + + - -
3 - + + +
15 + + + +
2 3 2 2
5 6 5 5
2 + + + +
8 + + + +
14 + + + +
3 3 3 3
2 + + - +
4 + + - +
10 + + + +
3 3 1 3
6 6 4 6
4 + + + +
6 + + + +
11 + + + +
3 3 3 3
5 + + + +
6 + + + +
11 - + + +
2 3 3 3
5 6 6 6
3 + + + +
7 + + + +
15 + + + +
3 3 3 3
7 + + + +
8 + + + +
9 + - + +
3 2 3 3
6 5 6 6
1 + + + +
9 + + + +
12 + + + +
3 3 3 3
12 + + + +
13 + + + +
14 + + - +
3 3 2 3
6 6 5 6
Exp. 1 Mean
1c
2d
Overall Mean
Exp. 2 Mean
Overall Mean
1c
Exp. 1 Mean
Exp. 1 Mean
Table C12. Study 2 testing of weekly fecal enrichment cultures of Campylobacter 
positivesa
Control
1c
2d
Overall Mean
Exp. 2 Mean
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-76
1c
2d
Exp. 1 Mean
cExperiment 1 were gilts
Overall Mean
L. reuteri DS-37
1c
2d
L. reuteri WB-72
2d
Overall Mean
L. reuteri DS-36
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 - - - -
10 - - - -
13 - - - -
0 0 0 0
1 - - - -
3 - - - -
15 - - - -
0 0 0 0
0 0 0 0
2 - - - -
8 - - - -
14 - - - -
0 0 0 0
2 - - - -
4 + - - -
10 - - - -
1 0 0 0
1 0 0 0
4 - - - -
6 - - - -
11 - - - -
0 0 0 0
5 - - - -
6 - - - -
11 - - - -
0 0 0 0
0 0 0 0
3 - - - -
7 - - - -
15 - - - -
0 0 0 0
7 - - - -
8 - - - -
9 - - - -
0 0 0 0
0 0 0 0
1 - - - -
9 + + - +
12 - - - -
1 1 0 1
12 - - - -
13 - - - -
14 - - - -
0 0 0 0
1 1 0 1
1c
2d
Overall Mean
Table C13. Study 2 testing of weekly fecal enrichment cultures of Salmonella 
positivesa  
Control
L. reuteri DS-37
1c
2d
Overall Mean
L. reuteri DS-36
1c
2d
Overall Mean
L. reuteri WB-72
1c
2d
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-76
1c
2d
Overall Mean
Exp. 2 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
1 - - - -
3 - - - -
15 - - - -
0 0 0 0
2 - - - -
4 - - - -
10 - - - -
0 0 0 0
5 - - - -
6 - - - -
11 - - - -
0 0 0 0
7 - - - -
8 - - - -
9 - - - -
0 0 0 0
12 - - - -
13 - - - -
14 - - - -
0 0 0 0
 Mean
L. reuteri DS-37 2
c
 Mean
aTesting was done on the Bax® system
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-76 2
c
 Mean
cExperiment 2 were barrows
L. reuteri DS-36
 Mean
2c
Table C14. Study 2 experiment 2 testing of weekly fecal enrichment cultures of 
Escherichia coli O157:H7 positivesa  
Control 2
c
 Mean
L. reuteri WB-72 2
c
 
 185
Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 111 109 100 136
10 109 121 119 137
13 130 93 99 108
117 108 106 127
1 98 95 109 102
3 87 84 120 86
15 93 91 114 106
93 90 114 98
105 99 110 113
2 121 104 100 108
8 99 98 106 116
14 104 103 105 108
108 102 104 111
2 97 91 115 98
4 103 95 122 111
10 128 93 114 101
109 93 117 103
109 97 110 107
4 118 124 136 132
6 126 113 98 127
11 110 110 99 126
118 116 111 128
5 90 76 145 99
6 100 101 104 102
11 168 105 121 109
119 94 123 103
119 105 117 116
3 158 125 115 118
7 109 107 96 116
15 113 93 111 103
127 108 107 112
7 102 107 127 117
8 91 88 109 97
9 98 86 113 94
97 94 116 103
112 101 112 108
1 166 106 107 129
9 119 117 115 117
12 114 119 113 116
133 114 112 121
12 101 94 131 102
13 116 87 134 106
14 103 90 121 101
107 90 129 103
120 102 120 112
L. reuteri DS-36
Overall Mean
aDescription of treatments, experiments, and pigs - see Table C2
1b
2c
L. reuteri WB-72
Overall Mean
Overall Mean
1b
2c
L. reuteri DS-37
1b
2c
Exp. 1 Mean
Table C15. Study 2 weekly glucose levels (mg/dL)
1b
2c
Overall Mean
Control
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
cExperiment 2 were barrows
bExperiment 1 were gilts
Exp. 2 Mean
Exp. 1 Mean
Overall Mean
L. reuteri WB-76
1b
2c
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 11 7 8 9
10 13 10 12 10
13 9 9 8 7
11 9 9 9
1 7 9 8 6
3 7 7 8 6
15 10 9 8 10
8 8 8 7
10 9 9 8
2 10 10 9 8
8 15 11 10 9
14 10 11 9 10
12 11 9 9
2 8 8 11 9
4 8 6 9 10
10 4 5 6 6
7 6 9 8
9 9 9 9
4 12 11 9 9
6 8 8 8 11
11 11 13 12 13
10 11 10 11
5 7 5 6 6
6 6 5 7 7
11 9 10 11 16
7 7 8 10
9 9 9 10
3 9 9 7 9
7 11 10 10 10
15 11 12 10 11
10 10 9 10
7 9 7 7 10
8 7 9 7 7
9 10 8 9 7
9 8 8 8
10 9 8 9
1 8 8 9 11
9 10 11 11 12
12 11 11 10 12
10 10 10 12
12 6 5 11 6
13 9 4 10 8
14 9 9 9 12
8 6 10 9
9 8 10 10
L. reuteri DS-37
2d
Overall Mean
bDescription of treatments, experiments, and pigs - see Table C2
aBUN - blood urea nitrogen
L. reuteri WB-76
1c
Overall Mean
2d
L. reuteri WB-72
1c
2d
Overall Mean
Overall Mean
Overall Mean
2d
1c
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Table C16. Study 2 weekly BUNa levels (mg/dL)
1c
2d
1c
Control
L. reuteri DS-36
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 0.9 0.9 0.9 1.0
10 1.0 1.0 1.0 1.0
13 0.9 1.2 1.1 1.0
0.9 1.0 1.0 1.0
1 1.3 1.1 1.1 1.1
3 1.3 1.3 1.4 1.3
15 1.2 1.3 1.1 1.3
1.3 1.2 1.2 1.2
1.1 1.1 1.1 1.1
2 0.8 1.0 0.9 0.9
8 1.0 1.0 0.9 1.1
14 1.0 1.1 1.0 1.0
0.9 1.0 0.9 1.0
2 1.2 1.2 1.4 1.3
4 1.1 1.1 1.3 1.2
10 1.0 0.8 0.8 0.9
1.1 1.0 1.2 1.1
1.0 1.0 1.1 1.1
4 0.9 1.0 1.0 1.1
6 0.9 0.8 0.9 0.9
11 0.9 1.2 1.3 1.4
0.9 1.0 1.1 1.1
5 1.3 1.2 1.4 1.3
6 1.2 1.2 1.3 1.4
11 1.5 1.2 1.5 1.2
1.3 1.2 1.4 1.3
1.1 1.1 1.2 1.2
3 0.9 1.1 1.0 1.1
7 1.0 1.0 1.0 1.0
15 1.0 1.2 1.2 0.9
1.0 1.1 1.1 1.0
7 1.1 1.3 1.1 1.3
8 1.0 1.1 1.0 0.9
9 1.0 0.9 1.0 0.9
1.0 1.1 1.0 1.0
1.0 1.1 1.1 1.0
1 1.0 0.9 1.2 1.1
9 1.0 1.1 1.1 1.2
12 1.0 0.9 1.0 1.0
1.0 1.0 1.1 1.1
12 1.2 1.1 1.4 1.1
13 1.3 0.8 1.2 1.1
14 0.9 1.1 1.2 1.1
1.1 1.0 1.3 1.1
1.1 1.0 1.2 1.1
Overall Mean
Overall Mean
2c
L. reuteri WB-76
L. reuteri WB-72
L. reuteri DS-36
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1b
2c
Overall Mean
Overall Mean
L. reuteri DS-37
Exp. 2 Mean
Table C17. Study 2 weekly creatinine levels (mg/dL)
1b
2c
1b
Overall Mean
Control
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
aDescription of treatments, experiments, and pigs - see Table C2
1b
1b
2c
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 12.0 7.8 8.2 9.2
10 13.8 10.0 11.6 10.0
13 10.1 7.8 6.9 6.6
12.0 8.5 8.9 8.6
1 5.6 7.9 7.1 5.8
3 5.2 5.4 5.5 4.9
15 7.8 6.9 7.4 7.8
6.2 6.7 6.7 6.2
9.1 7.6 7.8 7.4
2 12.2 10.6 9.6 8.4
8 14.5 11.0 10.3 8.3
14 10.2 10.1 9.0 9.7
12.3 10.6 9.6 8.8
2 6.7 6.4 7.7 7.2
4 7.6 5.5 6.6 8.1
10 4.0 6.3 7.4 7.0
6.1 6.1 7.2 7.4
9.2 8.3 8.4 8.1
4 14.1 11.4 9.1 8.0
6 9.5 10.9 9.4 12.3
11 12.3 10.8 9.1 9.7
12.0 11.0 9.2 10.0
5 5.2 4.1 4.2 4.8
6 5.1 4.1 5.5 5.3
11 5.8 8.3 7.6 13.2
5.4 5.5 5.8 7.8
8.7 8.3 7.5 8.9
3 10.7 8.3 7.1 7.9
7 11.0 9.8 9.9 9.2
15 10.8 9.8 8.4 12.2
10.8 9.3 8.5 9.8
7 7.5 5.3 6.3 7.2
8 6.9 7.9 7.3 7.3
9 10.1 8.8 8.8 7.7
8.2 7.3 7.5 7.4
9.5 8.3 8.0 8.6
1 8.2 9.2 7.9 10.5
9 9.9 9.8 10.1 10.2
12 11.1 12.3 10.1 11.5
9.7 10.4 9.4 10.7
12 5.1 4.8 7.8 5.5
13 7.2 5.4 8.0 7.2
14 9.5 8.4 7.6 10.6
7.3 6.2 7.8 7.8
8.5 8.3 8.6 9.3
bDescription of treatments, experiments, and pigs - see Table C2
aBUN - blood urea nitrogen
L. reuteri WB-72
L. reuteri WB-76
Overall Mean
1c
2d
1c
2d
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Table C18. Study 2 weekly BUNa:creatinine ratio levels
1c
2d
1c
2d
Control
L. reuteri DS-36
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-37
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 137 137 138 141
10 137 137 140 139
13 136 139 139 141
137 138 139 140
1 135 135 133 134
3 141 142 159 140
15 139 137 143 135
138 138 145 136
138 138 142 138
2 136 141 140 143
8 135 138 137 140
14 135 138 139 137
135 139 139 140
2 139 136 145 137
4 137 138 156 139
10 134 130 139 135
137 135 147 137
136 137 143 139
4 135 138 139 142
6 137 137 138 140
11 136 138 141 141
136 138 139 141
5 138 131 165 138
6 137 134 143 133
11 134 136 152 133
136 134 153 135
136 136 146 138
3 139 136 139 143
7 141 137 137 139
15 137 140 137 138
139 138 138 140
7 137 141 138 138
8 135 136 137 139
9 141 139 154 138
138 139 143 138
138 138 140 139
1 136 137 140 146
9 138 138 139 142
12 138 140 140 141
137 138 140 143
12 147 136 155 135
13 144 119 160 136
14 137 138 149 137
143 131 155 136
140 135 147 140
Table C19. Study 2 weekly sodium levels (mEq/L)
1b
2c
1b
2c
Control
L. reuteri DS-36
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-72
2c
1b
2c
L. reuteri DS-37
1b
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
Overall Mean
Overall Mean
1b
L. reuteri WB-76
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table C2
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 8.8 9.2 11.0 10.6
10 8.5 9.3 9.2 10.7
13 8.4 7.5 8.3 9.0
8.6 8.7 9.5 10.1
1 10.2 8.3 8.7 8.9
3 11.2 9.2 9.4 9.9
15 10.5 10.4 10.2 10.8
10.6 9.3 9.4 9.9
9.6 9.0 9.5 10.0
2 8.4 9.1 9.2 8.9
8 9.1 8.7 8.3 8.8
14 8.6 8.4 8.4 9.5
8.7 8.7 8.6 9.1
2 9.8 9.7 9.3 9.2
4 13.1 9.3 10.9 9.3
10 10.5 9.2 8.8 9.2
11.1 9.4 9.7 9.2
9.9 9.1 9.2 9.2
4 7.4 8.5 10.3 9.7
6 7.2 8.0 9.8 9.7
11 9.3 8.4 10.2 8.6
8.0 8.3 10.1 9.3
5 10.8 9.3 10.0 11.5
6 11.2 11.3 9.4 9.3
11 10.4 8.6 9.7 10.6
10.8 9.7 9.7 10.5
9.4 9.0 9.9 9.9
3 9.1 8.7 10.4 10.0
7 9.7 8.2 9.4 9.0
15 9.2 8.9 9.9 9.5
9.3 8.6 9.9 9.5
7 10.2 9.9 8.7 10.2
8 12.0 10.2 9.3 10.3
9 9.5 9.7 10.1 10.2
10.6 9.9 9.4 10.2
10.0 9.3 9.6 9.9
1 9.6 9.0 10.6 10.4
9 9.2 9.2 10.4 11.3
12 7.4 7.2 9.4 8.0
8.7 8.5 10.1 9.9
12 10.4 10.1 10.5 11.5
13 11.9 9.5 9.6 10.5
14 9.4 8.0 8.8 8.8
10.6 9.2 9.6 10.3
9.7 8.8 9.9 10.1
Table C20. Study 2 weekly potassium levels (mEq/L)
1b
2c
1b
2c
Control
L. reuteri DS-36
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-72
2c
1b
2c
L. reuteri DS-37
1b
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
Overall Mean
Overall Mean
1b
L. reuteri WB-76
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table C2
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 100 103 104 105
10 103 106 106 107
13 98 102 101 102
100 104 104 105
1 101 102 101 99
3 107 105 118 104
15 101 103 105 102
103 103 108 102
102 104 106 103
2 102 104 103 102
8 100 104 101 101
14 97 102 100 102
100 103 101 102
2 104 100 106 101
4 105 105 117 105
10 100 99 105 100
103 101 109 102
101 102 105 102
4 99 103 106 105
6 99 104 107 105
11 101 102 106 104
100 103 106 105
5 102 97 121 104
6 99 101 106 97
11 102 102 112 103
101 100 113 101
100 102 110 103
3 103 101 104 103
7 103 102 105 106
15 99 104 102 103
102 102 104 104
7 102 108 104 103
8 98 102 100 102
9 104 103 111 101
101 104 105 102
102 103 104 103
1 99 105 103 107
9 99 104 104 106
12 99 103 106 103
99 104 104 105
12 109 101 114 103
13 108 93 118 103
14 103 105 111 101
107 100 114 102
103 102 109 104
2c
Overall Mean
Overall Mean
Overall Mean
1b
2c
Table C21. Study 2 weekly chloride levels (mEq/L)
1b
2c
1b
Exp. 2 Mean
Exp. 2 Mean
Control
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-36
bExperiment 1 were gilts
cExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
2c
1b
1b
2c
aDescription of treatments, experiments, and pigs - see Table C2
Overall Mean
L. reuteri WB-72
L. reuteri WB-76
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri DS-37
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 27 25 18 25
10 25 21 21 20
13 27 27 28 26
26 24 22 24
1 24 23 23 28
3 24 25 27 23
15 25 22 27 25
24 23 26 25
25 24 24 25
2 22 25 23 25
8 24 24 26 30
14 27 24 29 24
24 24 26 26
2 23 26 26 26
4 20 24 24 23
10 19 25 26 27
21 25 25 25
23 25 26 26
4 28 25 18 26
6 30 25 22 25
11 26 28 24 24
28 26 21 25
5 24 24 32 21
6 26 20 27 26
11 14 24 29 23
21 23 29 23
25 24 25 24
3 22 26 22 27
7 26 25 21 24
15 26 22 23 24
25 24 22 25
7 24 20 19 24
8 26 26 27 25
9 23 26 31 27
24 24 26 25
25 24 24 25
1 21 24 23 29
9 27 25 23 25
12 26 27 25 26
25 25 24 27
12 26 26 30 23
13 25 20 31 26
14 24 26 28 28
25 24 30 26
25 25 27 26
Table C22. Study 2 weekly carbon dioxide levels (mEq/L)
1b
2c
1b
2c
Control
L. reuteri DS-36
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-72
2c
1b
2c
L. reuteri DS-37
1b
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
Overall Mean
Overall Mean
1b
L. reuteri WB-76
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table C2
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 19.2 17.6 26.6 21.6
10 17.7 19.7 22.7 21.7
13 19.5 17.7 19.0 21.8
18.8 18.3 22.8 21.7
1 19.8 18.0 17.7 15.8
3 21.6 21.6 23.6 22.9
15 23.4 21.7 21.4 20.0
21.6 20.4 20.9 19.6
20.2 19.4 21.8 20.6
2 20.0 20.7 22.6 24.2
8 19.4 18.8 19.2 18.0
14 19.7 19.5 18.4 20.6
19.7 19.7 20.1 20.9
2 21.3 18.9 22.6 19.6
4 25.4 19.0 26.5 19.9
10 24.9 15.6 17.4 17.1
23.9 17.8 22.2 18.9
21.8 18.8 21.1 19.9
4 15.0 19.4 25.2 21.2
6 14.8 15.5 19.4 19.1
11 18.4 16.3 21.5 21.0
16.1 17.1 22.0 20.4
5 23.8 18.9 21.1 25.1
6 22.4 24.1 20.2 19.2
11 28.5 17.8 20.4 17.6
24.9 20.3 20.6 20.6
20.5 18.7 21.3 20.5
3 23.2 17.9 23.2 23.1
7 21.7 18.1 20.6 17.3
15 21.9 22.2 22.7 19.9
22.3 19.4 22.2 20.1
7 21.4 22.6 23.3 20.5
8 23.1 18.2 19.1 21.7
9 24.0 20.1 22.7 21.3
22.8 20.3 21.7 21.2
22.6 19.9 21.9 20.6
1 24.4 18.0 23.9 20.8
9 20.9 18.4 22.6 22.5
12 20.5 17.1 18.9 20.3
21.9 17.8 21.8 21.2
12 22.5 18.8 21.7 20.9
13 22.6 15.0 20.7 17.7
14 19.4 14.5 19.4 16.8
21.5 16.1 20.6 18.5
21.7 17.0 21.2 19.8
Table C23. Study 2 weekly anion gap levels
1b
2c
1b
2c
Control
L. reuteri DS-36
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-72
2c
1b
2c
L. reuteri DS-37
1b
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
Overall Mean
Overall Mean
1b
L. reuteri WB-76
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table C2
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 10.6 10.4 10.0 10.3
10 10.5 10.6 10.6 10.4
13 10.8 10.7 9.8 9.9
10.6 10.6 10.1 10.2
1 9.8 10.1 10.6 10.4
3 10.7 10.4 12.6 10.6
15 10.7 9.9 10.7 10.8
10.4 10.1 11.3 10.6
10.5 10.4 10.7 10.4
2 9.8 10.5 10.4 10.2
8 9.8 9.8 10.3 10.6
14 10.8 10.9 10.2 9.8
10.1 10.4 10.3 10.2
2 10.9 10.9 11.6 10.8
4 10.0 10.5 12.1 10.8
10 10.0 9.6 10.5 10.3
10.3 10.3 11.4 10.6
10.2 10.4 10.9 10.4
4 10.6 10.8 10.4 10.7
6 10.5 11.5 10.0 10.6
11 10.1 10.0 9.9 10.1
10.4 10.8 10.1 10.5
5 10.7 9.0 12.3 10.5
6 10.7 10.8 11.5 10.5
11 9.6 10.4 11.9 10.2
10.3 10.1 11.9 10.4
10.4 10.4 11.0 10.4
3 10.5 10.6 10.0 10.6
7 11.4 10.3 9.6 10.4
15 10.5 10.1 10.2 9.9
10.8 10.3 9.9 10.3
7 10.9 10.5 10.5 10.7
8 11.1 10.0 10.3 10.9
9 10.6 10.0 11.9 10.8
10.9 10.2 10.9 10.8
10.8 10.3 10.4 10.6
1 10.7 10.4 10.1 11.1
9 10.7 10.5 10.1 10.5
12 10.5 10.1 9.9 10.3
10.6 10.3 10.0 10.6
12 11.2 10.3 11.9 10.9
13 11.7 9.0 12.2 10.4
14 10.9 10.6 11.6 11.0
11.3 10.0 11.9 10.8
11.0 10.2 11.0 10.7
Table C24. Study 2 weekly calcium levels (mEq/L)
1b
2c
1b
2c
Control
L. reuteri DS-36
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-72
2c
1b
2c
L. reuteri DS-37
1b
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
Overall Mean
Overall Mean
1b
L. reuteri WB-76
Exp. 2 Mean
aDescription of treatments, experiments, and pigs - see Table C2
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 4.1 4.3 4.7 5.2
10 4.5 4.4 4.7 4.9
13 4.6 4.7 4.8 5.2
4.4 4.5 4.7 5.1
1 4.8 4.2 4.5 4.6
3 4.9 5.0 6.0 5.4
15 4.8 4.9 5.1 5.0
4.8 4.7 5.2 5.0
4.6 4.6 5.0 5.1
2 4.5 4.7 5.1 5.4
8 4.5 4.3 4.6 5.1
14 4.8 4.5 4.9 5.2
4.6 4.5 4.9 5.2
2 5.1 5.2 5.6 5.4
4 5.4 4.2 5.0 4.4
10 4.8 4.3 4.5 4.8
5.1 4.6 5.0 4.9
4.9 4.5 5.0 5.1
4 4.1 4.3 4.9 5.1
6 4.3 4.4 4.6 4.9
11 4.2 4.6 4.8 4.9
4.2 4.4 4.8 5.0
5 5.1 4.4 5.9 5.4
6 5.0 5.2 4.8 4.9
11 4.2 4.8 5.8 4.8
4.8 4.8 5.5 5.0
4.5 4.6 5.1 5.0
3 4.8 4.8 5.0 5.6
7 4.4 4.2 4.4 4.9
15 4.6 4.8 4.8 4.8
4.6 4.6 4.7 5.1
7 5.2 5.2 5.0 5.3
8 5.0 4.4 4.8 5.3
9 4.6 4.7 5.7 5.3
4.9 4.8 5.2 5.3
4.8 4.7 5.0 5.2
1 4.6 4.3 4.6 5.3
9 4.8 4.8 5.0 5.5
12 4.7 4.8 5.1 5.3
4.7 4.6 4.9 5.4
12 5.2 4.8 6.0 5.9
13 5.3 3.9 5.9 4.6
14 4.0 3.9 4.9 4.8
4.8 4.2 5.6 5.1
4.8 4.4 5.3 5.2Overall Mean
L. reuteri WB-72
Table C25. Study 2 weekly total protein levels (g/dL)
1b
2c
1b
1b
1b
2c
Exp. 2 Mean
L. reuteri DS-36
2c
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-37
2c
Exp. 2 Mean
1b
2c
Exp. 2 Mean
Overall Mean
Overall Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
aDescription of treatments, experiments, and pigs - see Table C2
Control
Overall Mean
L. reuteri WB-76
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 2.5 2.4 2.9 3.1
10 2.4 2.4 2.7 3.0
13 2.8 2.6 2.6 2.9
2.6 2.5 2.7 3.0
1 2.4 2.1 2.4 2.6
3 2.8 2.8 3.3 3.2
15 2.5 2.8 3.0 3.1
2.6 2.6 2.9 3.0
2.6 2.5 2.8 3.0
2 2.7 3.0 3.3 3.3
8 2.5 2.6 2.8 3.3
14 2.8 2.9 3.4 3.6
2.7 2.8 3.2 3.4
2 2.9 3.0 3.3 3.1
4 3.3 2.5 3.2 2.8
10 2.4 2.2 2.6 3.1
2.9 2.6 3.0 3.0
2.8 2.7 3.1 3.2
4 2.5 3.0 3.4 3.6
6 2.2 2.3 2.6 2.9
11 2.5 2.6 2.8 2.9
2.4 2.6 2.9 3.1
5 2.8 2.2 3.1 3.1
6 2.8 2.8 2.5 2.6
11 2.2 2.5 2.9 2.4
2.6 2.5 2.8 2.7
2.5 2.6 2.9 2.9
3 3.1 3.0 3.4 3.6
7 2.7 2.6 2.8 3.1
15 2.6 2.8 2.5 2.6
2.8 2.8 2.9 3.1
7 3.1 3.1 3.0 3.4
8 2.9 2.5 2.6 3.2
9 2.9 2.6 3.1 3.2
3.0 2.7 2.9 3.3
2.9 2.8 2.9 3.2
1 2.6 2.3 2.8 3.3
9 3.0 2.8 3.2 3.3
12 2.8 2.8 3.0 3.2
2.8 2.6 3.0 3.3
12 3.0 2.6 3.8 3.5
13 3.2 2.1 3.8 2.8
14 2.4 2.3 3.0 3.0
2.9 2.3 3.5 3.1
2.8 2.5 3.3 3.2
L. reuteri WB-76
1b
L. reuteri DS-37
Control
L. reuteri DS-36
2c
Overall Mean
Overall Mean
Exp. 1 Mean
1b
Table C26. Study 2 weekly albumin levels (g/dL)
1b
2c
1b
2c
Exp. 1 Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
1b
2c
bExperiment 1 were gilts
cExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-72
Overall Mean
Overall Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 1.7 1.9 1.8 2.1
10 2.1 2.0 1.9 1.9
13 1.8 2.2 2.2 2.3
1.9 2.0 2.0 2.1
1 2.4 2.1 2.2 2.0
3 2.2 2.2 2.7 2.2
15 2.2 2.1 2.1 1.9
2.3 2.1 2.3 2.0
2.1 2.1 2.2 2.1
2 1.8 1.6 1.8 2.1
8 2.0 1.7 1.8 1.8
14 1.9 1.7 1.6 1.6
1.9 1.7 1.7 1.8
2 2.2 2.3 2.3 2.3
4 2.1 1.6 1.8 1.7
10 2.4 2.1 1.9 1.7
2.2 2.0 2.0 1.9
2.1 1.8 1.9 1.9
4 1.6 1.3 1.5 1.6
6 2.1 2.1 2.0 2.0
11 1.7 2.0 2.1 2.0
1.8 1.8 1.9 1.9
5 2.3 2.2 2.8 2.3
6 2.3 2.4 2.3 2.3
11 1.9 2.3 2.9 2.4
2.2 2.3 2.7 2.3
2.0 2.1 2.3 2.1
3 1.8 1.8 1.6 2.0
7 1.7 1.7 1.6 1.8
15 2.0 2.0 2.2 2.2
1.8 1.8 1.8 2.0
7 2.1 2.1 2.0 1.9
8 2.1 1.9 2.2 2.1
9 1.7 2.1 2.6 2.2
2.0 2.0 2.3 2.1
1.9 1.9 2.0 2.0
1 2.0 1.9 1.8 2.0
9 1.8 2.0 1.9 2.2
12 2.0 2.0 2.1 2.1
1.9 2.0 1.9 2.1
12 2.2 2.1 2.3 2.3
13 2.1 1.7 2.1 1.8
14 1.7 1.6 1.9 1.7
2.0 1.8 2.1 1.9
2.0 1.9 2.0 2.0Overall Mean
Overall Mean
Overall Mean
Exp. 1 Mean
1b
2c
1b
Table C27. Study 2 weekly globulin levels (g/dL)
1b
2c
1b
1b
Exp. 1 Mean
2c
Control
L. reuteri DS-36
L. reuteri WB-72
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2c
Overall Mean
Overall Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aDescription of treatments, experiments, and pigs - see Table C2
2c
L. reuteri DS-37
L. reuteri WB-76
 
 198
Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 1.5 1.3 1.5 1.4
10 1.1 1.2 1.4 1.6
13 1.5 1.2 1.2 1.2
1.4 1.2 1.4 1.4
1 1.0 1.0 1.1 1.3
3 1.3 1.2 1.2 1.4
15 1.1 1.3 1.4 1.6
1.1 1.2 1.2 1.4
1.3 1.2 1.3 1.4
2 1.5 1.8 1.8 1.6
8 1.3 1.5 1.6 1.8
14 1.5 1.7 1.6 2.2
1.4 1.7 1.7 1.9
2 1.3 1.3 1.5 1.4
4 1.6 1.5 1.8 1.7
10 1.0 1.0 1.4 1.8
1.3 1.3 1.6 1.6
1.4 1.5 1.6 1.8
4 1.6 2.3 2.3 2.3
6 1.1 1.1 1.3 1.4
11 1.4 1.3 1.3 1.5
1.4 1.6 1.6 1.7
5 1.2 1.0 1.1 1.3
6 1.2 1.1 1.1 1.1
11 1.2 1.1 1.0 1.0
1.2 1.1 1.1 1.1
1.3 1.3 1.4 1.4
3 1.7 1.7 2.1 1.8
7 1.6 1.5 1.8 1.8
15 1.3 1.4 1.2 1.2
1.5 1.5 1.7 1.6
7 1.4 1.5 1.5 1.8
8 1.4 1.3 1.2 1.6
9 1.7 1.2 1.2 1.4
1.5 1.3 1.3 1.6
1.5 1.4 1.5 1.6
1 1.3 1.2 1.6 1.6
9 1.6 1.4 1.7 1.5
12 1.4 1.4 1.4 1.6
1.4 1.3 1.6 1.6
12 1.3 1.3 1.7 1.5
13 1.5 1.2 1.8 1.5
14 1.4 1.4 1.6 1.8
1.4 1.3 1.7 1.6
1.4 1.3 1.6 1.6
L. reuteri WB-76
1b
L. reuteri DS-37
Control
L. reuteri DS-36
2c
Overall Mean
Overall Mean
Exp. 1 Mean
1b
Table C28. Study 2 weekly albumin:globulin ratio levels
1b
2c
1b
2c
Exp. 1 Mean
2c
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
1b
2c
bExperiment 1 were gilts
cExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-72
Overall Mean
Overall Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 96 74 54 45
10 95 63 53 49
13 70 151 85 54
87 96 64 49
1 76 48 69 50
3 54 43 84 49
15 95 61 74 64
75 51 76 54
81 73 70 52
2 79 79 47 43
8 60 75 59 47
14 62 63 74 63
67 72 60 51
2 41 52 51 43
4 536 42 54 48
10 49 50 49 48
209 48 51 46
138 60 56 49
4 66 72 69 51
6 77 101 82 65
11 72 61 48 47
72 78 66 54
5 60 59 54 50
6 70 65 114 50
11 66 51 75 46
65 58 81 49
69 68 74 52
3 188 72 58 50
7 54 83 97 45
15 86 80 75 57
109 78 77 51
7 54 45 45 43
8 68 45 47 45
9 87 54 60 50
70 48 51 46
90 63 64 48
1 62 102 70 67
9 58 85 64 45
12 77 68 56 53
66 85 63 55
12 48 49 59 53
13 101 48 81 100
14 65 52 67 55
71 50 69 69
69 67 66 62
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-72
Overall Mean
2d
L. reuteri WB-76
Exp. 2 Mean
Exp. 1 Mean
2d
Exp. 1 Mean
aAST - aspartate aminotransferase
Overall Mean
Exp. 1 Mean
Overall Mean
1c
2d
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
1c
1c
2d
Exp. 1 Mean
1c
Exp. 2 Mean
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Table C29. Study 2 weekly ASTa levels (U/L)
1c
2d
L. reuteri DS-37
Control
L. reuteri DS-36
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 55 41 42 39
10 80 65 61 61
13 68 51 61 56
68 52 55 52
1 51 41 53 46
3 48 45 53 44
15 67 52 64 69
55 46 57 53
62 49 56 53
2 53 69 61 47
8 53 65 52 59
14 43 54 55 56
50 63 56 54
2 39 48 52 43
4 83 47 50 59
10 45 33 39 46
56 43 47 49
53 53 52 52
4 65 60 52 56
6 80 59 73 74
11 57 64 54 62
67 61 60 64
5 44 50 77 75
6 56 73 68 60
11 45 60 57 58
48 61 67 64
58 61 64 64
3 59 56 49 48
7 54 67 60 66
15 71 52 61 70
61 58 57 61
7 53 46 50 60
8 58 51 51 48
9 61 46 53 49
57 48 51 52
59 53 54 57
1 50 46 56 63
9 51 49 44 39
12 76 56 49 62
59 50 50 55
12 35 38 56 47
13 66 49 72 52
14 59 54 66 63
53 47 65 54
56 49 57 54
Table C30. Study 2 weekly ALTa levels (U/L)
1c
2d
1c
Control
L. reuteri DS-36
2d
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
bDescription of treatments, experiments, and pigs - see Table C2
aALT - alanine aminotransferase 
L. reuteri DS-37
L. reuteri WB-72
1c
Exp. 2 Mean
Overall Mean
L. reuteri WB-76
Overall Mean
Exp. 2 Mean
cExperiment 1 were gilts
Exp. 2 Mean
1c
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
2d
2d
Overall Mean
2d
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 417 342 218 273
10 299 237 209 219
13 343 264 223 239
353 281 217 244
1 237 242 222 217
3 462 230 216 178
15 295 155 185 159
331 209 208 185
342 245 212 214
2 379 417 303 267
8 218 205 140 177
14 325 257 259 193
307 293 234 212
2 344 243 254 236
4 461 328 244 197
10 473 274 336 343
426 282 278 259
367 287 256 236
4 304 294 211 202
6 352 422 222 243
11 261 273 158 187
306 330 197 211
5 263 190 249 191
6 293 228 190 171
11 409 304 241 179
322 241 227 180
314 285 212 196
3 340 357 231 283
7 252 239 178 189
15 386 274 212 235
326 290 207 236
7 296 202 164 121
8 263 169 170 146
9 303 138 124 146
287 170 153 138
307 230 180 187
1 402 298 244 286
9 244 163 132 142
12 292 256 200 219
313 239 192 216
12 214 213 253 172
13 615 203 327 236
14 324 236 210 186
384 217 263 198
349 228 228 207
bDescription of treatments, experiments, and pigs - see Table C2
aALKPhos - alkaline phosphatase
L. reuteri WB-72
L. reuteri WB-76
Overall Mean
1c
2d
Exp. 2 Mean
Exp. 1 Mean
Overall Mean
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Table C31. Study 2 weekly ALKPhosa levels (U/L)
1c
2d
1c
2d
Control
L. reuteri DS-36
Exp. 1 Mean
Overall Mean
Overall Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri DS-37
Exp. 1 Mean
1c
2d
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Treatmenta Exp.a Piga Day 0b Week 1b Week 2b Week 3b
5 0.2 0.1 0.3 0.1
10 0.2 0.1 0.2 0.2
13 0.2 0.2 0.1 0.1
0.2 0.1 0.2 0.1
1 0.1 0.1 0.3 0.1
3 0.2 0.1 0.2 0.1
15 0.2 0.1 0.1 0.1
0.2 0.1 0.2 0.1
0.2 0.1 0.2 0.1
2 0.3 0.2 0.1 0.2
8 0.1 0.1 0.1 0.1
14 0.2 0.2 0.1 0.6
0.2 0.2 0.1 0.3
2 0.1 0.1 0.1 0.1
4 1.3 0.1 0.1 0.1
10 0.2 0.1 0.1 0.2
0.5 0.1 0.1 0.1
0.4 0.1 0.1 0.2
4 0.1 0.2 0.1 0.1
6 0.1 0.1 0.2 0.1
11 0.2 0.1 0.1 0.1
0.1 0.1 0.1 0.1
5 0.2 0.1 0.2 0.3
6 0.2 0.2 0.1 0.1
11 0.2 0.1 0.1 0.1
0.2 0.1 0.1 0.2
0.2 0.1 0.1 0.1
3 0.4 0.2 0.1 0.1
7 0.1 0.1 0.1 0.1
15 0.2 0.2 0.2 0.1
0.2 0.2 0.1 0.1
7 0.4 0.2 0.1 0.1
8 0.2 0.1 0.1 0.1
9 0.1 0.1 0.1 0.1
0.2 0.1 0.1 0.1
0.2 0.2 0.1 0.1
1 0.2 0.1 0.1 0.3
9 0.2 0.1 0.2 0.2
12 0.1 0.1 0.1 0.1
0.2 0.1 0.1 0.2
12 0.1 0.2 0.2 0.4
13 0.2 0.1 0.1 0.1
14 0.2 0.1 0.1 0.1
0.2 0.1 0.1 0.2
0.2 0.1 0.1 0.2
2d
1c
2d
Exp. 1 Mean
2d
L. reuteri WB-76
Overall Mean
2d
Exp. 1 Mean
1c
Control
Overall Mean
Overall Mean
Exp. 1 Mean
Overall Mean
aDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-72
L. reuteri DS-37
Overall Mean
cExperiment 1 were gilts
Table C32. Study 2 weekly bili, total levels (mg/dL)
1c
2d
1c
L. reuteri DS-36
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
bAll 0.1 individual pig values were equal to <0.1
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 54 64 74 88
10 58 62 75 84
13 63 65 69 85
58 64 73 86
1 53 56 73 77
3 68 92 87 90
15 76 74 92 70
66 74 84 79
62 69 78 82
2 50d 50d 87 84
8 67 63 81 84
14 78 65 89 89
65 59 86 86
2 71 89 80 95
4 50d 56 67 57
10 76 84 71 81
66 76 73 78
65 68 79 82
4 50d 50d 60 73
6 50 50d 52 50
11 50d 60 55 64
50 53 56 62
5 52 53 89 85
6 72 94 70 84
11 55 84 75 72
60 77 78 80
55 65 67 71
3 59 62 76 90
7 63 59 81 84
15 87 73 77 87
70 65 78 87
7 59 80 68 68
8 61 50d 76 71
9 54 50d 81 70
58 60 75 70
64 62 77 78
1 78 65 80 90
9 78 73 73 86
12 53 63 77 78
70 67 77 85
12 70 93 103 97
13 50d 59 91 68
14 50d 50d 50d 50d
57 67 81 72
63 67 79 78
bValues were equal to <50
aDescription of treatments, experiments, and pigs - see Table C2
L. reuteri DS-37
L. reuteri DS-36
1b
Overall Mean
Overall Mean
2c
Overall Mean
L. reuteri WB-76
Table C33. Study 2 weekly cholesterol levels (mg/dL)
1b
2c
1b
Control
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1b
2c
1b
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
2c
L. reuteri WB-72
2c
Overall Mean
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Treatmenta Exp.a Piga Day 0 Week 1 Week 2 Week 3
5 27 11 28 31
10 27 30 31 42
13 30 32 44 39
28 24 34 37
1 59 43 45 50
3 34 51 73 41
15 70 48 50 62
54 47 56 51
41 36 45 44
2 43 44 79 35
8 61 17 18 18
14 34 43 38 43
46 35 45 32
2 51 44 40 51
4 35 35 29 38
10 41 31 32 27
42 37 34 39
44 36 39 35
4 26 18 41 36
6 41 18 23 29
11 32 30 38 37
33 22 34 34
5 41 29 42 48
6 44 49 35 32
11 91 39 40 47
59 39 39 42
46 31 37 38
3 27 25 32 29
7 27 22 26 24
15 48 35 32 45
34 27 30 33
7 30 42 27 36
8 39 37 31 37
9 33 25 33 37
34 35 30 37
34 31 30 35
1 50 31 48 39
9 25 29 51 46
12 32 22 22 20
36 27 40 35
12 38 48 70 69
13 27 24 48 33
14 28 33 35 40
31 35 51 47
33 31 46 41
1b
2c
L. reuteri DS-36
Overall Mean
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1b
Overall Mean
Exp. 1 Mean
Table C34. Study 2 weekly triglyceride levels (mg/dL)
1b
2c
1b
1b
2c
Overall Mean
2c
Control
Exp. 2 Mean
Exp. 1 Mean
bExperiment 1 were gilts
cExperiment 2 were barrows
Overall Mean
L. reuteri WB-76
L. reuteri WB-72
L. reuteri DS-37
2c
aDescription of treatments, experiments, and pigs - see Table C2
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 24 27 26 32
10 22 25 31 28
13 28 21 23 27
25 24 27 29
1 22 24 26 30
3 27 38 28 33
15 31 31 37 31
27 31 30 31
26 28 29 30
2 17 14 27 26
8 28 27 31 30
14 35 28 36 31
27 23 31 29
2 29 36 32 35
4 11 25 26 24
10 31 31 29 30
24 31 29 30
25 27 30 29
4 21 16 23 26
6 21 14 16 17
11 21 27 23 26
21 19 21 23
5 22 23 41 42
6 31 39 25 31
11 24 34 26 26
26 32 31 33
23 26 26 28
3 26 24 27 32
7 25 22 25 24
15 31 26 26 27
27 24 26 28
7 25 31 29 27
8 24 16 26 27
9 22 16 28 27
24 21 28 27
26 23 27 27
1 28 21 26 26
9 34 26 30 30
12 21 23 28 25
28 23 28 27
12 28 38 36 37
13 16 22 31 24
14 17 23 19 19
20 28 29 27
24 26 28 27
bDescription of treatments, experiments, and pigs - see Table C2
aHDL - high-density lipoprotein
L. reuteri DS-36
Overall Mean
Overall Mean
2d
1c
2d
Overall Mean
1c
Exp. 1 Mean
1c
2d
L. reuteri WB-72
2d
L. reuteri WB-76
Overall Mean
Table C35. Study 2 weekly HDLa levels (mg/dL)
1c
2d
1c
Control
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-37
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 5 2 6 6
10 5 6 6 8
13 6 6 9 8
5 5 7 7
1 12 9 9 10
3 7 10 15 8
15 14 10 10 12
11 10 11 10
8 7 9 9
2 9 9 16 7
8 12 3 4 4
14 7 9 8 9
9 7 9 7
2 10 9 8 10
4 7 7 6 8
10 8 6 6 5
8 7 7 8
9 7 8 7
4 5 4 8 7
6 8 4 5 6
11 6 6 8 7
6 5 7 7
5 8 6 8 10
6 9 10 7 6
11 18 8 8 9
12 8 8 8
9 6 7 8
3 5 5 6 6
7 5 4 5 5
15 8 7 6 9
6 5 6 7
7 6 8 5 7
8 8 7 6 7
9 7 5 7 7
7 7 6 7
7 6 6 7
1 10 6 10 8
9 5 6 10 9
12 6 4 4 4
7 5 8 7
12 8 10 14 14
13 5 5 10 7
14 6 7 7 8
6 7 10 10
7 6 9 8
2d
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
Exp. 1 Mean
L. reuteri DS-37
L. reuteri WB-72
1c
L. reuteri WB-76
Exp. 1 Mean
1c
2d
2d
Overall Mean
1c
Table C36. Study 2 weekly VLDLa levels (mg/dL)
1c
2d
1c
Control
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri DS-36
Overall Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table C2
aVLDL - very low-density lipoprotein
Overall Mean
2d
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 0.274 0.331 0.397 0.257
10 0.330 0.267 0.259 0.265
13 0.253 0.282 0.331 0.305
0.285 0.293 0.329 0.275
1 0.161 0.361 0.401 0.261
3 0.231 0.368 0.550 0.269
15 0.418 0.469 0.372 0.749
0.270 0.399 0.441 0.426
0.278 0.346 0.385 0.351
2 0.240 0.303 0.225 0.306
8 0.253 0.337 0.392 0.350
14 0.180 0.255 0.340 0.249
0.224 0.298 0.319 0.302
2 0.263 0.777 0.922 0.389
4 0.733 0.556 0.718 0.368
10 0.344 0.332 0.519 0.490
0.447 0.555 0.720 0.416
0.335 0.426 0.519 0.359
4 0.276 0.283 0.353 0.245
6 0.525 0.270 0.266 0.275
11 0.202 0.251 0.411 0.349
0.334 0.268 0.344 0.290
5 0.496 0.619 0.811 0.273
6 0.505 0.554 0.861 0.705
11 0.516 0.745 0.698 0.400
0.506 0.639 0.790 0.459
0.420 0.453 0.567 0.374
3 0.226 0.303 0.268 0.340
7 0.259 0.244 0.351 0.253
15 0.254 0.165 0.398 0.275
0.246 0.237 0.339 0.289
7 0.525 0.520 0.892 0.624
8 0.175 0.213 0.594 0.267
9 0.310 0.653 0.959 0.264
0.337 0.462 0.815 0.385
0.291 0.350 0.577 0.337
1 0.333 0.355 0.266 0.424
9 0.393 0.461 0.343 0.371
12 0.253 0.294 0.309 0.271
0.326 0.370 0.306 0.355
12 0.314 0.499 0.781 0.359
13 0.466 0.734 0.965 0.301
14 0.226 0.543 0.494 0.554
0.336 0.592 0.747 0.405
0.331 0.481 0.526 0.380
bDescription of treatments, experiments, and pigs - see Table C2
1c
2d
L. reuteri WB-72
Overall Mean
Overall Mean
Overall Mean
L. reusteri WB-76
aIgA - immunoglobulin A
L. reuteri DS-37
Table C37. Study 2 weekly IgAa levels (mg/mL)
1c
2d
Overall Mean
Control
L. reuteri DS-36
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
dExperiment 2 were barrows
cExperiment 1 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
1c
2d
1c
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
2d
1c
2d
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 4.714 5.255 9.217 11.400
10 3.983 4.395 7.284 5.711
13 4.656 3.302 6.603 8.725
4.451 4.317 7.701 8.612
1 4.003 3.446 2.879 5.412
3 3.875 4.724 5.258 7.629
15 3.109 3.358 3.058 4.619
3.662 3.843 3.732 5.887
4.057 4.080 5.717 7.249
2 2.228 3.510 2.734 7.230
8 3.711 4.391 8.733 7.151
14 5.402 3.983 5.607 6.105
3.780 3.961 5.691 6.829
2 4.266 4.764 3.885 8.239
4 3.094 2.594 1.928 2.855
10 9.864 3.518 3.632 4.275
5.741 3.625 3.148 5.123
4.761 3.793 4.420 5.976
4 3.187 1.937 4.053 14.350
6 3.341 4.058 9.454 10.440
11 2.890 4.546 8.365 6.990
3.139 3.514 7.291 10.593
5 5.700 4.829 4.982 5.754
6 3.566 4.128 2.826 6.289
11 6.325 3.040 4.068 4.879
5.197 3.999 3.959 5.641
4.168 3.756 5.625 8.117
3 6.020 4.887 5.529 9.288
7 2.741 1.710 4.170 5.221
15 3.994 2.095 5.927 8.523
4.252 2.897 5.209 7.677
7 4.261 3.399 3.566 6.921
8 4.250 3.255 5.210 5.905
9 2.796 2.593 3.539 4.614
3.769 3.082 4.105 5.813
4.010 2.990 4.657 6.745
1 3.294 3.461 3.672 4.790
9 5.447 4.742 8.704 7.474
12 2.532 4.676 5.868 8.149
3.758 4.293 6.081 6.804
12 3.705 1.868 3.992 6.076
13 4.974 7.241 3.842 4.930
14 2.172 2.187 4.311 4.271
3.617 3.765 4.048 5.092
3.687 4.029 5.065 5.948
L. reusteri WB-76
2d
1c
Overall Mean
2d
1c
L. reuteri DS-37
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table C2
aIgG - immunoglobulin G
Table C38. Study 2 weekly IgGa levels (mg/mL)
1c
2d
1c
2d
L. reuteri WB-72
Control
L. reuteri DS-36
Exp. 2 Mean
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1c
2d
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Day 0 Week 1 Week 2 Week 3
5 1.040 1.843 2.009 1.639
10 1.569 1.936 1.898 2.067
13 1.539 2.779 2.562 3.407
1.383 2.186 2.156 2.371
1 2.887 0.904 0.795 1.124
3 2.522 1.343 1.697 1.818
15 1.137 1.523 1.224 1.222
2.182 1.257 1.239 1.388
1.782 1.721 1.697 1.880
2 1.584 2.342 1.971 1.586
8 1.021 1.166 1.163 1.147
14 1.306 1.418 1.395 1.621
1.304 1.642 1.510 1.451
2 2.357 1.654 2.520 1.665
4 2.014 1.908 1.901 1.531
10 1.694 0.966 1.127 0.305
2.022 1.509 1.849 1.167
1.663 1.576 1.680 1.309
4 1.727 1.246 1.486 2.479
6 1.864 2.590 2.028 1.993
11 0.673 1.756 1.855 1.865
1.421 1.864 1.790 2.112
5 1.192 1.131 2.025 1.250
6 2.436 3.073 2.797 3.025
11 2.122 1.835 2.985 1.289
1.917 2.013 2.602 1.855
1.669 1.939 2.196 1.984
3 0.957 1.614 2.686 2.559
7 1.041 1.246 1.313 1.700
15 1.735 2.697 2.763 1.883
1.244 1.852 2.254 2.047
7 1.496 1.635 1.581 1.633
8 1.159 1.111 2.910 0.833
9 1.166 1.922 2.004 0.871
1.274 1.556 2.165 1.112
1.259 1.704 2.210 1.580
1 2.431 2.228 3.297 2.138
9 0.941 1.709 1.396 1.215
12 1.118 2.624 2.220 2.636
1.497 2.187 2.304 1.996
12 1.765 0.836 1.510 1.247
13 1.841 2.265 2.743 2.332
14 1.005 1.314 1.552 1.209
1.537 1.472 1.935 1.596
1.517 1.829 2.120 1.796
Table C39. Study 2 weekly IgMa levels (mg/mL)
1c
2d
1c
Overall Mean
Control
Exp. 1 Mean
L. reuteri DS-36
2d
Exp. 1 Mean
dExperiment 2 were barrows
aIgM - immunoglobulin M
1c
L. reuteri DS-37
Exp. 1 Mean
L. reusteri WB-76
L. reuteri WB-72
1c
cExperiment 1 were gilts
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
Overall Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
bDescription of treatments, experiments, and pigs - see Table C2
Overall Mean
Overall Mean
2d
Exp. 1 Mean
Exp. 1 Mean
1c
2d
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Treatmentb Exp.b Pigb FIc
5 0.56
10 0.82
13 0.64
0.68
1 0.74
3 0.55
15 0.49
0.60
0.64
2 0.67
8 0.86
14 0.80
0.77
2 0.89
4 0.45
10 0.38
0.57
0.67
4 0.73
6 0.86
11 0.36
0.65
5 0.47
6 0.47
11 0.85
0.60
0.62
3 0.78
7 0.46
15 0.73
0.66
7 0.56
8 0.27
9 0.87
0.57
0.61
1 0.81
9 0.57
12 0.89
0.76
12 0.77
13 0.24
14 0.03
0.35
0.55
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 2 Mean
1d
2e
Overall Mean
Table C40. Study 2 overall LPSa challenge feed 
intake (kg)
Control
Overall Mean
1d
2e
Exp. 2 Mean
Exp. 1 Mean
L. reuteri WB-72
1d
2e
Overall Mean
cFI - feed intake
L. reuteri DS-36
1d
2e
Overall Mean
L. reuteri DS-37
L. reuteri WB-76
1d
2e
Overall Mean
bDescription of treatments, experiments, and pigs - 
see Table C2
aLPS - Escherichia coli  O111:B4 
lipopolysaccharide
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Treatmentb Exp.b Pigb Hour 0 Hour 6.0 Hour 12 Hour 24
5 17.33 16.51 16.24 16.60
10 18.51 17.92 17.78 19.23
13 19.96 19.41 19.37 20.50
18.60 17.95 17.80 18.78
1 16.24 15.97 15.51 17.28
3 19.78 19.69 19.14 19.41
15 15.33 14.97 14.79 16.33
17.12 16.87 16.48 17.67
17.86 17.41 17.14 18.23
2 15.88 15.33 15.06 15.79
8 19.32 18.82 18.37 19.91
14 22.41 21.91 22.00 22.72
19.20 18.69 18.48 19.47
2 20.50 20.14 19.87 21.27
4 20.23 20.50 19.32 20.05
10 13.79 13.52 13.24 13.83
18.17 18.05 17.48 18.39
18.69 18.37 17.98 18.93
4 18.42 17.92 17.42 18.64
6 19.78 19.23 19.14 20.50
11 19.05 18.33 18.28 18.87
19.08 18.49 18.28 19.34
5 16.87 16.87 16.87 16.78
6 14.61 14.70 14.42 14.97
11 16.24 15.97 15.42 17.06
15.91 15.85 15.57 16.27
17.49 17.17 16.93 17.80
3 18.60 18.14 17.96 18.78
7 19.50 19.01 19.28 19.41
15 16.51 16.06 15.83 17.19
18.20 17.74 17.69 18.46
7 19.96 19.87 19.23 19.69
8 14.61 14.51 13.70 13.88
9 16.51 16.24 15.79 17.42
17.02 16.87 16.24 16.99
17.61 17.30 16.96 17.73
1 17.69 17.42 16.96 17.74
9 17.51 17.15 16.87 17.92
12 20.96 20.32 19.82 21.00
18.72 18.29 17.89 18.88
12 17.96 17.69 17.64 19.50
13 18.51 18.05 17.78 18.51
14 17.33 16.78 16.51 16.60
17.93 17.51 17.31 18.20
18.33 17.90 17.60 18.54
Control
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
Table C41. Study 2 LPSa challenge swine weights (kg)
1c
2d
L. reuteri DS-37
1c
Exp. 1 Mean
Exp. 2 Mean
Overall Mean
Overall Mean
L. reuteri WB-72
1c
Exp. 1 Mean
2d
Exp. 2 Mean
L. reuteri DS-36
1c
Exp. 1 Mean
2d
Exp. 2 Mean
Overall Mean
dExperiment 2 were barrows
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table C2
cExperiment 1 were gilts
1c
Exp. 1 Mean
2d
Exp. 2 Mean
L. reuteri WB-76
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 39.24 40.29 40.96 40.52 40.18 39.63
10 38.79 39.79 40.52 39.68 39.07 39.46
12 39.24 39.46 39.90 39.02 39.63 39.24
39.09 39.85 40.46 39.74 39.63 39.44
1 39.29 40.13 40.90 39.90 39.24 40.13
3 39.41 39.79 40.46 40.85 41.01 40.68
15 39.18 38.85 40.57 39.96 39.79 39.57
39.29 39.59 40.64 40.24 40.02 40.13
39.19 39.72 40.55 39.99 39.82 39.78
2 38.96 39.57 40.24 39.74 39.90 39.85
8 39.13 39.90 40.02 39.79 39.57 39.41
14 39.41 40.68 40.96 40.52 39.57 39.29
39.16 40.05 40.40 40.02 39.68 39.52
2 39.13 39.57 39.90 39.35 39.90 40.07
4 39.68 40.07 40.79 40.40 40.79 40.40
10 39.57 40.29 40.90 40.63 40.52 40.02
39.46 39.98 40.53 40.13 40.40 40.16
39.31 40.02 40.47 40.07 40.04 39.84
4 38.74 39.52 40.18 39.79 39.74 39.35
6 39.07 39.29 40.52 39.35 39.29 39.41
11 39.35 40.24 40.46 40.13 40.52 39.46
39.05 39.68 40.39 39.76 39.85 39.41
5 39.29 39.79 40.13 40.18 40.02 39.96
6 39.07 39.18 39.85 39.74 39.63 39.96
11 39.41 39.29 40.29 40.46 39.35 39.35
39.26 39.42 40.09 40.13 39.66 39.76
39.16 39.55 40.24 39.94 39.76 39.58
3 39.18 39.74 40.85 40.57 39.96 39.68
7 39.13 39.90 40.52 39.85 40.40 39.29
15 38.96 38.24 40.29 39.68 39.85 39.68
39.09 39.29 40.55 40.03 40.07 39.55
7 38.96 39.52 40.63 40.90 40.74 40.40
8 38.79 40.02 40.52 40.13 39.74 39.57
9 39.07 39.29 39.57 38.85 39.35 39.57
38.94 39.61 40.24 39.96 39.94 39.85
39.02 39.45 40.39 40.00 40.01 39.70
1 39.18 39.68 40.35 39.35 39.57 39.85
9 39.07 39.63 40.79 39.74 39.68 39.35
12 39.07 39.29 39.79 40.29 39.63 39.46
39.11 39.53 40.31 39.79 39.63 39.55
12 38.79 39.96 40.52 39.68 39.52 39.79
13 39.24 39.96 40.79 40.52 40.07 39.79
14 39.24 39.35 40.40 40.74 40.07 39.85
39.09 39.76 40.57 40.31 39.89 39.81
39.10 39.65 40.44 40.05 39.76 39.68
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-72
1c
2d
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri DS-36
Table C42. Study 2 hourly LPSa challenge rectal temperatures (°C)
1c
2d
Overall Mean
Control
1c
2d
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri DS-37
1c
2d
Overall Mean
L. reuteri WB-76
1c
2d
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 136 143 143 96 79 122
10 137 140 141 120 74 118
13 108 110 133 103 52 114
127 131 139 106 68 118
1 102 114 99 91 68 116
3 86 104 92 69 68 104
15 106 117 101 111 98 103
98 112 97 90 78 108
113 121 118 98 73 113
2 108 114 116 98 63 103
8 116 126 161 121 93 124
14 108 106 132 84 57 114
111 115 136 101 71 114
2 98 99 96 103 84 113
4 111 110 113 110 95 108
10 101 110 98 72 71 124
103 106 102 95 83 115
107 111 119 98 77 114
4 132 120 142 122 68 120
6 127 122 131 94 61 114
11 126 127 136 115 99 99
128 123 136 110 76 111
5 99 100 104 102 73 110
6 102 98 94 102 76 137
11 109 104 98 112 87 119
103 101 99 105 79 122
116 112 118 108 77 117
3 118 141 155 89 76 113
7 116 108 135 114 73 120
15 103 96 105 79 57 91
112 115 132 94 69 108
7 117 107 114 133 102 115
8 97 113 94 77 51 153
9 94 101 94 89 62 112
103 107 101 100 72 127
108 111 116 97 70 117
1 129 122 140 98 72 142
9 117 123 130 113 81 104
12 116 125 157 141 103 123
121 123 142 117 85 123
12 102 102 98 65 63 113
13 106 119 100 77 69 103
14 101 99 94 77 76 78
103 107 97 73 69 98
112 115 120 95 77 111
Exp. 1 Mean
dExperiment 2 were barrows
cExperiment 1 were gilts
Exp. 2 Mean
Exp. 1 Mean
Control
Overall Mean
2d
1c
2d
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Overall Mean
L. reuteri DS-36
bDescription of treatments, experiments, and pigs - see Table C2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
L. reuteri WB-76
2d
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Table C43. Study 2 hourly LPSa challenge glucose levels (mg/dL)
1c
1c
2d
1c
2d
L. reuteri DS-37
1c
L. reuteri WB-72
Overall Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 9 9 9 10 13 12
10 10 11 11 10 11 15
13 7 6 7 7 11 12
9 9 9 9 12 13
1 6 7 7 9 12 8
3 6 7 7 11 15 15
15 10 10 10 8 8 8
7 8 8 9 12 10
8 8 9 9 12 12
2 8 8 9 9 12 10
8 9 9 10 9 8 11
14 10 10 10 10 14 10
9 9 10 9 11 10
2 9 9 10 10 10 11
4 10 10 10 9 7 11
10 6 7 7 10 16 11
8 9 9 10 11 11
9 9 9 10 11 11
4 9 9 10 9 9 11
6 11 11 12 10 10 11
11 13 14 14 13 12 10
11 11 12 11 10 11
5 6 6 7 7 10 13
6 7 8 8 10 13 11
11 16 15 16 15 10 9
10 10 10 11 11 11
10 11 11 11 11 11
3 9 8 9 8 13 11
7 10 10 10 10 9 10
15 11 11 11 10 12 14
10 10 10 9 11 12
7 10 9 9 10 9 11
8 7 7 7 8 12 15
9 7 8 8 8 9 10
8 8 8 9 10 12
9 9 9 9 11 12
1 11 11 11 12 17 15
9 12 12 12 11 11 14
12 12 12 12 11 8 12
12 12 12 11 12 14
12 6 6 6 7 13 15
13 8 8 8 8 10 10
14 12 12 12 12 12 8
9 9 9 9 12 11
10 10 10 10 12 12
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
1d
2e
1d
Exp. 2 Mean
Exp. 2 Mean
1d
2e
Overall Mean
Overall Mean
Table C44. Study 2 hourly LPSa challenge BUNb levels (mg/dL)
L. reuteri WB-72
Control
L. reuteri DS-36
L. reuteri DS-37
Overall Mean
Overall Mean
cDescription of treatments, experiments, and pigs - see Table C2
bBUN - blood urea nitrogen
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
L. reuteri WB-76
1d
2e
1d
2e
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 1.0 1.0 1.2 1.0 1.4 1.1
10 1.0 1.1 1.3 1.2 1.1 1.1
13 1.0 1.0 1.2 1.1 1.1 1.1
1 1.0 1.2 1.1 1.2 1.1
1 1.1 1.1 1.2 1.2 1.5 1.3
3 1.3 1.4 1.4 1.7 1.6 1.6
15 1.3 1.3 1.3 1.4 1.2 1.0
1.2 1.3 1.3 1.4 1.4 1.3
1.1 1.2 1.3 1.3 1.3 1.2
2 0.9 0.9 1.0 0.9 1.0 0.9
8 1.1 1.0 1.3 1.0 1.0 1.0
14 1.0 1.1 1.1 1.1 1.3 1.0
1.0 1.0 1.1 1.0 1.1 1.0
2 1.3 1.3 1.3 1.3 1.5 1.3
4 1.2 1.2 1.2 1.3 1.2 1.4
10 0.9 0.8 1.0 1.1 1.3 1.0
1.1 1.1 1.2 1.2 1.3 1.2
1.1 1.1 1.2 1.1 1.2 1.1
4 1.1 1.1 1.2 1.2 1.2 1.1
6 0.9 0.9 1.0 0.9 1.0 1.0
11 1.4 1.2 1.5 1.3 1.3 1.1
1.1 1.1 1.2 1.1 1.2 1.1
5 1.3 1.2 1.3 1.4 1.2 1.3
6 1.4 1.4 1.5 1.6 1.4 1.3
11 1.2 1.2 1.3 1.5 1.2 1.1
1.3 1.3 1.4 1.5 1.3 1.2
1.2 1.2 1.3 1.3 1.2 1.2
3 1.1 1.2 1.4 1.2 1.5 1.3
7 1.0 1.1 1.2 1.1 1.1 1.1
15 0.9 0.9 1.0 0.9 1.1 1.0
1.0 1.1 1.2 1.1 1.2 1.1
7 1.3 1.3 1.4 1.6 1.3 1.4
8 0.9 0.9 1.0 1.1 1.3 1.3
9 0.9 0.9 1.0 1.0 1.1 1.0
1.0 1.0 1.1 1.2 1.2 1.2
1.0 1.1 1.2 1.2 1.2 1.2
1 1.1 1.0 1.2 1.0 1.3 1.1
9 1.2 1.1 1.2 1.1 1.1 1.1
12 1.0 1.0 1.1 1.1 1.1 1.1
1.1 1.0 1.2 1.1 1.2 1.1
12 1.1 1.1 1.2 1.2 1.5 1.3
13 1.1 1.2 1.2 1.3 1.4 1.3
14 1.1 1.1 1.2 1.2 1.2 1.1
1.1 1.1 1.2 1.2 1.4 1.2
1.1 1.1 1.2 1.2 1.3 1.2
cExperiment 1 were gilts
dExperiment 2 were barrows
Overall Mean
Overall Mean
L. reuteri WB-76
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri DS-37
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
Control
1c
2d
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
Overall Mean
Exp. 2 Mean
L. reuteri DS-36
Exp. 1 Mean
L. reuteri WB-72
Table C45. Study 2 hourly LPSa challenge creatinine levels (mg/dL)
1c
2d
1c
2d
1c
2d
1c
Exp. 2 Mean
Overall Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 9.2 9.4 8.0 9.4 9.9 10.7
10 10.0 9.7 8.6 8.8 9.3 13.5
13 6.6 6.3 5.7 6.8 9.4 11.2
8.6 8.5 7.4 8.3 9.5 11.8
1 5.8 6.0 6.2 7.1 8.2 6.3
3 4.9 4.9 5.1 6.7 9.6 9.6
15 7.8 7.8 7.5 5.9 6.4 7.8
6.2 6.2 6.3 6.6 8.1 7.9
7.4 7.4 6.9 7.5 8.8 9.9
2 8.4 9.1 8.7 9.6 12.1 10.7
8 8.3 9.7 7.6 9.2 8.3 11.0
14 9.7 8.8 8.8 9.6 10.4 9.5
8.8 9.2 8.4 9.5 10.3 10.4
2 7.2 7.0 7.3 7.7 6.3 8.6
4 8.1 8.2 7.7 6.6 6.2 7.8
10 7.0 8.2 6.8 9.1 12.7 10.7
7.4 7.8 7.3 7.8 8.4 9.0
8.1 8.5 7.8 8.6 9.3 9.7
4 8.0 8.6 8.0 7.3 7.2 9.7
6 12.3 13.1 11.6 10.9 10.2 11.6
11 9.7 11.4 9.3 10.1 9.1 9.8
10.0 11.0 9.6 9.4 8.8 10.4
5 4.8 5.2 5.1 5.2 8.5 9.7
6 5.3 5.7 5.7 6.0 8.7 8.1
11 13.2 12.3 12.1 10.2 8.4 8.1
7.8 7.7 7.6 7.1 8.5 8.6
8.9 9.4 8.6 8.3 8.7 9.5
3 7.9 6.8 6.3 6.7 8.3 8.9
7 9.2 9.2 8.3 8.6 8.6 9.2
15 12.2 11.6 11.0 10.4 10.3 13.1
9.8 9.2 8.5 8.6 9.1 10.4
7 7.2 7.3 6.6 6.2 7.2 8.0
8 7.3 7.6 7.4 7.4 9.3 11.1
9 7.7 8.5 8.1 8.2 8.4 10.3
7.4 7.8 7.4 7.3 8.3 9.8
8.6 8.5 8.0 7.9 8.7 10.1
1 10.5 11.3 9.9 11.4 12.8 14.1
9 10.2 10.7 9.9 9.6 9.9 13.1
12 11.5 12.2 11.0 9.7 7.5 11.2
10.7 11.4 10.3 10.2 10.1 12.8
12 5.5 5.1 4.5 5.8 8.9 11.7
13 7.2 6.9 6.7 6.5 6.9 7.8
14 10.6 10.8 9.9 9.6 10.4 7.5
7.8 7.6 7.0 7.3 8.7 9.0
9.3 9.5 8.7 8.8 9.4 10.9
Exp. 1 Mean
Exp. 1 Mean
dExperiment 1 were gilts
eExperiment 2 were barrows
Overall Mean
1d
2e
L. reuteri DS-37
Exp. 2 Mean
Exp. 1 Mean
1d
2e
1d
2e
Exp. 1 Mean
Exp. 1 Mean
Table C46. Study 2 hourly LPSa challenge BUNb:creatinine ratio levels
L. reuteri WB-72
L. reuteri WB-76
Overall Mean
Overall Mean
Control
1d
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
cDescription of treatments, experiments, and pigs - see Table C2
bBUN - blood urea nitrogen
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
1d
2e
L. reuteri DS-36
Overall Mean
Overall Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 141 138 149 141 141 141
10 139 141 151 143 138 141
13 141 140 151 144 139 140
140 140 150 143 139 141
1 134 137 138 142 136 139
3 140 141 142 164 138 144
15 135 138 137 136 141 138
136 139 139 147 138 140
138 139 145 145 139 141
2 143 140 148 136 140 142
8 140 138 156 141 139 139
14 137 139 145 137 138 138
140 139 150 138 139 140
2 137 139 139 145 139 140
4 139 140 146 148 139 144
10 135 135 138 137 133 136
137 138 141 143 137 140
139 139 145 141 138 140
4 142 141 152 143 141 140
6 140 140 152 134 139 140
11 141 140 152 142 142 144
141 140 152 140 141 141
5 138 137 143 146 139 139
6 133 136 139 144 132 138
11 133 134 134 140 134 137
135 136 139 143 135 138
138 138 145 142 138 140
3 143 145 151 137 140 143
7 139 140 152 142 138 141
15 138 139 144 134 138 140
140 141 149 138 139 141
7 138 138 139 152 136 141
8 139 137 138 137 137 137
9 138 140 139 135 139 137
138 138 139 141 137 138
139 140 144 140 138 140
1 146 141 148 139 141 144
9 142 138 148 139 138 141
12 141 139 148 147 142 141
143 139 148 142 140 142
12 135 137 139 140 138 140
13 136 139 140 140 136 139
14 137 137 139 135 139 139
136 138 139 138 138 139
140 139 144 140 139 141
dExperiment 2 were barrows
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
2d
1c
Table C47. Study 2 hourly LPSa challenge sodium levels (mEq/L)
L. reuteri WB-72
cExperiment 1 were gilts
L. reuteri WB-76
Overall Mean
Overall Mean
2d
Overall Mean
Overall Mean
1c
2d
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
2d
1c
Control
L. reuteri DS-36
L. reuteri DS-37
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 10.6 9.7 9.4 8.9 7.6 8.2
10 10.7 9.1 9.6 9.0 7.4 8.9
13 9.0 8.6 9.2 8.0 8.0 8.9
10.1 9.1 9.4 8.6 7.7 8.7
1 8.9 8.1 9.1 8.7 7.3 8.5
3 9.9 9.5 9.3 11.0 8.0 8.7
15 10.8 10.2 10.6 9.8 8.8 9.9
9.9 9.3 9.7 9.8 8.0 9.0
10.0 9.2 9.5 9.2 7.9 8.9
2 8.9 8.3 9.0 8.5 8.0 8.8
8 8.8 9.0 8.8 7.5 7.2 9.5
14 9.5 8.6 8.8 8.0 7.5 8.5
9.1 8.6 8.9 8.0 7.6 8.9
2 9.2 8.6 9.9 10.3 8.6 8.2
4 9.3 9.0 10.5 9.3 8.1 8.6
10 9.2 8.8 8.7 8.1 6.8 7.6
9.2 8.8 9.7 9.2 7.8 8.1
9.2 8.7 9.3 8.6 7.7 8.5
4 9.7 8.8 9.8 9.1 7.9 8.6
6 9.7 8.8 9.2 8.3 7.2 8.3
11 8.6 9.4 8.7 7.8 8.0 8.0
9.3 9.0 9.2 8.4 7.7 8.3
5 11.5 9.4 10.1 9.5 8.3 8.3
6 9.3 9.3 10.1 9.7 7.6 9.7
11 10.6 9.6 9.6 9.1 7.1 8.9
10.5 9.4 9.9 9.4 7.7 9.0
9.9 9.2 9.6 8.9 7.7 8.6
3 10.0 10.0 9.2 8.9 7.7 8.9
7 9.0 8.7 8.2 7.6 7.0 7.8
15 9.5 9.0 9.5 8.8 7.3 8.6
9.5 9.2 9.0 8.4 7.3 8.4
7 10.2 8.7 10.9 10.1 8.1 9.0
8 10.3 9.6 8.8 9.3 7.6 9.2
9 10.2 9.1 9.3 9.0 8.0 9.7
10.2 9.1 9.7 9.5 7.9 9.3
9.9 9.2 9.3 9.0 7.6 8.9
1 10.4 10.4 9.8 8.9 7.5 8.6
9 11.3 9.6 11.2 9.5 8.1 8.8
12 8.0 7.8 10.4 8.5 7.3 8.0
9.9 9.3 10.5 9.0 7.6 8.5
12 11.5 9.1 9.9 9.9 7.6 9.0
13 10.5 9.6 9.5 8.1 7.5 8.2
14 8.8 7.8 9.4 8.0 7.4 7.4
10.3 8.8 9.6 8.7 7.5 8.2
10.1 9.1 10.0 8.8 7.6 8.3
cExperiment 1 were gilts
dExperiment 2 were barrows
Overall Mean
2d
1c
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1c
2d
Table C48. Study 2 hourly LPSa challenge potassium levels (mEq/L)
L. reuteri WB-72
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
Overall Mean
Overall Mean
2d
1c
Overall Mean
Overall Mean
Exp. 1 Mean
2d
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Control
L. reuteri DS-36
L. reuteri DS-37
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 105 104 105 105 103 103
10 107 107 106 104 105 105
13 102 102 103 101 100 103
105 104 105 103 103 104
1 99 102 102 104 102 103
3 104 105 103 120 99 106
15 102 102 105 101 100 105
102 103 103 108 100 105
103 104 104 106 102 104
2 102 103 104 102 102 105
8 101 102 106 98 102 103
14 102 103 104 103 100 104
102 103 105 101 101 104
2 101 102 102 107 100 103
4 105 106 113 110 104 105
10 100 103 100 100 99 100
102 104 105 106 101 103
102 103 105 103 101 103
4 105 104 106 104 104 102
6 105 107 109 105 105 102
11 104 109 109 105 105 109
105 107 108 105 105 104
5 104 104 106 111 99 106
6 97 99 100 105 94 103
11 103 101 103 107 103 102
101 101 103 108 99 104
103 104 106 106 102 104
3 103 106 104 101 100 104
7 106 106 108 104 104 107
15 103 104 100 101 102 104
104 105 104 102 102 105
7 103 103 107 114 103 103
8 102 101 103 99 99 101
9 101 101 100 97 101 101
102 102 103 103 101 102
103 104 104 103 102 103
1 107 107 105 101 101 106
9 106 105 105 102 104 107
12 103 106 104 102 100 103
105 106 105 102 102 105
12 103 101 101 104 97 102
13 103 103 103 105 101 106
14 101 103 104 101 102 107
102 102 103 103 100 105
104 104 104 103 101 105
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table C2
2d
1c
2d
L. reuteri WB-72
Overall Mean
1c
2d
Overall Mean
1c
2d
Exp. 1 Mean
Exp. 1 Mean
Table C49. Study 2 hourly LPSa challenge chloride levels (mEq/L)
Overall Mean
Overall Mean
Overall Mean
Control
L. reuteri DS-37
1c
1c
2d
L. reuteri DS-36
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 25 24 27 21 24 29
10 20 23 28 24 22 26
13 26 28 31 31 24 26
24 25 29 25 23 27
1 28 27 25 28 24 22
3 23 21 27 29 26 24
15 25 25 24 26 26 24
25 24 25 28 25 23
25 25 27 27 24 25
2 25 27 27 20 27 27
8 30 25 30 26 26 26
14 24 28 27 24 23 25
26 27 28 23 25 26
2 26 27 28 30 28 26
4 23 22 21 25 25 26
10 27 23 26 27 24 27
25 24 25 27 26 26
26 25 27 25 26 26
4 26 23 29 25 25 28
6 25 24 26 22 25 31
11 24 23 27 27 24 26
25 23 27 25 25 28
5 21 26 26 25 28 24
6 26 26 28 28 28 18
11 23 23 24 26 24 18
23 25 26 26 27 20
24 24 27 26 26 24
3 27 23 28 24 24 25
7 24 25 27 26 24 24
15 24 26 28 20 22 26
25 25 28 23 23 25
7 24 26 22 29 23 25
8 25 24 23 28 26 20
9 27 28 26 26 26 24
25 26 24 28 25 23
25 25 26 26 24 24
1 29 23 28 26 27 27
9 25 24 29 24 24 26
12 26 23 23 30 27 29
27 23 27 27 26 27
12 23 26 25 26 27 22
13 26 24 28 25 25 25
14 28 24 23 25 25 23
26 25 25 25 26 23
26 24 26 26 26 25
cExperiment 1 were gilts
dExperiment 2 were barrows
Overall Mean
2d
1c
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1c
2d
Table C50. Study 2 hourly LPSa challenge carbon dioxide levels (mEq/L)
L. reuteri WB-72
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
Overall Mean
Overall Mean
2d
1c
Overall Mean
Overall Mean
Exp. 1 Mean
2d
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Control
L. reuteri DS-36
L. reuteri DS-37
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 21.6 20.1 26.4 24.4 22.0 16.7
10 21.7 19.7 25.3 24.4 18.2 19.7
13 21.8 18.4 26.9 20.1 23.0 19.0
21.7 19.4 26.2 23.0 21.1 18.5
1 15.8 17.0 19.3 18.9 17.4 22.5
3 22.9 23.9 20.7 25.3 21.2 22.5
15 20.0 21.5 18.3 19.1 23.0 19.5
19.6 20.8 19.4 21.1 20.5 21.5
20.6 20.1 22.8 22.0 20.8 20.0
2 24.2 18.6 25.9 22.6 19.1 18.8
8 18.0 20.0 28.5 24.2 18.5 19.0
14 20.6 16.6 22.6 18.4 21.7 17.4
20.9 18.4 25.7 21.7 19.8 18.4
2 19.6 18.6 18.3 18.5 19.2 19.2
4 19.9 21.0 22.1 22.0 18.7 21.5
10 17.1 18.5 19.9 18.7 17.5 16.1
18.9 19.4 20.1 19.7 18.5 18.9
19.9 18.9 22.9 20.7 19.1 18.7
4 21.2 22.4 27.3 23.7 19.6 18.7
6 19.1 17.4 25.8 15.6 16.6 15.8
11 21.0 17.5 25.1 17.6 21.5 17.2
20.4 19.1 26.1 19.0 19.2 17.2
5 25.1 17.3 21.1 20.0 19.4 17.4
6 19.2 20.4 21.3 20.5 17.8 27.4
11 17.6 19.5 17.6 17.0 13.8 25.5
20.6 19.1 20.0 19.2 17.0 23.4
20.5 19.1 23.0 19.1 18.1 20.3
3 23.1 26.4 28.3 20.4 24.1 23.8
7 17.3 18.2 25.8 20.1 17.1 17.2
15 19.9 18.0 25.3 22.4 21.9 18.4
20.1 20.9 26.5 21.0 21.0 19.8
7 20.5 18.0 20.1 19.4 19.2 20.7
8 21.7 21.0 19.8 19.6 20.0 24.6
9 21.3 20.4 23.2 20.8 19.5 21.5
21.2 19.8 21.0 19.9 19.6 22.3
20.6 20.3 23.8 20.5 20.3 21.0
1 20.8 21.1 25.6 20.8 20.8 20.4
9 22.5 19.0 26.2 23.1 17.7 17.2
12 20.3 18.4 31.4 23.7 22.3 16.4
21.2 19.5 27.7 22.5 20.3 18.0
12 20.9 19.5 23.0 19.4 21.9 24.3
13 17.7 21.6 18.2 18.3 17.4 16.2
14 16.8 17.8 21.1 17.0 19.2 17.0
18.5 19.6 20.8 18.2 19.5 19.2
19.8 19.6 24.3 20.4 19.9 18.6
cExperiment 1 were gilts
dExperiment 2 were barrows
Overall Mean
2d
1c
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1c
2d
Table C51. Study 2 hourly LPSa challenge anion gap levels
L. reuteri WB-72
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
Overall Mean
Overall Mean
2d
1c
Overall Mean
Overall Mean
Exp. 1 Mean
2d
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Control
L. reuteri DS-36
L. reuteri DS-37
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 10.3 9.6 12.6 9.0 7.9 9.1
10 10.4 10.1 15.1 12.7 8.2 10.3
13 9.9 9.7 13.9 10.0 7.5 10.0
10.2 9.8 13.9 10.6 7.9 9.8
1 10.4 10.5 10.3 8.4 8.9 11.2
3 10.6 10.7 10.5 11.4 9.0 9.7
15 10.8 10.5 10.3 9.6 9.8 10.1
10.6 10.6 10.4 9.8 9.2 10.3
10.4 10.2 12.1 10.2 8.6 10.1
2 10.2 9.8 13.6 8.3 8.2 9.6
8 10.6 10.3 14.6 12.0 8.8 10.8
14 9.8 10.1 12.1 8.5 7.8 10.0
10.2 10.1 13.4 9.6 8.3 10.1
2 10.8 10.6 10.7 10.7 9.9 10.8
4 10.8 9.8 10.6 9.7 8.9 10.0
10 10.3 9.8 10.1 7.9 8.3 9.3
10.6 10.1 10.5 9.4 9.0 10.0
10.4 10.1 12.0 9.5 8.7 10.1
4 10.7 10.5 15.0 11.1 8.6 10.2
6 10.6 10.3 14.4 8.2 8.8 10.2
11 10.1 9.8 14.4 10.2 8.0 9.7
10.5 10.2 14.6 9.8 8.5 10.0
5 10.5 10.1 10.5 9.9 9.1 9.5
6 10.5 10.5 10.8 9.8 8.7 9.6
11 10.2 10.2 9.8 9.6 9.3 10.6
10.4 10.3 10.4 9.8 9.0 9.9
10.4 10.2 12.5 9.8 8.8 10.0
3 10.6 10.6 14.1 7.9 7.2 10.2
7 10.4 10.4 14.6 10.4 8.2 9.8
15 9.9 9.6 12.6 6.8 8.3 9.7
10.3 10.2 13.8 8.4 7.9 9.9
7 10.7 10.7 10.6 10.7 9.3 9.7
8 10.9 10.7 10.4 9.7 9.8 10.0
9 10.8 10.8 11.0 9.8 9.8 10.4
10.8 10.7 10.7 10.1 9.6 10.0
10.6 10.5 12.2 9.2 8.8 10.0
1 11.1 10.0 12.9 9.3 8.8 10.2
9 10.5 9.7 15.5 10.5 7.4 9.7
12 10.3 9.8 13.8 12.1 9.4 10.3
10.6 9.8 14.1 10.6 8.5 10.1
12 10.9 10.8 11.1 9.8 9.7 10.3
13 10.4 10.7 10.5 9.2 9.1 9.4
14 11.0 10.6 10.5 8.7 9.4 9.6
10.8 10.7 10.7 9.2 9.4 9.8
10.7 10.3 12.4 9.9 9.0 9.9
cExperiment 1 were gilts
dExperiment 2 were barrows
Overall Mean
2d
1c
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
1c
2d
Table C52. Study 2 hourly LPSa challenge calcium levels (mEq/L)
L. reuteri WB-72
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
Overall Mean
Overall Mean
2d
1c
Overall Mean
Overall Mean
Exp. 1 Mean
2d
bDescription of treatments, experiments, and pigs - see Table C2
Exp. 1 Mean
Control
L. reuteri DS-36
L. reuteri DS-37
1c
1c
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 5.2 4.7 6.5 4.7 5.3 5.0
10 4.9 4.4 7.6 6.4 4.5 4.8
13 5.2 4.8 7.4 5.8 5.0 5.1
5.1 4.6 7.2 5.6 4.9 5.0
1 4.6 4.4 4.4 4.3 4.2 4.5
3 5.4 5.0 5.1 5.9 5.0 5.1
15 5.0 4.5 4.1 3.9 4.5 4.3
5.0 4.6 4.5 4.7 4.6 4.6
5.1 4.6 5.9 5.2 4.8 4.8
2 5.4 4.5 7.2 4.1 4.5 4.9
8 5.1 4.7 7.7 6.3 4.7 5.2
14 5.2 4.9 6.4 4.5 4.7 4.9
5.2 4.7 7.1 5.0 4.6 5.0
2 5.4 5.2 5.2 5.5 5.5 5.2
4 4.4 4.2 4.2 4.3 4.3 4.2
10 4.8 4.4 4.4 4.3 4.2 4.2
4.9 4.6 4.6 4.7 4.7 4.5
5.1 4.7 5.9 4.8 4.7 4.8
4 5.1 4.9 7.5 5.7 4.8 5.0
6 4.9 4.6 6.9 3.5 4.3 4.9
11 4.9 4.4 7.3 4.8 4.1 4.7
5.0 4.6 7.2 4.7 4.4 4.9
5 5.4 4.7 4.9 4.6 4.7 4.5
6 4.9 4.8 4.9 4.6 4.6 4.7
11 4.8 4.7 4.2 4.3 4.4 4.5
5.0 4.7 4.7 4.5 4.6 4.6
5.0 4.7 6.0 4.6 4.5 4.7
3 5.6 5.2 7.7 4.0 4.7 5.2
7 4.9 4.5 7.5 5.4 4.5 4.6
15 4.8 4.3 6.3 3.6 4.7 4.3
5.1 4.7 7.2 4.3 4.6 4.7
7 5.3 5.0 4.8 4.9 4.6 4.7
8 5.3 5.1 4.4 4.6 4.9 4.9
9 5.3 4.9 4.9 4.7 5.1 4.9
5.3 5.0 4.7 4.7 4.9 4.8
5.2 4.8 5.9 4.5 4.8 4.8
1 5.3 4.4 6.3 4.7 5.0 4.8
9 5.5 5.0 8.3 5.4 4.3 5.1
12 5.3 4.9 7.1 6.9 5.8 5.2
5.4 4.8 7.2 5.7 5.0 5.0
12 5.9 5.1 5.3 4.8 5.2 5.1
13 4.6 4.8 4.7 4.4 4.3 4.3
14 4.8 4.5 4.2 3.9 4.3 4.3
5.1 4.8 4.7 4.4 4.6 4.6
5.2 4.8 6.0 5.0 4.8 4.8
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-76
Exp. 2 Mean
Exp. 1 Mean
1c
2
Overall Mean
cExperiment 1 were gilts
2
Overall Mean
Overall Mean
Exp. 1 Mean
1c
1c
2d
1c
2
Exp. 2 Mean
2d
1c
Exp. 2 Mean
Exp. 1 Mean
Table C53. Study 2 hourly LPSa challenge total protein levels (g/dL)
L. reuteri WB-72
L. reuteri DS-37
L. reuteri DS-36
Control
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 3.1 2.7 4.0 2.9 3.1 2.7
10 3.0 2.7 4.9 4.2 2.7 2.8
13 2.9 2.6 4.4 3.3 2.8 2.8
3.0 2.7 4.4 3.5 2.9 2.8
1 2.6 2.5 2.6 2.4 2.3 2.6
3 3.2 2.9 3.0 3.5 2.8 2.8
15 3.1 2.8 2.5 2.5 2.8 2.5
3.0 2.7 2.7 2.8 2.6 2.6
3.0 2.7 3.6 3.1 2.8 2.7
2 3.3 2.7 4.6 2.6 2.8 2.9
8 3.3 3.1 5.4 4.4 3.1 3.3
14 3.6 3.3 4.6 3.1 3.2 3.3
3.4 3.0 4.9 3.4 3.0 3.2
2 3.1 3.1 3.1 3.2 3.2 3.1
4 2.8 2.6 2.7 2.7 2.6 2.6
10 3.1 2.8 2.8 2.7 2.6 2.5
3.0 2.8 2.9 2.9 2.8 2.7
3.2 2.9 3.9 3.1 2.9 3.0
4 3.6 3.3 5.3 4.0 3.2 3.3
6 2.9 2.7 4.3 2.0 2.5 2.8
11 2.9 2.5 4.5 3.0 2.4 2.7
3.1 2.8 4.7 3.0 2.7 2.9
5 3.1 2.7 2.7 2.7 2.6 2.4
6 2.6 2.6 2.6 2.5 2.4 2.5
11 2.4 2.4 2.2 2.3 2.2 2.4
2.7 2.6 2.5 2.5 2.4 2.4
2.9 2.7 3.6 2.8 2.6 2.7
3 3.6 3.4 5.3 2.6 3.2 3.4
7 3.1 2.9 4.9 3.6 2.9 2.9
15 2.6 2.3 3.7 2.0 2.6 2.4
3.1 2.9 4.6 2.7 2.9 2.9
7 3.4 3.1 3.1 3.2 2.9 2.9
8 3.2 3.3 2.8 2.9 2.9 3.0
9 3.2 2.9 2.9 2.8 3.0 2.8
3.3 3.1 2.9 3.0 2.9 2.9
3.2 3.0 3.8 2.9 2.9 2.9
1 3.3 2.8 4.5 3.0 3.2 2.8
9 3.3 2.8 5.4 3.4 2.6 3.0
12 3.2 3.0 4.8 4.6 3.6 3.2
3.3 2.9 4.9 3.7 3.1 3.0
12 3.5 3.1 3.3 3.0 3.1 3.1
13 2.8 2.8 2.8 2.6 2.4 2.5
14 3.0 2.8 2.7 2.5 2.7 2.6
3.1 2.9 2.9 2.7 2.7 2.7
3.2 2.9 3.9 3.2 2.9 2.9
cExperiment 1 were gilts
dExperiment 2 were barrows
1c
2d
L. reuteri DS-37
2d
Overall Mean
L. reuteri WB-72
Exp. 2 Mean
2d
Exp. 1 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
Exp. 1 Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-76
1c
Overall Mean
1c
1c
2d
Overall Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table C2
Table C54. Study 2 hourly LPSa challenge albumin levels (g/dL)
Control
Overall Mean
L. reuteri DS-36
1c
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 2.1 1.9 2.5 1.9 2.2 2.2
10 1.9 1.7 2.7 2.2 1.8 1.9
13 2.3 2.2 3.1 2.5 2.2 2.3
2.1 1.9 2.8 2.2 2.1 2.1
1 2.0 1.9 1.8 1.9 1.9 1.9
3 2.2 2.1 2.1 2.4 2.2 2.3
15 1.9 1.7 1.6 1.4 1.7 1.8
2.0 1.9 1.8 1.9 1.9 2.0
2.1 1.9 2.3 2.1 2.0 2.1
2 2.1 1.8 2.5 1.5 1.7 2.0
8 1.8 1.6 2.4 1.9 1.6 1.9
14 1.6 1.6 1.7 1.4 1.4 1.5
1.8 1.7 2.2 1.6 1.6 1.8
2 2.3 2.1 2.1 2.3 2.3 2.1
4 1.7 1.6 1.4 1.6 1.6 1.6
10 1.7 1.6 1.6 1.6 1.6 1.7
1.9 1.8 1.7 1.8 1.8 1.8
1.9 1.7 2.0 1.7 1.7 1.8
4 1.6 1.6 2.2 1.7 1.6 1.7
6 2.0 1.9 2.5 1.4 1.8 2.1
11 2.0 1.9 2.8 1.9 1.7 2.0
1.9 1.8 2.5 1.7 1.7 1.9
5 2.3 2.0 2.1 2.0 2.1 2.1
6 2.3 2.2 2.2 2.1 2.2 2.2
11 2.4 2.3 2.0 2.0 2.2 2.1
2.3 2.2 2.1 2.0 2.2 2.1
2.1 2.0 2.3 1.9 1.9 2.0
3 2.0 1.7 2.4 1.3 1.5 1.8
7 1.8 1.7 2.6 1.8 1.6 1.7
15 2.2 2.0 2.6 1.6 2.0 2.0
2.0 1.8 2.5 1.6 1.7 1.8
7 1.9 1.9 1.7 1.8 1.7 1.8
8 2.1 1.9 1.6 1.7 1.9 2.0
9 2.2 2.0 2.0 2.0 2.1 2.1
2.1 1.9 1.8 1.8 1.9 2.0
2.0 1.9 2.2 1.7 1.8 1.9
1 2.0 1.7 1.8 1.7 1.9 2.0
9 2.2 2.0 2.9 2.0 1.8 2.1
12 2.1 1.8 2.4 2.3 2.2 2.0
2.1 1.8 2.4 2.0 2.0 2.0
12 2.3 2.0 2.0 1.8 2.1 2.0
13 1.8 1.9 1.8 1.7 1.8 1.8
14 1.7 1.7 1.5 1.4 1.6 1.7
1.9 1.9 1.8 1.6 1.8 1.8
2.0 1.9 2.1 1.8 1.9 1.9
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Control
1c
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
cExperiment 1 were gilts
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
bDescription of treatments, experiments, and pigs - see Table C2
L. reuteri WB-76
1c
Table C55. Study 2 hourly LPSa challenge globulin levels (g/dL)
2d
L. reuteri DS-37
2d
1c
2d
L. reuteri WB-72
2d
1c
2d
Overall Mean
Overall Mean
L. reuteri DS-36
1c
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 1.4 1.4 1.6 1.5 1.4 1.2
10 1.6 1.5 1.8 2.0 1.5 1.5
13 1.2 1.2 1.4 1.3 1.3 1.3
1.4 1.4 1.6 1.6 1.4 1.3
1 1.3 1.3 1.5 1.2 1.2 1.3
3 1.4 1.4 1.4 1.5 1.3 1.3
15 1.6 1.6 1.6 1.7 1.6 1.4
1.4 1.4 1.5 1.5 1.4 1.3
1.4 1.4 1.6 1.5 1.4 1.3
2 1.6 1.5 1.8 1.7 1.6 1.4
8 1.8 1.9 2.3 2.3 1.9 1.7
14 2.2 2.0 2.7 2.2 2.2 2.2
1.9 1.8 2.3 2.1 1.9 1.8
2 1.4 1.4 1.5 1.4 1.4 1.5
4 1.7 1.7 1.9 1.7 1.6 1.7
10 1.8 1.8 1.8 1.7 1.6 1.5
1.6 1.6 1.7 1.6 1.5 1.6
1.8 1.7 2.0 1.8 1.7 1.7
4 2.3 2.0 2.4 2.3 2.1 1.9
6 1.4 1.4 1.7 1.4 1.3 1.3
11 1.5 1.4 1.6 1.6 1.4 1.3
1.7 1.6 1.9 1.8 1.6 1.5
5 1.3 1.3 1.3 1.4 1.2 1.1
6 1.1 1.2 1.2 1.2 1.1 1.2
11 1.0 1.1 1.1 1.1 1.0 1.1
1.1 1.2 1.2 1.2 1.1 1.1
1.4 1.4 1.6 1.5 1.4 1.3
3 1.8 2.0 2.2 2.0 2.1 1.8
7 1.8 1.7 1.9 1.9 1.8 1.8
15 1.2 1.2 1.5 1.2 1.3 1.2
1.6 1.6 1.9 1.7 1.7 1.6
7 1.8 1.7 1.8 1.8 1.7 1.6
8 1.6 1.7 1.8 1.7 1.5 1.5
9 1.4 1.5 1.5 1.4 1.4 1.3
1.6 1.6 1.7 1.6 1.5 1.5
1.6 1.6 1.8 1.7 1.6 1.5
1 1.6 1.6 2.6 1.7 1.7 1.4
9 1.5 1.5 1.9 1.7 1.5 1.4
12 1.6 1.7 2.0 1.9 1.7 1.6
1.6 1.6 2.2 1.8 1.6 1.5
12 1.5 1.5 1.6 1.6 1.5 1.6
13 1.5 1.5 1.6 1.5 1.3 1.4
14 1.8 1.7 1.8 1.8 1.6 1.5
1.6 1.6 1.7 1.6 1.5 1.5
1.6 1.6 1.9 1.7 1.6 1.5
cExperiment 1 were gilts
dExperiment 2 were barrows
1c
2d
L. reuteri DS-37
2d
Overall Mean
L. reuteri WB-72
Exp. 2 Mean
2d
Exp. 1 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2d
Exp. 1 Mean
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
L. reuteri WB-76
1c
Overall Mean
1c
1c
2d
Overall Mean
Exp. 1 Mean
bDescription of treatments, experiments, and pigs - see Table C2
Table C56. Study 2 hourly LPSa challenge albumin:globulin ratio levels
Control
Overall Mean
L. reuteri DS-36
1c
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 45 55 93 80 126 85
10 49 53 104 100 89 81
13 54 59 100 90 117 112
49 56 99 90 111 93
1 50 57 67 66 87 70
3 49 56 60 89 102 101
15 64 56 70 82 126 119
54 56 66 79 105 97
52 56 82 85 108 95
2 43 45 75 46 96 51
8 47 61 97 100 98 85
14 63 64 130 85 101 69
51 57 101 77 98 68
2 43 49 58 74 77 65
4 48 52 60 66 91 65
10 48 54 54 64 66 61
46 52 57 68 78 64
49 54 79 73 88 66
4 51 58 94 78 69 50
6 65 62 98 54 69 68
11 47 61 98 70 64 61
54 60 97 67 67 60
5 50 51 52 62 77 83
6 50 63 74 90 122 94
11 46 59 54 69 87 75
49 58 60 74 95 84
52 59 78 71 81 72
3 50 66 123 79 175 96
7 45 51 95 77 81 61
15 57 61 93 60 70 52
51 59 104 72 109 70
7 43 42 68 59 64 55
8 45 64 63 71 97 65
9 50 49 52 51 71 56
46 52 61 60 77 59
48 56 82 66 93 64
1 67 74 100 83 105 69
9 45 53 99 81 101 76
12 53 55 82 87 74 52
55 61 94 84 93 66
12 53 42 49 62 84 53
13 100 110 121 128 156 169
14 55 55 57 64 76 60
69 69 76 85 105 94
62 65 85 84 99 80
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
2e
Overall Mean
cDescription of treatments, experiments, and pigs - see Table C2
bAST - aspartate aminotransferase
Overall Mean
1d
2e
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Table C57. Study 2 hourly LPSa challenge ASTb levels (U/L)
Control
Overall Mean
L. reuteri DS-36
1d
L. reuteri DS-37
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1d
2e
L. reuteri WB-72
Overall Mean
2e
1d
L. reuteri WB-76
1d
2e
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 39 38 50 45 50 43
10 61 57 90 78 64 61
13 56 57 78 65 64 66
52 51 73 63 59 57
1 46 50 49 49 54 47
3 44 47 46 54 53 52
15 69 71 67 68 74 69
53 56 54 57 60 56
53 53 63 60 60 56
2 47 48 62 46 54 58
8 59 56 77 72 61 61
14 56 53 62 52 57 54
54 52 67 57 57 58
2 43 42 45 45 46 43
4 59 57 59 59 60 54
10 46 44 43 48 49 40
49 48 49 51 52 46
52 50 58 54 55 52
4 56 55 77 65 58 54
6 74 71 90 57 66 68
11 62 57 84 64 56 57
64 61 84 62 60 60
5 75 69 69 70 73 70
6 60 62 63 63 69 63
11 58 62 56 58 61 58
64 64 63 64 68 64
64 63 73 63 64 62
3 48 50 68 49 59 58
7 66 65 93 74 69 66
15 70 65 85 54 70 61
61 60 82 59 66 62
7 60 60 61 61 62 58
8 48 54 47 51 60 52
9 49 50 47 51 55 46
52 55 52 54 59 52
57 57 67 57 63 57
1 63 62 75 65 69 62
9 39 41 57 44 43 46
12 62 59 77 78 66 56
55 54 70 62 59 55
12 47 46 47 48 49 46
13 52 53 56 58 58 53
14 63 59 58 58 63 51
54 53 54 55 57 50
54 53 62 59 58 52
Exp. 1 Mean
L. reuteri DS-36
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
cDescription of treatments, experiments, and pigs - see Table C2
Table C58. Study 2 hourly LPSa challenge ALTb levels (U/L)
L. reuteri DS-37
L. reuteri WB-72
L. reuteri WB-76
Overall Mean
Overall Mean
1d
2e
1d
Control
Overall Mean
Overall Mean
1d
2e
1d
2e
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
bALT - alanine aminotransferase 
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
1d
2e
Overall Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 273 253 359 235 296 234
10 219 204 375 279 201 206
13 239 229 362 254 226 226
244 229 365 256 241 222
1 217 216 214 191 240 206
3 178 171 174 190 198 168
15 159 159 153 137 162 128
185 182 180 173 200 167
214 205 273 214 221 195
2 267 225 357 176 229 223
8 177 161 265 199 148 154
14 193 216 264 164 184 193
212 201 295 180 187 190
2 236 236 224 226 257 214
4 197 187 194 179 182 145
10 343 293 371 327 334 258
259 239 263 244 258 206
236 220 279 212 222 198
4 202 199 322 217 206 173
6 243 235 354 152 229 231
11 187 159 306 186 147 153
211 198 327 185 194 186
5 191 177 177 170 168 130
6 171 174 186 157 160 141
11 179 180 172 161 177 165
180 177 178 163 168 145
196 187 253 174 181 166
3 283 306 425 188 289 299
7 189 182 310 205 183 160
15 235 212 323 148 243 201
236 233 353 180 238 220
7 121 127 116 119 109 98
8 146 140 141 143 197 224
9 146 139 139 125 156 121
138 135 132 129 154 148
187 184 242 155 196 184
1 286 222 357 248 332 264
9 142 138 230 131 118 126
12 219 213 306 275 246 199
216 191 298 218 232 196
12 172 163 191 162 199 166
13 236 235 255 216 246 229
14 186 200 193 154 199 177
198 199 213 177 215 191
207 195 255 198 223 194
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri WB-76
2e
1d
2
1d
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1d
2
Table C59. Study 2 hourly LPSa challenge ALKPhosb levels (U/L)
Overall Mean
1d
2e
Control
L. reuteri DS-37
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
L. reuteri DS-36
Overall Mean
cDescription of treatments, experiments, and pigs - see Table C2
bALKPhos - alkaline phosphatase
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2
Overall Mean
Overall Mean
1d
L. reuteri WB-72
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Treatmentb Exp.b Pigb Hour 0c Hour 1.5c Hour 3.0c Hour 6.0c Hour 12c Hour 24c
5 0.1 0.1 0.3 0.1 1.0 0.1
10 0.2 0.1 0.5 0.4 0.6 0.1
13 0.1 0.1 0.2 0.4 0.9 0.2
0.1 0.1 0.3 0.3 0.8 0.1
1 0.1 0.1 0.1 0.2 0.6 0.1
3 0.1 0.1 0.1 0.3 0.5 0.1
15 0.1 0.1 0.1 0.1 0.1 0.1
0.1 0.1 0.1 0.2 0.4 0.1
0.1 0.1 0.2 0.3 0.6 0.1
2 0.2 0.1 0.3 0.1 0.5 0.1
8 0.1 0.1 0.2 0.1 0.2 0.1
14 0.6 0.1 0.6 0.2 0.7 0.1
0.3 0.1 0.4 0.1 0.5 0.1
2 0.1 0.1 0.1 0.3 0.3 0.1
4 0.1 0.1 0.1 0.1 0.2 0.1
10 0.2 0.3 0.4 0.9 0.8 0.1
0.1 0.2 0.2 0.4 0.4 0.1
0.2 0.1 0.3 0.3 0.5 0.1
4 0.1 0.1 0.4 0.2 0.6 0.1
6 0.1 0.1 0.3 0.1 0.3 0.1
11 0.1 0.2 0.2 0.1 0.1 0.1
0.1 0.1 0.3 0.1 0.3 0.1
5 0.3 0.1 0.1 0.1 0.1 0.1
6 0.1 0.1 0.1 0.1 0.5 0.2
11 0.1 0.3 0.1 0.2 0.1 0.1
0.2 0.2 0.1 0.1 0.2 0.1
0.1 0.2 0.2 0.1 0.3 0.1
3 0.1 0.1 0.4 0.2 1.0 0.1
7 0.1 0.1 0.3 0.1 0.4 0.1
15 0.1 0.1 0.3 0.1 0.5 0.1
0.1 0.1 0.3 0.1 0.6 0.1
7 0.1 0.1 0.2 0.1 0.4 0.1
8 0.1 0.6 0.2 0.1 0.7 0.2
9 0.1 0.1 0.1 0.1 0.2 0.1
0.1 0.3 0.2 0.1 0.4 0.1
0.1 0.2 0.3 0.1 0.5 0.1
1 0.3 0.4 0.2 0.2 0.9 0.1
9 0.2 0.1 0.4 0.1 0.3 0.1
12 0.1 0.1 0.2 0.2 0.3 0.1
0.2 0.2 0.3 0.2 0.5 0.1
12 0.4 0.1 0.2 0.2 0.5 0.1
13 0.1 0.2 0.1 0.4 1.0 0.2
14 0.1 0.1 0.1 0.1 0.2 0.5
0.2 0.1 0.1 0.2 0.6 0.3
0.2 0.2 0.2 0.2 0.5 0.2
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Control
Overall Mean
Overall Mean
Exp. 1 Mean
Table C60. Study 2 hourly LPSa challenge bili, total levels (mg/dL)
1d
2e
1d
L. reuteri DS-36
1d
2e
1d
2e
L. reuteri WB-72
L. reuteri DS-37
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
cAll 0.1 individual pig values were equal to <0.1
bDescription of treatments, experiments, and pigs - see Table C2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
1d
2e
L. reuteri WB-76
Overall Mean
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 88 55 107 66 73 74
10 84 73 124 101 70 77
13 85 75 122 90 85 86
86 68 118 86 76 79
1 77 68 68 56 62 66
3 90 79 78 73 55 69
15 70 60 50e 50e 50e 53
79 69 63 60 56 63
82 68 92 73 66 71
2 84 69 109 50e 56 71
8 84 73 118 90 71 72
14 89 91 110 70 75 84
86 78 112 70 67 76
2 95 90 89 85 83 73
4 57 52 52 50e 50e 50e
10 81 67 70 58 59 58
78 70 70 64 64 60
82 74 91 67 66 68
4 73 67 103 43 56 61
6 50e 50e 73 50e 53 56
11 64 50 95 52 50e 53
62 56 90 48 53 57
5 85 75 71 50 50e 50e
6 84 80 79 65 69 66
11 72 70 62 55 59 68
80 75 71 57 64 61
71 65 81 53 57 59
3 90 84 120 53 77 82
7 84 79 129 87 71 72
15 87 77 113 52 74 65
87 80 121 64 74 73
7 68 64 55 50e 50e 50e
8 71 61 52 50e 50e 63
9 70 61 58 50e 57 50e
70 62 55 50 52 54
78 71 88 57 63 64
1 90 67 102 75 84 72
9 86 76 116 65 55 71
12 78 73 105 88 77 81
85 72 108 76 72 75
12 97 85 87 67 75 61
13 68 67 65 53 52 68
14 50e 50e 50e 50e 50e 67
72 67 67 57 59 65
78 70 88 66 66 70
Exp. 1 Mean
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
1c
2d
L. reuteri WB-76
Overall Mean
eValues were equal to <50
bDescription of treatments, experiments, and pigs - see Table C2
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
L. reuteri DS-37
Overall Mean
Overall Mean
1c
2d
1c
2d
Table C61. Study 2 hourly LPSa challenge cholesterol levels (mg/dL)
L. reuteri DS-36
Control
Overall Mean
Overall Mean
L. reuteri WB-72
1c
2d
1c
2d
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Treatmentb Exp.b Pigb Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 31 25 40 19 51 25
10 42 33 45 30 48 31
13 39 48 65 56 111 41
37 35 50 35 70 32
1 50 34 33 31 91 69
3 41 33 35 46 71 45
15 62 48 50 34 47 57
51 38 39 37 70 57
44 37 45 36 70 45
2 35 30 40 17 51 23
8 18 17 33 14 18 23
14 43 34 38 27 79 73
32 27 37 19 49 40
2 51 43 44 48 59 43
4 38 33 25 25 35 28
10 27 33 46 38 68 27
39 36 38 37 54 33
35 32 38 28 52 36
4 36 28 45 26 40 35
6 29 21 35 14 52 23
11 37 26 39 18 18 28
34 25 40 19 37 29
5 48 53 45 26 38 29
6 32 36 28 23 47 28
11 47 42 31 23 34 58
42 44 35 24 40 38
38 34 37 22 38 34
3 29 36 51 16 91 34
7 24 32 39 20 30 14
15 45 35 52 27 56 40
33 34 47 21 59 29
7 36 24 24 24 31 24
8 37 40 29 31 61 52
9 37 26 31 25 55 35
37 30 28 27 49 37
35 32 38 24 54 33
1 39 17 39 24 99 31
9 46 29 52 11 20 28
12 20 20 25 18 27 20
35 22 39 18 49 26
12 69 56 52 38 114 35
13 33 34 35 29 42 29
14 40 28 30 23 44 62
47 39 39 30 67 42
41 31 39 24 58 34
cExperiment 1 were gilts
dExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
L. reuteri WB-72
2d
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1c
2d
1c
2d
1c
Overall Mean
bDescription of treatments, experiments, and pigs - see Table C2
Overall Mean
L. reuteri WB-76
L. reuteri DS-36
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
L. reuteri DS-37
1c
2d
1c
2d
Table C62. Study 2 hourly LPSa challenge triglyceride levels (mg/dL)
Control
Overall Mean
Exp. 2 Mean
Exp. 1 Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 32 27 37 18 14 17
10 28 24 45 29 21 26
13 27 25 28 24 22 25
29 25 37 24 19 23
1 30 28 26 16 18 26
3 33 30 28 21 11 11
15 31 27 23 15 16 17
31 28 26 17 15 18
30 27 31 21 17 20
2 26 20 33 13 11 14
8 30 26 44 27 21 24
14 31 32 39 20 19 26
29 26 39 20 17 21
2 35 33 31 30 28 24
4 24 23 22 14 11 9
10 30 25 27 17 13 11
30 27 27 20 17 15
29 27 33 20 17 18
4 26 23 36 20 15 17
6 17 15 24 10 16 19
11 26 21 38 17 10 16
23 20 33 16 14 17
5 42 37 36 23 13 9
6 31 29 29 18 12 9
11 26 24 22 17 14 20
33 30 29 19 13 13
28 25 31 18 13 15
3 32 30 43 16 19 26
7 24 23 37 20 14 12
15 27 24 36 15 17 15
28 26 39 17 17 18
7 27 26 23 16 9 7
8 27 22 21 15 9 15
9 27 24 22 16 18 13
27 24 22 16 12 12
27 25 30 16 14 15
1 26 19 29 19 20 16
9 30 26 40 19 17 24
12 25 23 33 23 19 24
27 23 34 20 19 21
12 37 34 35 22 23 17
13 24 23 22 12 9 9
14 19 18 16 9 10 11
27 25 24 14 14 12
27 24 29 17 16 17
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
Exp. 1 Mean
cDescription of treatments, experiments, and pigs - see Table C2
bHDL - high-density lipoprotein
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
2e
1d
2e
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri DS-36
L. reuteri WB-76
1d
Overall Mean
Overall Mean
Overall Mean
Overall Mean
1d
Exp. 1 Mean
Table C63. Study 2 hourly LPSa challenge HDLb levels (mg/dL)
1d
2e
2e
L. reuteri DS-37
L. reuteri WB-72
1d
Control
Exp. 1 Mean
Exp. 1 Mean
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 6 5 8 4 10 5
10 8 7 9 6 10 6
13 8 10 13 11 22 8
7 7 10 7 14 6
1 10 7 7 6 18 14
3 8 7 7 9 14 9
15 12 10 10 7 9 11
10 8 8 7 14 11
9 8 9 7 14 9
2 7 6 8 3 10 5
8 4 3 7 3 4 5
14 9 7 8 5 16 15
7 5 8 4 10 8
2 10 9 9 10 12 9
4 8 7 5 5 7 6
10 5 7 9 8 14 5
8 8 8 8 11 7
7 7 8 6 11 8
4 7 6 9 5 8 7
6 6 4 7 3 10 5
11 7 5 8 4 4 6
7 5 8 4 7 6
5 10 11 9 5 8 6
6 6 7 6 5 9 6
11 9 8 6 5 7 12
8 9 7 5 8 8
8 7 8 5 8 7
3 6 7 10 3 18 7
7 5 6 8 4 6 3
15 9 7 10 5 11 8
7 7 9 4 12 6
7 7 5 5 5 6 5
8 7 8 6 6 12 10
9 7 5 6 5 11 7
7 6 6 5 10 7
7 6 8 5 11 7
1 8 3 8 5 20 6
9 9 6 10 2 4 6
12 4 4 5 4 5 4
7 4 8 4 10 5
12 14 11 10 8 23 7
13 7 7 7 6 8 6
14 8 6 6 5 9 12
10 8 8 6 13 8
8 6 8 5 12 7
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
dExperiment 1 were gilts
eExperiment 2 were barrows
L. reuteri DS-36
Overall Mean
2e
1d
2e
1d
Control
Overall Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri WB-76
1d
2e
L. reuteri DS-37
L. reuteri WB-72
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 1 Mean
cDescription of treatments, experiments, and pigs - see Table C2
bVLDL - very low-density lipoprotein
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Table C64. Study 2 hourly LPSa challenge VLDLb levels (mg/dL)
2e
1d
2e
Overall Mean
Overall Mean
1d
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 0.257 0.281 0.406 0.347 0.302 1.147
10 0.265 0.254 0.301 0.278 0.418 0.692
13 0.305 0.265 0.315 0.285 0.443 2.095
0.275 0.267 0.341 0.304 0.387 1.311
1 0.261 0.366 0.455 0.288 0.359 0.669
3 0.269 0.308 0.541 0.405 0.586 0.773
15 0.749 0.577 0.463 0.515 0.621 0.558
0.426 0.417 0.486 0.403 0.522 0.666
0.351 0.342 0.414 0.353 0.455 0.989
2 0.306 0.256 0.299 0.305 0.247 0.635
8 0.350 0.283 0.410 0.575 0.283 0.985
14 0.249 0.547 0.305 0.249 0.385 0.596
0.302 0.362 0.338 0.376 0.305 0.739
2 0.389 0.496 1.054 0.634 0.621 0.550
4 0.368 0.760 0.662 0.592 0.548 0.825
10 0.490 0.544 0.393 0.685 0.652 0.594
0.416 0.600 0.703 0.637 0.607 0.656
0.359 0.481 0.521 0.506 0.456 0.697
4 0.245 0.307 0.332 0.281 0.251 0.372
6 0.275 0.243 0.369 0.303 0.202 0.543
11 0.349 0.227 0.264 0.259 0.373 0.425
0.290 0.259 0.322 0.281 0.275 0.447
5 0.273 0.448 0.607 0.373 0.658 0.494
6 0.705 0.403 0.924 0.564 0.633 0.585
11 0.400 0.524 0.501 0.472 0.976 0.804
0.459 0.458 0.677 0.470 0.756 0.628
0.374 0.359 0.499 0.375 0.515 0.537
3 0.340 0.274 0.255 0.237 0.232 0.406
7 0.253 0.242 0.411 0.318 0.287 0.528
15 0.275 0.368 0.349 0.309 0.486 0.516
0.289 0.295 0.338 0.288 0.335 0.483
7 0.624 0.429 0.671 0.480 0.780 0.678
8 0.267 0.361 0.413 0.381 0.283 0.412
9 0.264 0.657 0.723 0.657 0.766 0.556
0.385 0.482 0.602 0.506 0.610 0.549
0.337 0.388 0.470 0.397 0.472 0.516
1 0.424 0.343 0.377 0.244 0.401 1.049
9 0.371 0.286 0.404 0.323 1.150 0.988
12 0.271 0.218 0.307 0.278 0.846 0.429
0.355 0.282 0.363 0.282 0.799 0.822
12 0.359 0.359 0.382 0.504 0.819 0.643
13 0.301 0.540 0.544 0.647 0.795 0.467
14 0.554 0.356 0.399 0.538 0.558 0.538
0.405 0.418 0.441 0.563 0.724 0.549
0.380 0.350 0.402 0.422 0.761 0.686
bIgA - immunoglobulin A
Exp. 1 Mean
Exp. 1 Mean
Control
2e
1d
2e
Overall Mean
Exp. 1 Mean
Exp. 2 Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
Overall Mean
L. reuteri WB-76
2e
Overall Mean
Exp. 2 Mean
Table C65. Study 2 hourly LPSa challenge IgAb levels (mg/mL)
1d
1d
2e
1d
2e
L. reuteri WB-37
1d
L. reuteri WB-72
Overall Mean
eExperiment 2 were barrows
dExperiment 1 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Overall Mean
L. reuteri DS-36
cDescription of treatments, experiments, and pigs - see Table C2
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 11.400 9.382 8.735 5.075 5.407 10.670
10 5.711 5.570 3.627 2.264 8.491 8.146
13 8.725 8.299 4.744 4.600 10.560 11.780
8.612 7.750 5.702 3.980 8.153 10.199
1 5.412 4.980 6.991 3.399 4.848 3.995
3 7.629 5.873 9.679 9.447 8.110 4.525
15 4.619 7.344 3.338 3.602 3.824 7.021
5.887 6.066 6.669 5.483 5.594 5.180
7.249 6.908 6.186 4.731 6.873 7.690
2 7.230 4.696 5.100 3.120 2.626 10.050
8 7.151 6.224 3.314 3.305 3.811 9.885
14 6.105 5.037 3.618 4.055 7.231 14.530
6.829 5.319 4.011 3.493 4.556 11.488
2 8.239 4.749 6.155 5.647 4.516 4.762
4 2.855 2.990 2.860 3.016 2.657 12.370
10 4.275 4.261 3.282 4.742 4.040 5.887
5.123 4.000 4.099 4.468 3.738 7.673
5.976 4.660 4.055 3.981 4.147 9.581
4 14.350 5.018 4.942 3.469 2.920 7.345
6 10.440 7.728 7.539 4.375 4.714 11.720
11 6.990 6.440 3.450 3.786 8.247 7.573
10.593 6.395 5.310 3.877 5.294 8.879
5 5.754 5.333 6.484 3.817 4.358 7.669
6 6.289 5.421 7.026 4.078 4.411 6.745
11 4.879 5.441 3.537 5.341 5.504 8.963
5.641 5.398 5.682 4.412 4.758 7.792
8.117 5.897 5.496 4.144 5.026 8.336
3 9.288 6.321 5.128 3.632 3.579 8.962
7 5.221 4.277 3.452 3.365 4.744 6.985
15 8.523 5.110 3.538 4.964 11.690 8.056
7.677 5.236 4.039 3.987 6.671 8.001
7 6.921 6.973 7.330 4.482 3.905 7.148
8 5.905 6.152 6.635 4.012 3.622 8.934
9 4.614 5.415 4.316 4.082 5.161 8.585
5.813 6.180 6.094 4.192 4.229 8.222
6.745 5.708 5.067 4.090 5.450 8.112
1 4.790 6.120 5.198 2.809 3.037 6.137
9 7.474 10.640 4.376 3.114 11.300 12.830
12 8.149 8.775 4.069 4.393 8.973 12.470
6.804 8.512 4.548 3.439 7.770 10.479
12 6.076 6.556 4.018 4.232 6.088 7.635
13 4.930 5.735 3.890 4.647 4.837 7.604
14 4.271 5.086 2.816 3.695 7.899 5.997
5.092 5.792 3.575 4.191 6.275 7.079
5.948 7.152 4.061 3.815 7.022 8.779
Table C66. Study 2 hourly LPSa challenge IgGb levels (mg/mL)
L. reuteri WB-72
Control
L. reuteri DS-36
L. reuteri WB-37
Overall Mean
Overall Mean
1d
2e
1d
1d
2e
1d
2e
Overall Mean
Overall Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Overall Mean
cDescription of treatments, experiments, and pigs - see Table C2
bIgG - immunoglobulin G
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
2e
L. reuteri WB-76
Exp. 2 Mean
dExperiment 1 were gilts
eExperiment 2 were barrows
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
1d
2e
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Treatmentc Exp.c Pigc Hour 0 Hour 1.5 Hour 3.0 Hour 6.0 Hour 12 Hour 24
5 1.639 1.438 1.647 0.931 0.993 2.117
10 2.067 1.989 1.392 1.100 3.765 3.989
13 3.407 2.825 2.242 1.576 4.647 5.249
2.371 2.084 1.760 1.202 3.135 3.785
1 1.124 0.850 0.831 0.758 1.042 1.538
3 1.818 1.445 1.263 3.817 2.009 2.123
15 1.222 1.271 1.197 1.186 1.378 1.498
1.388 1.189 1.097 1.920 1.476 1.720
1.880 1.636 1.429 1.561 2.306 2.752
2 1.586 1.493 1.648 0.945 0.990 3.699
8 1.147 1.194 0.674 0.506 0.786 2.022
14 1.621 1.442 1.066 0.847 2.679 2.852
1.451 1.376 1.129 0.766 1.485 2.858
2 1.665 1.267 1.260 1.877 1.841 1.293
4 1.531 1.091 1.270 1.703 1.932 1.939
10 0.305 0.875 0.922 1.123 2.321 1.363
1.167 1.078 1.151 1.568 2.031 1.532
1.309 1.227 1.140 1.167 1.758 2.195
4 2.479 1.837 1.840 1.131 1.130 3.287
6 1.993 1.897 1.644 0.974 1.220 3.386
11 1.865 1.444 0.903 0.864 2.499 2.512
2.112 1.726 1.462 0.990 1.616 3.062
5 1.250 0.895 0.967 0.840 0.980 1.120
6 3.025 2.722 1.605 2.821 4.033 2.731
11 1.289 1.057 1.371 3.370 2.121 1.897
1.855 1.558 1.314 2.344 2.378 1.916
1.984 1.642 1.388 1.667 1.997 2.489
3 2.559 1.446 1.264 0.937 0.994 2.604
7 1.700 1.557 1.313 1.222 1.164 3.136
15 1.883 1.737 1.337 1.487 6.008 3.468
2.047 1.580 1.305 1.215 2.722 3.069
7 1.633 1.632 1.185 1.501 1.621 1.695
8 0.833 0.681 0.582 0.856 0.670 1.027
9 0.871 1.004 1.358 1.447 1.960 1.525
1.112 1.106 1.042 1.268 1.417 1.416
1.580 1.343 1.173 1.242 2.069 2.243
1 2.138 2.947 2.815 1.656 1.704 7.571
9 1.215 1.515 0.855 0.632 2.488 3.156
12 2.636 2.844 1.627 1.401 3.629 4.427
1.996 2.435 1.766 1.230 2.607 5.051
12 1.247 1.026 1.158 1.331 1.911 1.552
13 2.332 1.878 2.348 2.376 2.820 2.906
14 1.209 1.133 0.981 1.214 2.127 1.449
1.596 1.346 1.496 1.640 2.286 1.969
1.796 1.891 1.631 1.435 2.447 3.510
eExperiment 2 were barrows
1d
bIgM - immunoglobulin M
Overall Mean
Overall Mean
Control
1d
2e
1d
2e
Overall Mean
Overall Mean
Exp. 2 Mean
L. reuteri WB-76
L. reuteri WB-72
L. reuteri WB-37
Exp. 1 Mean
Exp. 1 Mean
Exp. 1 Mean
Table C67. Study 2 hourly LPSa challenge IgMb levels (mg/mL)
Overall Mean
aLPS - Escherichia coli  O111:B4 lipopolysaccharide
1d
2e
1d
2e
cDescription of treatments, experiments, and pigs - see Table C2
dExperiment 1 were gilts
Exp. 1 Mean
Exp. 1 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
Exp. 2 Mean
2e
L. reuteri DS-36
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Analyte Units Ranges Reference(s)a
Glucose mg/dL 81.72 - 150.00 1, 2, 3, 4, 6, 7
BUNb mg/dL 8.70 - 30.00 1, 2, 3, 4, 5, 7
Creatinine mg/dL 0.91 - 2.70 2, 4, 5
BUN:Creatinie ratio NAc
Sodium  mEq/L 133 - 165 1, 3, 7
Potassium mEq/L 4.8 - 7.2 1, 2, 3, 7
Chloride mEq/L 93 - 109 1, 2, 3, 6, 7
Carbon dioxide mEq/L 20.9 - 26.1 1
Anion gap 16.8 - 19.4 3
Calcium mg/dL 9.4 - 12.5 2, 3, 4, 5, 6, 8
Total protein g/dL 4.40 - 8.90 2, 3, 4, 5, 7
Albumin g/dL 2.2 - 7.6 2, 3, 4, 5, 7
Globulin g/dL 5.29 - 6.43 2
Albumin:Globulin ratio 0.6 - 1.4 2, 4
ASTd U/L 25.0 - 134.5 2, 3, 4, 5
ALTe U/L 18.0 - 46.6 2, 4, 5
ALKPhosf U/L 88 - 689 3, 4, 5, 7
Bili, total mg/dL 0.0363 - 1.000 2, 3, 4, 5, 7
Table D1. Adapted complete metabolic profile values for swine
fALKPhos - alkaline phosphatase
eALT -  alanine aminotransferase
dAST -  aspartate aminotransferase
cNA - Not Available
bBUN -  blood urea nitrogen
aNumbers refer to refernces listed on next page.
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Analyte Units Ranges Reference(s)a
Cholesterol mg/dL 51.69 - 145.00 1, 2, 3, 4, 5
Triglycerides mg/dL 27.11 - 28.49 5
HDLb mg/dL 8.83 - 12.17 5
VLDLc mg/dL 5.33 - 5.61 5
bHDL -  high-density lipoprotein
aNumbers refer to refernces listed on next page.
Table D2. Adapted lipid panel values for swine
cVLDL -  very low-density lipoprotein
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Iga Units Range Reference(s)b
IgAc mg/mL 0.369 - 0.609 1, 2
IgGd mg/mL 4.980 - 7.904 1, 2
IgMe mg/mL 1.735 - 4.440 1, 2
dIgG - Immunoglobulin G
cIgA - Immunoglobulin A
aIg - Immunoglobulin
bNumbers refer to refernces listed on next page.
eIgM - Immunoglobulin M
Table D3. Adapted immunoglobulins for swine
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